<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30319362</article-id>
<article-id pub-id-type="pmc">6170615</article-id>
<article-id pub-id-type="doi">10.3389/fncel.2018.00323</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Bidirectional Microglia–Neuron Communication in Health and Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Szepesi</surname>
<given-names>Zsuzsanna</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/569749/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Manouchehrian</surname>
<given-names>Oscar</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/570237/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bachiller</surname>
<given-names>Sara</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/302476/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deierborg</surname>
<given-names>Tomas</given-names>
</name>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/491744/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff><institution>Experimental Neuroinflammation Laboratory, Department of Experimental Medical Science, Lund University</institution>, <addr-line>Lund</addr-line>, <country>Sweden</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Alessandro Tozzi, University of Perugia, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Alfonso Grimaldi, Istituto Italiano di Tecnologia (IIT), Italy; Arianna Bellucci, Università degli Studi di Brescia, Italy</p>
</fn>
<corresp id="c001">*Correspondence: Tomas Deierborg, <email>tomas.deierborg@med.lu.se</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>12</volume>
<elocation-id>323</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>9</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Szepesi, Manouchehrian, Bachiller and Deierborg.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Szepesi, Manouchehrian, Bachiller and Deierborg</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Microglia are ramified cells that exhibit highly motile processes, which continuously survey the brain parenchyma and react to any insult to the CNS homeostasis. Although microglia have long been recognized as a crucial player in generating and maintaining inflammatory responses in the CNS, now it has become clear, that their function are much more diverse, particularly in the healthy brain. The innate immune response and phagocytosis represent only a little segment of microglia functional repertoire that also includes maintenance of biochemical homeostasis, neuronal circuit maturation during development and experience-dependent remodeling of neuronal circuits in the adult brain. Being equipped by numerous receptors and cell surface molecules microglia can perform bidirectional interactions with other cell types in the CNS. There is accumulating evidence showing that neurons inform microglia about their status and thus are capable of controlling microglial activation and motility while microglia also modulate neuronal activities. This review addresses the topic: how microglia communicate with other cell types in the brain, including fractalkine signaling, secreted soluble factors and extracellular vesicles. We summarize the current state of knowledge of physiological role and function of microglia during brain development and in the mature brain and further highlight microglial contribution to brain pathologies such as Alzheimer’s and Parkinson’s disease, brain ischemia, traumatic brain injury, brain tumor as well as neuropsychiatric diseases (depression, bipolar disorder, and schizophrenia).</p>
</abstract>
<kwd-group>
<kwd>fractalkine</kwd>
<kwd>extracellular vesicles</kwd>
<kwd>neuroinflammation</kwd>
<kwd>neurodegeneration</kwd>
<kwd>microglia</kwd>
<kwd>neuron</kwd>
<kwd>cytokines</kwd>
</kwd-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="427"></ref-count>
<page-count count="26"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Microglia – Guards of the CNS Homeostasis</title>
<p>Microglia are the resident immune cells of the central nervous system, which represent about 5–12% of total CNS cells in the healthy brain and the spinal cord. Microglia are derived from the myeloid precursors cells in the embryonic yolk sac and they travel to the area of the developing CNS during early embryogenesis (<xref ref-type="bibr" rid="B333">Schulz et al., 2012</xref>; <xref ref-type="bibr" rid="B130">Ginhoux et al., 2013</xref>; <xref ref-type="bibr" rid="B191">Kierdorf and Prinz, 2013</xref>; <xref ref-type="bibr" rid="B131">Ginhoux and Prinz, 2015</xref>; <xref ref-type="bibr" rid="B396">Wieghofer and Prinz, 2016</xref>; <xref ref-type="bibr" rid="B163">Hoeffel and Ginhoux, 2018</xref>). Microglial progenitors are already present around the neural tube at embryonic day 9 in mice, and from the fifth gestational week in humans. After neural entry, microglia progenitors migrate through the developing nerve tissue and undergo massive proliferation before they reach their final density (<xref ref-type="bibr" rid="B129">Ginhoux et al., 2010</xref>; <xref ref-type="bibr" rid="B384">Verney et al., 2010</xref>). Embryonic microglia develop into highly ramified mature microglia via regulatory factors such as Pu.1, IL-34, and CSF-1 (<xref ref-type="bibr" rid="B333">Schulz et al., 2012</xref>; <xref ref-type="bibr" rid="B190">Kierdorf et al., 2013</xref>). Microglia are broadly distributed throughout the CNS although quantity and location among species varies (<xref ref-type="bibr" rid="B214">Lawson et al., 1990</xref>; <xref ref-type="bibr" rid="B246">Mittelbronn et al., 2001</xref>). Despite their broad distribution, microglia represent a rather heterogeneous community with different subpopulation based on specific brain regions. Each microglia subpopulation develop unique features and they can be distinguished by capacities and functions (<xref ref-type="bibr" rid="B128">Gertig and Hanisch, 2014</xref>; <xref ref-type="bibr" rid="B260">Neiva et al., 2014</xref>; <xref ref-type="bibr" rid="B97">Doorn et al., 2015</xref>; <xref ref-type="bibr" rid="B135">Grabert et al., 2016</xref>; <xref ref-type="bibr" rid="B82">De Biase et al., 2017</xref>). Microglia are considered to be the resident macrophages in the CNS and are long-lived, self-renewing cells, autonomous from peripheral monocytes that normally do not enter the brain.</p>
<p>Phenotypically, ramified microglia have been described as ‘quiescent’ or remaining in a ‘resting’ state. However, these views radically changed after <italic>in vivo</italic> imaging studies have revealed the extraordinary active nature of microglia processes in the healthy brain (<xref ref-type="bibr" rid="B81">Davalos et al., 2005</xref>; <xref ref-type="bibr" rid="B267">Nimmerjahn et al., 2005</xref>). Microglia are constantly restless and their processes undergo continuous cycles of extension and withdrawal and <italic>de novo</italic> formation to scan their environment for disruptions in brain homeostasis thereby ‘resting’ microglia are able to acquire numerous phenotypes. Each microglia process seems to have a defined territory and they are able to scan their environment within several hours. Microglia process movement is systematically aimed at synapses to monitor and regulate neuronal activity, indicating the presence of specific signaling mechanisms that direct microglial processes to synapses (<xref ref-type="bibr" rid="B220">Li et al., 2012</xref>, <xref ref-type="bibr" rid="B218">2013</xref>; <xref ref-type="bibr" rid="B94">Dissing-Olesen et al., 2014</xref>). When microglia detect ‘danger’ signals that compromise CNS homeostasis- for instance through pathogen recognition receptors- they rapidly change their appearance by shortening of cellular processes, enlargement of their soma and they transform into a reactive phenotype. Reactive microglia can further evolve into phagocytic or amoeboid microglia that completely lack cellular processes (<xref ref-type="bibr" rid="B353">Streit, 2000</xref>; <xref ref-type="bibr" rid="B348">Stence et al., 2001</xref>; <xref ref-type="bibr" rid="B309">Ransohoff and Perry, 2009</xref>; <xref ref-type="bibr" rid="B136">Graeber and Streit, 2010</xref>; <xref ref-type="bibr" rid="B189">Kettenmann et al., 2011</xref>). In response to CNS injury or infections, microglia are able to upregulate expression of many cell surface receptors including toll-like receptors (TLRs), phagocytic receptors (CR3, CR4), scavenger receptors (CD36, CD91) and release various complement factors (<xref ref-type="bibr" rid="B362">Tian et al., 2012</xref>). However, microglia activation does not refer to a single phenotype, and a continuum of microglia activation is rather considered. They are able to acquiring numerous phenotypes upon activation ranging from a phagocytic to an antigen presenting phenotype that mainly depends on the type of stimuli provided in their environment (<xref ref-type="bibr" rid="B365">Town et al., 2005</xref>; <xref ref-type="bibr" rid="B334">Schwartz et al., 2006</xref>; <xref ref-type="bibr" rid="B39">Boche et al., 2013</xref>). Once activated, microglia can be potent immune effector cells and initiate both innate and adaptive immune responses and produce a number of cytokines, chemokines and growth factors (<xref ref-type="bibr" rid="B309">Ransohoff and Perry, 2009</xref>; <xref ref-type="bibr" rid="B224">Loane and Kumar, 2016</xref>; <xref ref-type="bibr" rid="B386">von Bernhardi et al., 2016</xref>). Microglia accept a wide variety of inputs and they are also able to provide an appropriate response to a multitude of reactions. Therefore, microglia activation is considered to be a flexible and adaptive process rather than being stereotypic and granted (<xref ref-type="bibr" rid="B334">Schwartz et al., 2006</xref>; <xref ref-type="bibr" rid="B148">Hanisch and Kettenmann, 2007</xref>; <xref ref-type="bibr" rid="B83">Deczkowska et al., 2018</xref>). Importantly, microglia are also capable of morphological remodeling without any indication of an insult or neurodegeneration. Chronic stress, enhanced glutamatergic neurotransmission or light deprivation can lead to hyper-ramification of microglia and more frequent neuron–microglia contacts (<xref ref-type="bibr" rid="B368">Tremblay et al., 2010</xref>; <xref ref-type="bibr" rid="B161">Hinwood et al., 2012</xref>; <xref ref-type="bibr" rid="B388">Walker et al., 2013</xref>; <xref ref-type="bibr" rid="B364">Torres-Platas et al., 2014</xref>; <xref ref-type="bibr" rid="B411">Yirmiya et al., 2015</xref>). These observations suggest that there is information transmission between microglia and neurons and microglia are continuously informed about the actual activity or state of neurons in their vicinity.</p>
</sec>
<sec>
<title>Reciprocal Neuron–Microglia Communication</title>
<p>Microglia are in close contact with neurons as well as oligodendrocytes and astrocytes. Astrocytes are the most abundant glial cells in the CNS and they show significant contribution to synapse formation, maintenance and elimination, thus regulating the overall architecture and activity of neuronal circuits. Astrocytes perform direct contacts with their neuronal pre- and postsynaptic counterparts and they also release soluble factors to modulate synaptic transmission of both excitatory and inhibitory synapses. This led to the concept of the ‘tripartite synapse,’ a synapse composed of two neurons and an astrocyte as an integrated functional unit (<xref ref-type="bibr" rid="B289">Perea et al., 2009</xref>; <xref ref-type="bibr" rid="B269">Nistico et al., 2017</xref>; <xref ref-type="bibr" rid="B107">Farhy-Tselnicker and Allen, 2018</xref>). The tripartite synapses are supplemented by microglia, which are specially attracted by synapse activity, location of crosstalk between neurons and glial cells. In the healthy brain, microglia exhibit an actively repressed ‘surveying’ phenotype that is dependent on a dynamic crosstalk between microglia and neurons (<xref ref-type="bibr" rid="B36">Biber et al., 2007</xref>; <xref ref-type="bibr" rid="B189">Kettenmann et al., 2011</xref>; <xref ref-type="bibr" rid="B192">Kierdorf and Prinz, 2017</xref>). It has been proposed that the removal of this neuronal derived inhibitory control represents a type of danger signal for microglia, indicating that neuronal function is impaired and leads to alterations of microglia morphology and function. The reciprocal neuron–microglia communication is mediated by numerous soluble factors, extracellular vesicles (EVs) as well as contact-dependent mechanisms, and is essential for adaptive neuroplasticity and learning (<xref ref-type="bibr" rid="B296">Posfai et al., 2018</xref>).</p>
</sec>
<sec>
<title>Classical Cell-To-Cell Communication</title>
<p>In the healthy brain microglia remain remarkably quiescent or ‘unactivated’ while undertaking surveillance roles. It is now recognized that this ‘unactivated’ state is under the control, at least in part, of neuronal factors, including CD200 and fractalkine (CX3CL1) as the most studied cell-to-cell proteins (<xref ref-type="bibr" rid="B105">Eyo and Wu, 2013</xref>) (<bold>Figures <xref ref-type="fig" rid="F1">1</xref></bold>, <bold><xref ref-type="fig" rid="F2">2</xref></bold>). CD200 is a glycoprotein widely found on the cell membranes of neurons, astrocytes and oligodendrocytes in the CNS (<xref ref-type="bibr" rid="B399">Wright et al., 2001</xref>; <xref ref-type="bibr" rid="B12">Barclay et al., 2002</xref>; <xref ref-type="bibr" rid="B200">Koning et al., 2009</xref>). The target receptor of CD200, CD200R, is only found on macrophages and microglia (<xref ref-type="bibr" rid="B160">Hernangomez et al., 2012</xref>). When neuronal CD200 interacts with microglial CD200R, the microglia will be kept in its inactivated, resting state (<xref ref-type="bibr" rid="B164">Hoek et al., 2000</xref>; <xref ref-type="bibr" rid="B36">Biber et al., 2007</xref>) thus CD200 signaling plays a critical role in neuronal protection. Defaults in CD200 signaling have been observed in several neuroinflammatory conditions like in multiple sclerosis (MS), Alzheimer’s disease, or in the aging brain (<xref ref-type="bibr" rid="B160">Hernangomez et al., 2012</xref>; <xref ref-type="bibr" rid="B381">Varnum et al., 2015</xref>; <xref ref-type="bibr" rid="B402">Xie et al., 2017</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Bidirectional signaling between microglia (green) and neuron (purple). Neuron–microglia communication is mediated by receptor–ligand interactions as well as by various soluble factors. Microglia are equipped with a group of surface receptors, which trigger signals and regulate specific microglia function like phagocytosis, motility and viability. Many of the receptor ligands, such as CX3CR1, CD200R, and CD172a are released or expressed on the surface of neurons. Receptor–ligand interactions represent a classical contact dependent communication between microglia and neurons. Microglia and neurons reciprocally release soluble factors that can modulate cell functions and promote tissue homeostasis.</p>
</caption>
<graphic xlink:href="fncel-12-00323-g001"></graphic>
</fig>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Fractalkine (CX3CR1–CX3CL1) signaling between microglia (green) and neuron (purple) in normal (green square) and pathologic (red square) states. CX3CL1 is either membrane-bound or cleaved by metalloproteinases to become soluble. Membrane bound CX3CL1 is an OFF-signal, that keeps microglia in a surveying state, and soluble CX3CL1 is believed to act as a chemoattractant, stimulating migration of inflammatory cells. Fractalkine signaling has many roles in both healthy and pathologic conditions. Black triangles indicate increase (<inline-graphic xlink:href="fncel-12-00323-i001.jpg"></inline-graphic>), decrease (<inline-graphic xlink:href="fncel-12-00323-i002.jpg"></inline-graphic>) or not specified (<inline-graphic xlink:href="fncel-12-00323-i003.jpg"></inline-graphic>).</p>
</caption>
<graphic xlink:href="fncel-12-00323-g002"></graphic>
</fig>
<p>The lack of CD200 in an experimental animal model for MS (EAE) revealed an accelerated progression of the MS symptoms, indicating that microglia attain a dysregulated activation in absence of CD200-signaling (<xref ref-type="bibr" rid="B164">Hoek et al., 2000</xref>).</p>
<p>Fractalkine, also known as CX3CL1, is a unique chemokine that is constitutively expressed in neurons (mainly in the prosencephalon) (<xref ref-type="bibr" rid="B359">Tarozzo et al., 2003</xref>). The fractalkine receptor, CX3CR1, is predominantly found on microglia and on neurons in less amount in the normal CNS (<xref ref-type="bibr" rid="B150">Harrison et al., 1998</xref>; <xref ref-type="bibr" rid="B244">Meucci et al., 2000</xref>; <xref ref-type="bibr" rid="B151">Hatori et al., 2002</xref>; <xref ref-type="bibr" rid="B282">Paolicelli et al., 2014</xref>) and CX3CL1–CX3CR1 signaling has been considered a neuronal ‘off signal’ that keeps microglia in a surveying phenotype (<xref ref-type="bibr" rid="B268">Nishiyori et al., 1998</xref>; <xref ref-type="bibr" rid="B231">Maciejewski-Lenoir et al., 1999</xref>; <xref ref-type="bibr" rid="B36">Biber et al., 2007</xref>). It should be noted that under chronic inflammatory conditions, glial cells also express CX3CL1 (<xref ref-type="bibr" rid="B171">Hughes et al., 2002</xref>).</p>
<p>CX3CL1 is found both as membrane-bound, to neuronal membranes, and cleaved (soluble) into the extracellular space (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). The cleavage of CX3CL1 in its heavily glycosylated chemokine domain is performed by metalloproteinases (MMPs) (<xref ref-type="bibr" rid="B126">Garton et al., 2001</xref>). CX3CL1 bound to the membrane is believed to be important for adhesion, while the soluble CX3CL1 acts a chemo-attractant, recruiting inflammatory cells (<xref ref-type="bibr" rid="B19">Bazan et al., 1997</xref>; <xref ref-type="bibr" rid="B328">Schall, 1997</xref>; <xref ref-type="bibr" rid="B247">Mizoue et al., 2001</xref>). The G-protein-linked receptor CX3CR1 triggers several intracellular secondary messengers, such as P13K, AKT, and NF-κB, and thus regulates apoptotic, proliferative, transcriptional and migratory functions in microglia (<xref ref-type="bibr" rid="B5">Al-Aoukaty et al., 1998</xref>; <xref ref-type="bibr" rid="B57">Chandrasekar et al., 2003</xref>). The fractalkine receptor is expressed by other cell types than microglia, such as monocytes, dendritic cells and natural killer cells, but because these cells don’t frequently cross the brain–blood barrier (BBB) in healthy brains, microglia are believed to be the main recipient of CX3CL1-signaling in the normal CNS (<xref ref-type="bibr" rid="B172">Imai et al., 1997</xref>; <xref ref-type="bibr" rid="B150">Harrison et al., 1998</xref>; <xref ref-type="bibr" rid="B371">Truman et al., 2008</xref>; <xref ref-type="bibr" rid="B248">Mizutani et al., 2012</xref>; <xref ref-type="bibr" rid="B398">Wolf et al., 2013</xref>).</p>
<p>Expression of fractalkine increases in the CNS during embryonic and postnatal maturation and promotes microglial recruitment to neuronal circuits that need rewiring during a period of activity-dependent remodeling. In return, microglia modulate neuronal function and survival via the release of trophic factors (<xref ref-type="bibr" rid="B374">Ueno et al., 2013</xref>). In the absence of fractalkine signaling, microglial colonization is impaired in the somatosensory, motor cortex and the hippocampus during the early postnatal development (<xref ref-type="bibr" rid="B284">Paolicelli and Gross, 2011</xref>; <xref ref-type="bibr" rid="B167">Hoshiko et al., 2012</xref>) (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>).</p>
<p>Replacing the CX3XR1-gene with GFP, in the CX3CR1-GFP knock-in mouse line (<xref ref-type="bibr" rid="B183">Jung et al., 2000</xref>), has been proved to be a very useful tool to study microglial function and fractalkine signaling in the healthy brain. Experimental paradigms comparing CX3CR1-GFP homozygous mice (CX3CR1<sup>-/-</sup>) that entirely lack CX3CR1, and therefore of fractalkine signaling in the brain, with heterozygotes (CX3CR1<sup>-/+</sup>) proved to be extremely useful strategy to disclose the molecular players in neuron–microglia communication in a non-invasive way related to fractalkine signaling.</p>
<p>Besides fractalkine, numerous other chemokines are produced and released by neurons and glial cells (by both astrocytes and microglia) in the CNS. CCL2/MCP-1 is expressed in the neurons principally during pathological conditions as most studies have shown, although some observations support the notion of a constitutive neuronal CCL2 expression (<xref ref-type="bibr" rid="B76">Coughlan et al., 2000</xref>; <xref ref-type="bibr" rid="B11">Banisadr et al., 2005</xref>; <xref ref-type="bibr" rid="B71">Conductier et al., 2010</xref>). The receptor for CCL2 is found in microglia and its activation trigger chemotaxis of cultured microglia. An induction of neuronal CCL2 expression was described in response to various types of injury and degeneration such as ischemia, Alzheimer’s disease, MS, axonal injury, amyotrophic lateral sclerosis (ALS) or peripheral nerve injury (<xref ref-type="bibr" rid="B14">Barna et al., 1994</xref>; <xref ref-type="bibr" rid="B59">Che et al., 2001</xref>; <xref ref-type="bibr" rid="B280">Pang et al., 2001</xref>; <xref ref-type="bibr" rid="B307">Rancan et al., 2001</xref>; <xref ref-type="bibr" rid="B332">Schreiber et al., 2001</xref>; <xref ref-type="bibr" rid="B15">Baron et al., 2005</xref>; <xref ref-type="bibr" rid="B41">Bose and Cho, 2013</xref>; <xref ref-type="bibr" rid="B291">Perner et al., 2018</xref>). The chemokine CCL2 is also produced by glial cells (<xref ref-type="bibr" rid="B14">Barna et al., 1994</xref>; <xref ref-type="bibr" rid="B147">Hanisch, 2002</xref>; <xref ref-type="bibr" rid="B155">He et al., 2016</xref>) as perivascular astrocytes have been identified as the most common and predominant source of CCL2 in the CNS in various neuroinflammatory conditions (<xref ref-type="bibr" rid="B8">Andjelkovic et al., 2002</xref>; <xref ref-type="bibr" rid="B141">Guillemin et al., 2003</xref>). Another chemokine, CXCL12/SDF-1 (stromal cell-derived factor 1) and its receptor CXCR4 have been reported to be produced and expressed predominately by astrocytes and neurons. Astrocytic activation of CXCR4 can lead to the release of pro-inflammatory cytokines and prostaglandins, and it is able to trigger glutamate exocytosis from astrocytes thereby modulate neuronal activity. A unique chemokine, CCL21, is exclusively expressed on endangered neurons after injury and activate microglia through chemokine receptor CXCR3 (<xref ref-type="bibr" rid="B37">Biber et al., 2001</xref>; <xref ref-type="bibr" rid="B92">Dijkstra et al., 2004</xref>; <xref ref-type="bibr" rid="B380">van Weering et al., 2010</xref>).</p>
<p>Overall, chemokines are able to control neuron–microglia interactions through diverse intracellular signaling upon chemokine receptor activation and contribute to a variety of cellular functions such as modulation of neurotransmission, regulating cell survival and BBB permeability, exert neuroprotection, migration of neuronal progenitors, stem cells and axonal sprouting (<xref ref-type="bibr" rid="B232">Mackay, 2001</xref>; <xref ref-type="bibr" rid="B243">Mellado et al., 2001</xref>; <xref ref-type="bibr" rid="B312">Reaux-Le Goazigo et al., 2013</xref>; <xref ref-type="bibr" rid="B427">Zheng et al., 2017</xref>).</p>
<p>Furthermore, many other inhibitory receptors/molecules can be found on microglial surfaces that interact with ligands from neurons (both secreted and membrane-bound). An example is the integrin CD47, which communicates a “don’t eat me”-signal to microglial CD172a (<xref ref-type="bibr" rid="B378">van Beek et al., 2005</xref>; <xref ref-type="bibr" rid="B36">Biber et al., 2007</xref>) (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>) by recruiting tyrosine-protein phosphatases SHP-1 and SHP-2, down-regulating phagocytosis as well as by increasing the synthesis of TGF-β (reviewed in <xref ref-type="bibr" rid="B139">Griffiths et al., 2007</xref>).</p>
</sec>
<sec>
<title>Fractalkine Signaling Regulates Synapse Development and Synaptic Plasticity</title>
<p>During the first week of postnatal life vast amounts of synapses are generated during an intensive period of synaptogenesis and this is also when microglia density reaches its maximum (<xref ref-type="bibr" rid="B79">Dalmau et al., 2003</xref>). Neuronal networks are refined by synaptic pruning, a selective and activity-driven process that eliminates redundant, developing synapses. Microglia make contacts with presynaptic axon terminals and postsynaptic dendritic spines that can be followed by a complement-dependent phagocytosis and elimination (<xref ref-type="bibr" rid="B387">Wakselman et al., 2008</xref>; <xref ref-type="bibr" rid="B369">Tremblay and Majewska, 2011</xref>; <xref ref-type="bibr" rid="B78">Cunningham et al., 2013</xref>; <xref ref-type="bibr" rid="B184">Jung and Chung, 2018</xref>).</p>
<p>Fractalkine signaling has been implicated in microglial pruning of dendritic spines during normal brain development (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). <xref ref-type="bibr" rid="B284">Paolicelli and Gross (2011)</xref> and <xref ref-type="bibr" rid="B283">Paolicelli et al. (2011)</xref> showed that a decreased microglial density in the hippocampus of CX3CR<sup>-</sup>/<sup>-</sup> mice was associated with a temporary boost in dendritic spine numbers on pyramidal neurons and an excess of immature synapses compared with CX3CR<sup>-</sup>/<sup>+</sup> littermates. It is suggested that microglia lacking the CX3CR1 receptor fail to recognize synapses displaying fractalkine. Comparing homozygous CX3CL1<sup>-/-</sup> and heterozygous CX3CL1<sup>-/+</sup> mice, microglial fractalkine signaling was shown to play a crucial role in the maturation of excitatory glutamatergic synapses and remodeling of neuronal circuits during postnatal development (<xref ref-type="bibr" rid="B29">Bertollini et al., 2006</xref>; <xref ref-type="bibr" rid="B302">Ragozzino et al., 2006</xref>; <xref ref-type="bibr" rid="B167">Hoshiko et al., 2012</xref>; <xref ref-type="bibr" rid="B421">Zhan et al., 2014</xref>) (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>); although, the role of neuron–microglial crosstalk in this context is still not fully understood. In the developing barrel field of the somatosensory cortex, fractalkine (CX3CL1/CX3CR1) signaling has been also shown to regulate microglial recruitment to the location where developing thalamocortical synapses are concentrated (i.e., barrel centers). <xref ref-type="bibr" rid="B167">Hoshiko et al. (2012)</xref> showed that microglia entry into the barrel centers is temporally delayed in CX3CR1<sup>-/-</sup> mice compared with WTs at the developmental stage, when fractalkine is overexpressed within the barrels. CX3CR1 deficiency also delays the functional maturation of glutamate receptors and results in a significantly lower proportion of postsynaptic AMPARs in CX3CR1<sup>-/-</sup> than in CX3CR1<sup>-/+</sup> mice. Moreover, the developmental switch from GluN2B to GluN2A-containing NMDA receptors, which are known to occur during the early weeks of postnatal development of thalamocortical area, was delayed in CX3CR1<sup>-/-</sup> mice but this delay was only transient. These observations support to the notion that microglia influence synaptic maturation during development and fractalkine signaling deficiency induced a transient impairment in the maturation of glutamate receptor functional expression at thalamocortical synapses. However, the exact mechanism by which microglial cells influence synapse maturation is complex and it is not fully understood. Microglia release several signaling molecules known to modulate the functional expression of glutamate receptors. For instance, glia-derived TNF-α facilitates AMPA receptors trafficking and membrane insertion (<xref ref-type="bibr" rid="B20">Beattie et al., 2002</xref>; <xref ref-type="bibr" rid="B346">Stellwagen et al., 2005</xref>). Also, TNF-α specifically controls the glutamate release step of gliotransmission in the hippocampal dentate gyrus (<xref ref-type="bibr" rid="B321">Santello et al., 2011</xref>). Similarly, brain-derived neurotrophic factor (BDNF) released by microglia has been demonstrated to modulate spine density and the expression of AMPA and NMDA receptors in cortical neurons of adult mice (<xref ref-type="bibr" rid="B285">Parkhurst et al., 2013</xref>). <xref ref-type="bibr" rid="B286">Pascual et al. (2012)</xref> have showed <italic>in vitro</italic> that microglia are able to regulate synaptic neurotransmission by releasing ATP, which binds to P2Y1R located on astrocytes and enhances excitatory postsynaptic current. Also, microglia regulate synaptic functions and neuronal development of cultured neurons through the interactions of the microglia-released interleukin 10 (IL-10) with IL-10 receptors (IL-10R) expressed by neurons (<xref ref-type="bibr" rid="B221">Lim et al., 2013</xref>). Thereby, fractalkine-dependent recruitment of microglia within the barrel centers might induce the release of microglia-derived signaling factors necessary for alterations of the functional expression of glutamate receptors at thalamocortical synapses.</p>
<p>Moreover, a lack of CX3CL1-signaling, and therefore a weakened crosstalk between neurons and microglia, affects transmission efficiency in synapses of the adult brain. It was observed that CX3CR1<sup>-/-</sup> had fewer multi-synaptic boutons in the hippocampus CA1 region compared to wild-type littermates indicating a lasting impairment of synaptic connectivity (<xref ref-type="bibr" rid="B421">Zhan et al., 2014</xref>). Changes in long-term potentiation (LTP) have been found in CX3CR1<sup>-/-</sup> mice, and were accompanied with deficits in behavior related to learning and memory (<xref ref-type="bibr" rid="B315">Rogers et al., 2011</xref>). The Rotarod test revealed that motor control in particular was negatively affected in these mice, compared to control animals. However, the CX3CR1<sup>-/-</sup> mice also appear to have deficits in associative learning, measured by fear-conditioning tests, and in hippocampal-dependent memory formation – as revealed with Morris water maze. These findings indicate that fractalkine signaling plays a significant role in learning and memory, and the effects appear to be dependent on the activity of interleukin 1β (IL-1β). The expression of IL-1β was increased in both heterozygous and homozygous CX3CR1 knockouts, and the hippocampal infusion of the IL-1β antagonist, IL-1ra, reversed the behavioral deficits in the CX3CR1<sup>-/-</sup> mice, indicating that IL-1β, released from microglia, could mediate these effects (<xref ref-type="bibr" rid="B315">Rogers et al., 2011</xref>). The dose-dependent inhibitory effects of IL-1β on LTP in the hippocampus are supported by other studies and this inhibition is consistent with the high distribution of IL-1R1 on hippocampal neurons (<xref ref-type="bibr" rid="B229">Lynch, 2015</xref>). The inhibitory effects of IL-1β in hippocampus have been linked with stimulation of the stress-activated kinases, p38 and JNK (<xref ref-type="bibr" rid="B271">O’Donnell et al., 2000</xref>; <xref ref-type="bibr" rid="B383">Vereker et al., 2000</xref>). Interestingly, the anti-inflammatory IL-10, which could be also released by microglia, has been demonstrated to antagonize certain actions of IL-1β. IL-10 is able to abrogate the IL-1β -induced inhibition of glutamate release and LTP and its stimulatory effect on JNK signaling (<xref ref-type="bibr" rid="B187">Kelly et al., 2001</xref>).</p>
<p>Although fractalkine signaling has a significant role in synapse pruning, it is not the only signaling pathway involved in this complex process. Microglial complement 3 receptor (C3R) has been also determined participating in developmental synaptic pruning. In the healthy developing brain, C1q, the protein that initiates the classical complement pathway of the complement system, promotes activation of C3, which opsonizes subsets of synapses for elimination and promote microglial engulfment and phagocytosis of synaptic elements. This process is significantly downregulated in the mature brain (<xref ref-type="bibr" rid="B351">Stevens et al., 2007</xref>; <xref ref-type="bibr" rid="B327">Schafer et al., 2012</xref>; <xref ref-type="bibr" rid="B32">Bialas and Stevens, 2013</xref>). However, in an early phase of AD this normal developmental synaptic pruning pathway can be locally reactivated and it mediates synapse loss. <xref ref-type="bibr" rid="B165">Hong et al. (2016)</xref> demonstrated that in an AD-like mouse strain, C1q was increased and co-localized with synapses even before visible plaque deposition, and blocking C1q, C3 or the microglial receptor CR3, decreased microglial phagocytosis and early synapse loss. The possible relationships between fractalkine signaling and the classical complement pathway could further complicate the topic of developmental and pathological synaptic pruning and it demands more research. Microglia-synapse interactions and synapse removal has also been discovered in many brain pathologies. Synaptic dysfunction and loss, as well as microglial activation, are early events in neurodegenerative diseases such as AD and Huntington’s disease (<xref ref-type="bibr" rid="B292">Perry and O’Connor, 2010</xref>). Despite the extensive research of the topic, the question is remaining: are microglia initiating synapse defects and loss in neurodegenerative diseases or is their activation just a secondary phenomenon during pathogenesis?</p>
<p>Apart from the fractalkine and complement signaling, a role for microglial DAP12 (DNAX-activation protein 12) has also been reported in the development of functional neuronal synapses. Intriguingly, in genetically deficient DAP12 mice, developmental apoptosis of neurons was decreased (<xref ref-type="bibr" rid="B387">Wakselman et al., 2008</xref>) but synaptic plasticity was enhanced (<xref ref-type="bibr" rid="B317">Roumier et al., 2004</xref>). Interestingly, DAP12 function has also been linked to TREM2 (triggering receptor expressed in myeloid cells 2) both are expressed on microglia in the brain and form a receptor-adaptor complex. TREM2/DAP12 signaling is known to regulate microglial phagocytosis and connected to numerous other intracellular signaling pathways implicated in regulation of synaptic plasticity (<xref ref-type="bibr" rid="B193">Kiialainen et al., 2005</xref>; <xref ref-type="bibr" rid="B168">Hsieh et al., 2009</xref>) (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>).</p>
<p>Overall, the proper microglia functions and their interactions with synaptic elements are considered to be instrumental for appropriate neuronal development and also support the homeostasis of neuronal networks in adults.</p>
</sec>
<sec>
<title>Soluble Factors Mediating Neuron–Microglia Communication</title>
<p>Neurons are able to release further immune-related soluble factors that bind to cognate receptors on microglia and promote specific microglia phenotype (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). These comprise neurotrophins, neuropeptides, neurotransmitters, anti-inflammatory cytokines and chemokines (<xref ref-type="bibr" rid="B36">Biber et al., 2007</xref>; <xref ref-type="bibr" rid="B188">Kerschensteiner et al., 2009</xref>).</p>
<p>For instance, the multifunctional cytokine, transforming growth factor beta (TGF-β), which is expressed by both neurons and glial cells, has been recognized as a vital regulator for microglia differentiation that promotes a unique transcription profile and surface structure of adult microglia (<xref ref-type="bibr" rid="B50">Butovsky et al., 2014</xref>). Also, TGF-β is a potent regulator of cytotoxicity and neuroinflammation in the nervous system (<xref ref-type="bibr" rid="B180">John et al., 2003</xref>; <xref ref-type="bibr" rid="B324">Saud et al., 2005</xref>). Its importance is to down-regulate microglial responses as showed by increased microglial activity and neuronal loss in the brains of TGF-β-deficient mice (<xref ref-type="bibr" rid="B45">Brionne et al., 2003</xref>). Smad pathway has been considered as one of the main signal transduction pathway activated by TGF-β receptors, which is responsible for the regulatory and neuroprotective effects of TGF-β. TGF-β-Smad signaling is involved in the induction of the quiescent phenotype of microglia within the CNS (<xref ref-type="bibr" rid="B3">Abutbul et al., 2012</xref>). Binding of TGF-β and its receptor induces ligand dependent assembly of a heteromeric receptor complex, receptor-kinase activation and subsequent phosphorylation and activation of SMAD proteins. SMADs are transcriptional regulators that accumulate in the nucleus and directly regulate gene transcription to evoke cell-type-specific and context-dependent transcriptional programs (<xref ref-type="bibr" rid="B330">Schmierer and Hill, 2007</xref>). Besides Smad proteins, there are additional signaling pathways activated by TGF-β, including ERK, p38 and PI3K those can mediate synergistic or antagonistic effects thereby, the responses of activated microglia are the end result of interactions of different signaling pathways (<xref ref-type="bibr" rid="B89">Derynck and Zhang, 2003</xref>; <xref ref-type="bibr" rid="B215">Lee et al., 2007</xref>).</p>
<p>Furthermore, CD45, a leukocyte common antigen, is constitutively expressed at moderate levels on microglia. Its activation leads to inhibition of microglia activity via negative regulation of the Src/p44/42 MAPK cascade (<xref ref-type="bibr" rid="B358">Tan et al., 2000</xref>). The endogenous ligand of CD45 is CD22 has been found at neuronal membranes and neurons secrete CD22 following neuronal injury in order to inhibit microglial proinflammatory cytokine production (<xref ref-type="bibr" rid="B255">Mott et al., 2004</xref>).</p>
<p>Electrically active neurons can suppress the interferon-gamma (IFNγ)-induced increase in the expression of pro-inflammatory MHC class II molecules on microglia in the intact CNS (<xref ref-type="bibr" rid="B382">Vass and Lassmann, 1990</xref>) and in cultured hippocampal slices (<xref ref-type="bibr" rid="B262">Neumann et al., 1996</xref>). The neurotransmitter glutamate, which is released during synaptic activity, is involved in the regulation of microglial cells via glutamate receptors, including metabotropic receptors (<xref ref-type="bibr" rid="B109">Fazio et al., 2018</xref>). Glutamate does not necessarily act directly on microglial cells. Instead neuronal released trophic factors such as neurotrophin-3 (NT-3), BDNF and nerve growth factor (NGF) were identified as activity-dependent regulators of microglial MHC class II expression and induction of pro-inflammatory molecules. Neuron-derived glutamate stimulates BDNF and NGF production or release while the regulation of NT3 production by synaptic activity appears to be indirect. Neurotrophins bind to two different classes of receptors: the tyrosine kinase receptors (trkA, trkB, or trkC) or the p75 neurotrophin receptor (also known as the low-affinity NGF receptor). <xref ref-type="bibr" rid="B263">Neumann et al. (1998)</xref> and <xref ref-type="bibr" rid="B261">Neumann (2001)</xref> have showed that NGF and, to a lower extent, NT3 but not BDNF acted directly on isolated microglia through the p75 neurotrophin receptor as MHC class II inducibility could be enhanced by neutralizing locally released neurotrophins (NGF, BDNF, and NT3) or blocking the p75 neurotrophin receptor. Thus, neurotrophins secreted by electrically active neurons are able to control the antigen-presenting potential of microglia, which is mediated partly via the p75 neurotrophin receptor.</p>
<p>Several neurotransmitters have modulatory effects on microglial activity and proliferation that are related to local neurochemical environment and could differ across various brain regions (<xref ref-type="bibr" rid="B239">McCluskey and Lampson, 2001</xref>). As mentioned, glutamate can exert an inhibitory regulation of microglial cells via metabotropic glutamate receptors (mGluRs; <xref ref-type="bibr" rid="B109">Fazio et al., 2018</xref>). Microglia also express GABA-B receptors which activation strongly decreases the LPS-induced secretion of certain but not all inflammatory cytokines (<xref ref-type="bibr" rid="B207">Kuhn et al., 2004</xref>). Glycine, which is the other inhibitory neurotransmitter, also attenuates the production of inflammatory cytokines and the phagocytic activity of brain macrophages (<xref ref-type="bibr" rid="B419">Zeilhofer, 2008</xref>). Similarly, noradrenalin reduces the LPS-stimulated release of NO, IL-6, and TNF-α. Dopamine has also been reported to modulate the activation, proliferation, and cytokine release in immune cells (<xref ref-type="bibr" rid="B323">Sarkar et al., 2010</xref>). Both D1 and D2 dopamine receptors mediate anti-inflammatory effects and inhibit neuroinflammation and attenuate brain injury after intracerebral hemorrhage in mice (<xref ref-type="bibr" rid="B426">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="B392">Wang et al., 2018</xref>).</p>
<p>In response to any disturbance of their microenvironment, microglia are able to respond rapidly and these responses are mediated, in part, by neuron-released nucleotides such as ATP and UDP (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). The role of the nucleotides for microglial activation and proliferation has been established, particularly during the early phase of brain injury (<xref ref-type="bibr" rid="B154">Haynes et al., 2006</xref>; <xref ref-type="bibr" rid="B272">Ohsawa et al., 2012</xref>; <xref ref-type="bibr" rid="B375">Ulmann et al., 2013</xref>). The chemotactic properties of ATP are mediated by microglial P2Y12 purinergic receptors and the absence of P2Y12 leads to impaired microglia process motility during injury. <xref ref-type="bibr" rid="B81">Davalos et al. (2005)</xref> confirmed the relevance of ATP-induced microglial chemotaxis <italic>in vivo</italic> in the mouse cortex. The authors showed that laser-induced injury to brain tissue resulted in robust microglial branch extension toward the site of injury and the process of the chemotaxis was abolished by an ATP/ADP degrading enzyme (<xref ref-type="bibr" rid="B81">Davalos et al., 2005</xref>). ATP-induced microglial chemotaxis was then confirmed in acute mouse brain slices in the mouse spinal cord (<xref ref-type="bibr" rid="B61">Chen et al., 2010</xref>; <xref ref-type="bibr" rid="B90">Dibaj et al., 2010</xref>) and retina (<xref ref-type="bibr" rid="B119">Fontainhas et al., 2011</xref>) as well as in other animal models. Another purinergic receptor, P2Y6, is also expressed by microglia and UDP signaling through P2Y6 receptors triggered microglial phagocytosis following hippocampal excitotoxicity (<xref ref-type="bibr" rid="B198">Koizumi et al., 2007</xref>). Extensive and prolonged neuronal release of glutamate directly leads to neuronal death but also serves as activation signal for microglia through a variety of microglial glutamate receptors like AMPA, kainate, and mGluRs (<xref ref-type="bibr" rid="B35">Biber et al., 1999</xref>; <xref ref-type="bibr" rid="B145">Hagino et al., 2004</xref>). It has been demonstrated that the activation of microglia mGluR2 triggers TNF-α-induced neurotoxicity through activation of TNF receptor-1 and facilitating the activation of caspase-3. Microglia also released FasL, which further potentiated TNF-α neurotoxicity after mGlu2 stimulation (<xref ref-type="bibr" rid="B360">Taylor et al., 2005</xref>).</p>
<p>In return, microglia influence and modulate neuronal function by the release of soluble factors, including cytokines, prostaglandins and neurotrophic factors, which bind to neuronal receptors. IL-1β, prostaglandins (PGE<sub>2</sub>), BDNF and tumor necrosis factor-alpha (TNF-α) are often released by microglia in response to variations in neuron-derived signals.</p>
<p>Brain-derived neurotrophic factor plays and important role in neuronal survival and differentiation and as a neuromodulator, directly involved in the control of neuronal activity and synaptic plasticity (<xref ref-type="bibr" rid="B322">Santos et al., 2010</xref>) (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). The neuromodulatory effect of BDNF has been recognized both on glutamatergic and GABAergic synapses in the CNS (<xref ref-type="bibr" rid="B134">Gottmann et al., 2009</xref>). Apart from neuron and astroglia, microglia also release BDNF as it was first shown in microglia cultures (<xref ref-type="bibr" rid="B102">Elkabes et al., 1996</xref>) and then confirmed in different regions of the CNS during the course of various neurological disorders such as traumatic injury, Parkinson’s disease, MS, and neuropathic pain (<xref ref-type="bibr" rid="B18">Batchelor et al., 1999</xref>; <xref ref-type="bibr" rid="B197">Knott et al., 2002</xref>; <xref ref-type="bibr" rid="B345">Stadelmann et al., 2002</xref>; <xref ref-type="bibr" rid="B366">Trang et al., 2011</xref>; <xref ref-type="bibr" rid="B341">Song et al., 2016</xref>). The synthesis and release of BDNF in microglia appear to be tightly associated with the activation of ATP sensitive purinergic receptors, such as P2X4R. The activation of P2X4R leads a significant intracellular Ca<sup>2+</sup> flow and the downstream activation of signaling pathways like p38 MAP kinase, which controls the synthesis and release of BDNF (<xref ref-type="bibr" rid="B367">Trang et al., 2009</xref>). Then, microglia-derived BDNF rapidly downregulates K<sup>+</sup>-Cl<sup>-</sup> co-transporter KCC2 expression in neuronal membranes through tyrosine kinase B receptor (TrkB) which, disrupting Cl<sup>-</sup> homeostasis and the strength of GABA<sub>A</sub><sup>-</sup> and glycine receptor-mediated inhibition thereby leads to an altered neuronal network activity (<xref ref-type="bibr" rid="B113">Ferrini and De Koninck, 2013</xref>). Although the low levels of microglia-derived cytokines are demonstrated to support homeostatic neuroplasticity, these signaling pathways could be further augmented during inflammatory conditions and mediate neurotoxicity (<xref ref-type="bibr" rid="B346">Stellwagen et al., 2005</xref>; <xref ref-type="bibr" rid="B285">Parkhurst et al., 2013</xref>; <xref ref-type="bibr" rid="B299">Pribiag and Stellwagen, 2014</xref>; <xref ref-type="bibr" rid="B347">Stellwagen and Lewitus, 2014</xref>).</p>
</sec>
<sec>
<title>Microglial Communication by Extracellular Vesicles</title>
<p>Extracellular vesicles are recently discovered way of communication between cells in the CNS that are providing new insights into the brain physiology and pathophysiology of several diseases (<xref ref-type="bibr" rid="B16">Basso and Bonetto, 2016</xref>; <xref ref-type="bibr" rid="B318">Rufino-Ramos et al., 2017</xref>; <xref ref-type="bibr" rid="B281">Paolicelli et al., 2018</xref>; <xref ref-type="bibr" rid="B370">Trotta et al., 2018</xref>). Indeed, we found recently that inflammatory stimuli to microglia leads to distinct populations of released EVs, both in terms of size and protein content (<xref ref-type="bibr" rid="B405">Yang et al., 2018a</xref>).</p>
<p>In one of the earliest study on EVs in the CNS, membrane exovesicles were identified as vehicles for spreading morphogens through epithelia during <italic>Drosophila melanogaster</italic> development (<xref ref-type="bibr" rid="B138">Greco et al., 2001</xref>). Since then the influence of EVs in tissue development has also been observed in the developing mouse brain and undifferentiated neuronal culture (<xref ref-type="bibr" rid="B237">Marzesco et al., 2005</xref>; <xref ref-type="bibr" rid="B108">Faure et al., 2006</xref>; <xref ref-type="bibr" rid="B236">Marzesco, 2013</xref>).</p>
<p>The family of EVs contains different types of vesicles that are distinguishable by their size, biological origin and function. The EV family comprises exosomes (40–120 nm) that are released from multivesicular endosomes, microvesicles (100–1,000 nm) that are budding from the plasma membrane and apoptotic bodies (800–5,000 nm) that are released by cells during apoptosis (<xref ref-type="bibr" rid="B67">Cocucci et al., 2009</xref>; <xref ref-type="bibr" rid="B143">Gyorgy et al., 2011</xref>; <xref ref-type="bibr" rid="B68">Colombo et al., 2014</xref>; <xref ref-type="bibr" rid="B66">Cocucci and Meldolesi, 2015</xref>; <xref ref-type="bibr" rid="B98">Dozio and Sanchez, 2017</xref>).</p>
<p>All brain cells, including neurons (<xref ref-type="bibr" rid="B108">Faure et al., 2006</xref>; <xref ref-type="bibr" rid="B209">Lachenal et al., 2011</xref>) astrocytes (<xref ref-type="bibr" rid="B91">Dickens et al., 2017</xref>) microglia (<xref ref-type="bibr" rid="B166">Hooper et al., 2012</xref>; <xref ref-type="bibr" rid="B297">Prada et al., 2013</xref>; <xref ref-type="bibr" rid="B132">Glebov et al., 2015</xref>) and oligodendrocytes (<xref ref-type="bibr" rid="B202">Kramer-Albers et al., 2007</xref>; <xref ref-type="bibr" rid="B116">Fitzner et al., 2011</xref>; <xref ref-type="bibr" rid="B121">Fruhbeis et al., 2013</xref>) secrete EVs. EVs contain different bioactive compounds including cell surface receptors, mitochondrial and cytosolic proteins, metabolic enzymes and genetic materials such as microRNAs and mRNAs (<xref ref-type="bibr" rid="B2">Abels and Breakefield, 2016</xref>; <xref ref-type="bibr" rid="B98">Dozio and Sanchez, 2017</xref>; <xref ref-type="bibr" rid="B298">Prada et al., 2018</xref>). Additionally, EVs could carry pathological markers, such as α-synuclein, tau, amyloid beta (Aβ) (<xref ref-type="bibr" rid="B304">Rajendran et al., 2006</xref>; <xref ref-type="bibr" rid="B266">Ngolab et al., 2017</xref>; <xref ref-type="bibr" rid="B377">Valdinocci et al., 2017</xref>) and pathogenic prion proteins (<xref ref-type="bibr" rid="B331">Schneider and Simons, 2013</xref>; <xref ref-type="bibr" rid="B385">Vilette et al., 2018</xref>) as well as huntingtin (<xref ref-type="bibr" rid="B424">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="B86">Deng et al., 2017</xref>) that implicate exchange of EVs in pathological conditions. EVs are able to influence the behavior of recipient cells in multiple ways: they may transfer receptors and/or bioactive lipids between cells; they can modulate functional target cells by delivering intracellular proteins or transferring mRNA; and may act as signaling complexes through the stimulation of target cells (<xref ref-type="bibr" rid="B16">Basso and Bonetto, 2016</xref>). In the CNS, there is an extensive cross talk between neurons and microglia and alongside the actual cell-to-cell contact and the cellular release of soluble factors, microglia and neurons can communicate by bidirectional release of EVs, which permits an exchange of a wide range of biomolecules across long distances (<xref ref-type="bibr" rid="B127">Garzetti et al., 2014</xref>; <xref ref-type="bibr" rid="B210">Lai et al., 2014</xref>; <xref ref-type="bibr" rid="B303">Rajendran et al., 2014</xref>; <xref ref-type="bibr" rid="B416">Zaborowski et al., 2015</xref>; <xref ref-type="bibr" rid="B49">Budnik et al., 2016</xref>; <xref ref-type="bibr" rid="B203">Kramer-Albers and Hill, 2016</xref>).</p>
<p>Microvesicles released by microglia are known to differ in shape and size (100 nm – 1 mm) and they are able to modulate the activity of neighboring microglial population and/or neurons in the surroundings. For instance, microglia-derived EVs can increase glutamate release at the presynaptic sites of neuronal synapses thereby enhances excitatory synaptic transmission. The stimulation of synaptic activity occurs via enhanced neuronal sphingolipid metabolism (<xref ref-type="bibr" rid="B9">Antonucci et al., 2012</xref>). <xref ref-type="bibr" rid="B122">Gabrielli et al. (2015)</xref> demonstrated that microglial EVs are also able to modulate synaptic transmission through the modulation of the endocannabinoid system. Endocannabinoids are secreted through microglial EVs that have on their surface <italic>N</italic>-arachidonoylethanolamine (AEA), which can stimulate type-1 cannabinoid receptors (CB<sub>1</sub>), and inhibit presynaptic transmission of GABAergic neurons.</p>
<p>Microvesicles shedding from microglia is an intriguing topic but little is yet known and therefore warrants further investigations. Extracellular ATP is a key stimulant for vesicles shedding from microglia via the P2X7 ATP receptor (P2X7R) that activates the p38 MAPK cascade through src kinase-mediated phosphorylation. Phosphorylated p38 triggers microvesicle shedding and IL-1β release from glia cells via a process that requires activation of acid sphingomyelinases (<xref ref-type="bibr" rid="B34">Bianco et al., 2005</xref>, <xref ref-type="bibr" rid="B33">2009</xref>). Additionally, IL-1β-loaded microvesicles released by microglia via P2X7-p38 pathway can enhance the sensitivity of mechanical allodynia and thermal hyperalgesia induced by nerve injury (<xref ref-type="bibr" rid="B217">Li et al., 2017</xref>). Microglial P2X7R is also responsible for the release of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) into the extracellular space, which could be involved in the regulation of neuroinflammation and/or neuritogenesis in the brain (<xref ref-type="bibr" rid="B356">Takenouchi et al., 2015</xref>). Others and we have applied a proteomic approach to characterize the proteome of EVs released by microglia. Several proteins involved in protein translation, transcription, cell adhesion/extracellular matrix organization, autophagy-lysosomal pathway and cellular metabolism, that may influence the response of target cells to EVs were identified (<xref ref-type="bibr" rid="B99">Drago et al., 2017</xref>; <xref ref-type="bibr" rid="B405">Yang et al., 2018a</xref>). Interestingly, upon LPS stimulation proteins related to RNA processing and protein translation were upregulated in the EVs (<xref ref-type="bibr" rid="B405">Yang et al., 2018a</xref>). Furthermore, glial microvesicles can contain purine nucleoside phosphorylase, a crucial enzyme in purine metabolism which converts ribonucleosides into purine bases and it can be released into the extracellular space through P2X<sub>7</sub>R activation, indicating that glial cells may support neuronal activity by maintaining the homeostasis of the purinergic system (<xref ref-type="bibr" rid="B287">Pena-Altamira et al., 2018</xref>). Serotonin can also stimulate exosome release both in primary microglia cultures and BV2 cell lines (<xref ref-type="bibr" rid="B132">Glebov et al., 2015</xref>). Additionally, stimulation with lipopolysaccharide induces microvesicles release from microglia that can carry proinflammatory mediators (<xref ref-type="bibr" rid="B174">Jablonski et al., 2016</xref>; <xref ref-type="bibr" rid="B208">Kumar et al., 2017</xref>). We found LPS stimulation of microglia specifically upregulated TNF, and to a lower extent IL-6, in EVs released (<xref ref-type="bibr" rid="B405">Yang et al., 2018a</xref>).</p>
<p>Accumulated research confirms the role of microglia-released EVs in neurodegenerative conditions. For instance, shedding of microglia-derived microvesicles was demonstrated after traumatic brain injury (TBI), ischemic stroke, spinal cord injury and in neuropathic pain (<xref ref-type="bibr" rid="B208">Kumar et al., 2017</xref>; <xref ref-type="bibr" rid="B170">Huang et al., 2018</xref>; <xref ref-type="bibr" rid="B249">Mondello et al., 2018</xref>; <xref ref-type="bibr" rid="B277">Osier et al., 2018</xref>). Microvesicle from the animals with TBI are loaded with pro-inflammatory mediators (IL-1β and microRNA-155) and can activate additional glial cells that may contribute to progressive neuroinflammatory response in the injured brain (<xref ref-type="bibr" rid="B208">Kumar et al., 2017</xref>). ALS is a fatal disease characterized by progressive degeneration of motor neurons and by the formation of inclusions consisting of SOD1 and TDP-43 in motor neurons. Recently, exosomes from astrocytes have been noted that are able to transfer misfolded SOD1 to spinal neurons and subsequently cause selective motor neuron death (<xref ref-type="bibr" rid="B17">Basso et al., 2013</xref>). In AD, toxic Aβ and hyperphosphorylated tau can be spread between cells by exosomes and therefore they have been known for contributing to apoptosis and neuronal loss. <xref ref-type="bibr" rid="B304">Rajendran et al. (2006)</xref>, have shown (in N2a and Hela cells) that Aβ is present in multivesicular bodies (MVBs), and it is released into the extracellular space in exosomes upon MVBs fusion with the plasma membrane. Extracellular Aβ also activates microglia, and activated microglia-shed microvesicles into their environment. α-Synuclein exposure to murine microglial cell line BV2 increased the secretion of EVs enriched in TNF-α and MHCII molecules and promotes neuronal apoptosis (<xref ref-type="bibr" rid="B58">Chang et al., 2013</xref>). Furthermore, <xref ref-type="bibr" rid="B181">Joshi et al. (2014)</xref> have demonstrated that microglia-shed microvesicles promote the extracellular formation of highly toxic soluble form of Aβ thereby induces neurotoxicity. They have also found that microglia generate neurotoxic species following Aβ internalization, which are delivered to neurons possibly on the external membrane of microvesicles, which leads to neuronal damage.</p>
<p>On the other hand, microglia are able to clear Aβ by phagocytosis of the EVs loaded with Aβ. <xref ref-type="bibr" rid="B415">Yuyama et al. (2015)</xref> and <xref ref-type="bibr" rid="B413">Yuyama and Igarashi (2016</xref>, <xref ref-type="bibr" rid="B414">2017</xref>) have demonstrated that neuronal exosomes can sequester Aβ through its abundant glycosphingolipids and then Aβ could be taken up and digested by microglia. The administration of neuronal exosomes into the brain of APP transgenic mice results in a decreased amyloid deposition and neuronal exosomes can effectively ameliorates AD pathology (<xref ref-type="bibr" rid="B415">Yuyama et al., 2015</xref>; <xref ref-type="bibr" rid="B413">Yuyama and Igarashi, 2016</xref>, <xref ref-type="bibr" rid="B414">2017</xref>). <xref ref-type="bibr" rid="B357">Tamboli et al. (2010)</xref> have described another possible way by which microglia-shed exosomes could digest extracellular Aβ and thereby promote amyloid clearance. The insulin degrading enzyme (IDE) that is known to be effectively degrade extracellular amyloid deposits was found to be associated and released by exosomes shed by microglia (<xref ref-type="bibr" rid="B357">Tamboli et al., 2010</xref>). Microglial exosomes are also involved in the spread of tau pathology as was shown by numerous studies (<xref ref-type="bibr" rid="B320">Saman et al., 2012</xref>; <xref ref-type="bibr" rid="B242">Medina and Avila, 2014</xref>; <xref ref-type="bibr" rid="B10">Asai et al., 2015</xref>; <xref ref-type="bibr" rid="B393">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="B84">DeLeo and Ikezu, 2018</xref>; <xref ref-type="bibr" rid="B142">Guix et al., 2018</xref>). Thus, in the context of neurodegeneration, microglia-derived EVs could play complex and also controversial roles. Microglial EVs have been demonstrated to spread toxic and mutant proteins, while other studies indicated their positive impact on protein aggregates clearance and regulation of neuronal viability. In line with this, various studies demonstrated that microglia activation in early stages of AD pathogenesis could be neuroprotective. However, in the late stage of the disease, microglial MVs have been found responsible for the transportation and distribution of soluble toxic proteins like Aβ and α-synuclein peptides, and to promote the spread of the disease (<xref ref-type="bibr" rid="B26">Benilova et al., 2012</xref>; <xref ref-type="bibr" rid="B363">Tofaris, 2017</xref>; <xref ref-type="bibr" rid="B77">Croese and Furlan, 2018</xref>; <xref ref-type="bibr" rid="B423">Zhang S. et al., 2018</xref>).</p>
</sec>
<sec>
<title>Microglia in Pathological Conditions</title>
<p>It has become evident that microglial cells are involved in essentially all brain diseases ranging from AD and PD, TBI, brain ischemia and psychiatric diseases such as schizophrenia (<xref ref-type="bibr" rid="B397">Wohleb, 2016</xref>; <xref ref-type="bibr" rid="B179">Joe et al., 2018</xref>; <xref ref-type="bibr" rid="B290">Perea et al., 2018</xref>; <xref ref-type="bibr" rid="B349">Stephenson et al., 2018</xref>). The outcome of many pathologies of the CNS appear to rely heavily on the activity of microglia, including their release of cytokines, chemokines and growth factors (<xref ref-type="bibr" rid="B308">Ransohoff and Cardona, 2010</xref>). Importantly, microglial functions are largely dependent on the type of activation stimuli, time after stimulation and local factors during pathological conditions. Microglia responses are not inevitably neurotoxic and various neuroprotective effects of activated microglia have been observed <italic>in vivo</italic> (<xref ref-type="bibr" rid="B372">Turrin and Rivest, 2006</xref>; <xref ref-type="bibr" rid="B355">Szalay et al., 2016</xref>). In general, rapid and acute activation of microglia is associated with inflammatory changes but these are designed to combat the immediate insult and ultimately return the tissue homeostasis. This acute reaction could therefore be considered to be neuroprotective in the longer perspective, unless the acute response is augmented and prolonged. Persistent microglial activation with the associated increase in expression of inflammatory cytokines and chemokines, accompanied by recruitment of peripheral cells into the brain, is typically characterized as detrimental chronic neuroinflammation (<xref ref-type="bibr" rid="B228">Lynch, 2009</xref>; <xref ref-type="bibr" rid="B227">Lynch et al., 2010</xref>). This prolonged and chronic microglia activation is considered to be neurotoxic and can impair neuronal activity. This ambivalent role of microglia in neurodegenerative diseases has been extensively reviewed in the literature, searching for a consensus amidst conflicting data and summating whether the activity of microglia is helpful or not in pathologies of the brain (<xref ref-type="bibr" rid="B169">Hu et al., 2012</xref>; <xref ref-type="bibr" rid="B176">Jiang et al., 2014</xref>; <xref ref-type="bibr" rid="B224">Loane and Kumar, 2016</xref>; <xref ref-type="bibr" rid="B355">Szalay et al., 2016</xref>; <xref ref-type="bibr" rid="B100">Du et al., 2017</xref>).</p>
<p>Neuroinflammation occurs not only in the brain, but also in the retina and optic nerve – which are outgrowths from the diencephalon and thus considered parts of the CNS (<xref ref-type="bibr" rid="B225">London et al., 2013</xref>). In fact, retinal homeostasis is dependent on many of the same bidirectional signaling pathways between brain microglia and neurons, such as fractalkine signaling (<xref ref-type="bibr" rid="B186">Karlstetter et al., 2015</xref>). The retina and the brain are affected in several neurodegenerative diseases and because they are similar, they respond similarly to any disturbances of tissue homeostasis and share common pathogenic mechanisms (<xref ref-type="bibr" rid="B225">London et al., 2013</xref>). For instance the extracellular deposits of beta-amyloid and intraneuronal accumulation of hyperphosphorylated tau protein reported in AD are also found in the retina and optic nerve. Similarly, PD involves the degeneration of dopaminergic cells in the retina (<xref ref-type="bibr" rid="B306">Ramirez et al., 2017</xref>). Excellent reviews are available covering the topic of microglia involvement in retinal physiology and pathology (<xref ref-type="bibr" rid="B389">Wang J.W. et al., 2016</xref>; <xref ref-type="bibr" rid="B4">Akassoglou et al., 2017</xref>; <xref ref-type="bibr" rid="B178">Jin et al., 2017</xref>; <xref ref-type="bibr" rid="B311">Rathnasamy et al., 2018</xref>).</p>
</sec>
<sec>
<title>Contribution Factors of Microglia and Fractalkine Signaling in AD and PD</title>
<p>Alzheimer’s disease is a progressive neurodegenerative disorder characterized by the plaque-forming accumulation of amyloid-β (Aβ) and the deposition of neurofibrillary tangles (NFTs, composed of hyper-phosphorylated tau protein) within the brain parenchyma. Beta-amyloidosis is a result from an imbalance production versus clearance of Aβ peptides. Microglia are able to engulf and phagocyte the extracellular Aβ via stimulation of triggering-receptor-expressed on myeloid cells 2 (TREM2). TREM2 is a cell surface protein that is selectively and highly expressed by microglia and it is linked to an anti-inflammatory phenotype (<xref ref-type="bibr" rid="B69">Colonna and Facchetti, 2003</xref>; <xref ref-type="bibr" rid="B241">Mecca et al., 2018</xref>). TREM2 interacts with the adaptor protein DNAX-activating protein of 12-kDa (DAP12), which initiate intracellular signal transduction pathways that regulate microglial phagocytosis and activation. TREM2 is critical for microglial phagocytosis of for example, cellular debris in order to maintain tissue homeostasis (<xref ref-type="bibr" rid="B264">Neumann and Takahashi, 2007</xref>). In AD condition, TREM2-deficient microglia demonstrated a reduced uptake of Aβ-lipoprotein complexes <italic>in vitro</italic> (<xref ref-type="bibr" rid="B409">Yeh et al., 2016</xref>) and a less effective Aβ internalization <italic>in vivo</italic> (<xref ref-type="bibr" rid="B394">Wang et al., 2015</xref>; <xref ref-type="bibr" rid="B390">Wang Y. et al., 2016</xref>; <xref ref-type="bibr" rid="B412">Yuan et al., 2016</xref>). Microglia also have an ability to build a protective barrier around amyloid deposits, that is composed of tightly packed and thereby less toxic amyloid fibrils (<xref ref-type="bibr" rid="B70">Condello et al., 2015</xref>).</p>
<p>On the other hand, microglia have significant role in complement-mediated synapse loss in AD (<xref ref-type="bibr" rid="B165">Hong et al., 2016</xref>; <xref ref-type="bibr" rid="B118">Fonseca et al., 2017</xref>; <xref ref-type="bibr" rid="B175">Jiang and Bhaskar, 2017</xref>). In line with this, disabled microglial proliferation and microglial depletion protects against synapse loss in amyloidosis mouse models but does not necessarily have effect on the formation and maintenance of β-amyloid plaques (<xref ref-type="bibr" rid="B137">Grathwohl et al., 2009</xref>; <xref ref-type="bibr" rid="B274">Olmos-Alonso et al., 2016</xref>; <xref ref-type="bibr" rid="B344">Spangenberg et al., 2016</xref>). Complement activation also appears to exacerbate tau pathology and induces NFTs in AD mouse models via unclear mechanisms (<xref ref-type="bibr" rid="B46">Britschgi and Wyss-Coray, 2007</xref>; <xref ref-type="bibr" rid="B117">Fonseca et al., 2009</xref>). <xref ref-type="bibr" rid="B10">Asai et al. (2015)</xref> have showed that microglia are able to spread tau pathology across the brain by microglial uptake and exosomal release of tau in a mouse model of tauopathy. In addition to synapse elimination and aggravation of tau pathology, activated microglia release proinflammatory mediators in response to extracellular protein aggregates and thereby causing harm to neurons (<xref ref-type="bibr" rid="B158">Heneka et al., 2013</xref>; <xref ref-type="bibr" rid="B337">Shi et al., 2017</xref>).</p>
<p>Microglial fractalkine signaling plays variable roles in different stages of AD pathogenesis in association with neuroinflammation, neurotoxicity, and synaptic plasticity (<xref ref-type="bibr" rid="B60">Chen et al., 2016</xref>; <xref ref-type="bibr" rid="B422">Zhang L. et al., 2018</xref>). The neuronal soluble CX3CL1 is likely to keep the microglial phenotype in a rather neuroprotective state by acting on CX3CR1 in microglia, since the disruption of CX3CL1–CX3CR1 signaling leads to dysregulate microglial responses and neuronal damage (<xref ref-type="bibr" rid="B54">Cardona et al., 2006</xref>; <xref ref-type="bibr" rid="B110">Febinger et al., 2015</xref>) (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). Indeed, hAPP-CX3CR1<sup>-/-</sup> mice as well as hTau-CX3CR1<sup>-/-</sup> mice showed increased expression of inflammatory factors, enhanced tau phosphorylation, and exacerbated neuronal dysfunction and cognitive deficits (<xref ref-type="bibr" rid="B31">Bhaskar et al., 2010</xref>; <xref ref-type="bibr" rid="B64">Cho et al., 2011</xref>) (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). However, others have demonstrated that both APP-PS1/CX3CR1<sup>-/-</sup> and CRND8/CX3CR1<sup>-/-</sup> mice showed reduction in Aβ deposition with increased number of microglia (<xref ref-type="bibr" rid="B216">Lee et al., 2010</xref>; <xref ref-type="bibr" rid="B223">Liu et al., 2010</xref>). Moreover, in some cases the suppression of CX3CL1–CX3CR1 alleviated Aβ-induced neurotoxicity and memory deficiency (<xref ref-type="bibr" rid="B401">Wu et al., 2013</xref>; <xref ref-type="bibr" rid="B101">Dworzak et al., 2015</xref>). Additionally, the level of plasma soluble CX3CL1 was found to be significantly greater in the patients with mild to moderate AD than in the patients with severe AD, and the level of CX3CL1 is inversely correlated to AD severity (<xref ref-type="bibr" rid="B195">Kim et al., 2008</xref>), suggesting an early neuroinflammatory role in AD pathogenesis. Thus, CX3CL1/CX3CR1 signaling may play a beneficial role in controlling AD progression by inhibiting the inflammation and tau phosphorylation but at a cost of the increased Aβ deposition. One possible hypothesis is that, in early AD the intra-neuronal Aβ accumulation causes a mild decrease in neuron–microglia crosstalk via CX3CL1–CX3CR1 signaling that leads to an enhanced microglial phagocytosis of Aβ while resulting in tau hyper-phosphorylation. Later as AD is progressing, the communication between neurons and microglia is further exacerbated and the CX3CL1–CX3CR1 signaling is severely downgraded that gives rise to deregulated microglia and abnormally excited neuron, which leads to neuron damage and loss. Indeed, we have found remarkable early activation of inflammatory pathways in microglia at 6 weeks of age, before plaque deposition, in the 5xFAD mouse model of AD using a proteomic approach (<xref ref-type="bibr" rid="B43">Boza-Serrano et al., 2018</xref>).</p>
<p>Parkinson’s disease is characterized by the selective loss of dopaminergic neurons in substantia nigra. The pathological hallmarks are the formation of Lewy-bodies and intraneuronal protein inclusions mainly consist of α-synuclein. Microglial activation and neuroinflammation clearly contribute to neurodegeneration seen in PD, although the exact cellular mechanisms are not known yet. Neuron–microglia communication via fractalkine signaling provides an effective endogenous mechanism to moderate microglia activation and suppress the release of pro-inflammatory factors during the course of the disease (<xref ref-type="bibr" rid="B140">Grimmig et al., 2016</xref>). Maintaining or enhancing CX3CL1-CX3CR1 communication has been proved to be neuroprotective in multiple rodent models of PD (<xref ref-type="bibr" rid="B278">Pabon et al., 2011</xref>; <xref ref-type="bibr" rid="B254">Morganti et al., 2012</xref>; <xref ref-type="bibr" rid="B258">Nash et al., 2015</xref>). However, the action of fractalkine is intricate and regulated on multiple levels; for example, the CX3CR1<sup>-/-</sup> mice have been demonstrated an enhanced Aβ phagocytosis and at the same time a decline in α-synuclein degradation (<xref ref-type="bibr" rid="B361">Thome et al., 2015</xref>) (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). It remains to be determined if this action is mediated by membrane bound fractalkine or the cleaved, soluble form.</p>
</sec>
<sec>
<title>Microglia in Traumatic Brain Injury</title>
<p>Injuries to the CNS, including TBI, are the leading causes of death and severe disability for people under 40 years of age in the developed world (<xref ref-type="bibr" rid="B95">Donat et al., 2017</xref>). The clinical consequences of TBIs are very diverse including immediate death, complete recovery and permanent cognitive, emotional and physical impairments. TBIs are major risk factors for dementia (<xref ref-type="bibr" rid="B95">Donat et al., 2017</xref>; <xref ref-type="bibr" rid="B319">Saber et al., 2017</xref>) and chronic traumatic encephalitis (CTE) (<xref ref-type="bibr" rid="B275">Omalu, 2014</xref>). The primary injury of TBIs, caused by trauma to the head which for example might stretch, compress or tear blood vessels and axons, is not the only reason why patients die or are disabled (<xref ref-type="bibr" rid="B300">Prins et al., 2013</xref>). A lot of the damage is also caused by the secondary events such as edema, metabolic and blood flow disturbances, free radical formation, glutamate excitotoxicity, blood–brain barrier breakage, as well as neuroinflammation, i.e., activation of microglia and subsequent recruitment of peripheral leukocytes (<xref ref-type="bibr" rid="B300">Prins et al., 2013</xref>; <xref ref-type="bibr" rid="B95">Donat et al., 2017</xref>; <xref ref-type="bibr" rid="B319">Saber et al., 2017</xref>). Microglial activation in this context is multifactorial, e.g., primed by pro-inflammatory cytokines (<xref ref-type="bibr" rid="B95">Donat et al., 2017</xref>) or triggered through purinergic receptors by ATP released from necrotic neurons (<xref ref-type="bibr" rid="B81">Davalos et al., 2005</xref>; <xref ref-type="bibr" rid="B106">Fang et al., 2009</xref>), and could persist for years if not resolved (<xref ref-type="bibr" rid="B44">Braun et al., 2017</xref>). The methods for investigating the role of microglial activity following TBI, have been utilizing the same mouse models as have been discussed earlier in this review. Subjecting CX3CR1<sup>GFP/GFP</sup> mice to experimental TBI have enabled studies of the fractalkine axis between microglia and neurons in a context of TBI (<xref ref-type="bibr" rid="B110">Febinger et al., 2015</xref>; <xref ref-type="bibr" rid="B104">Erturk et al., 2016</xref>; <xref ref-type="bibr" rid="B418">Zanier et al., 2016</xref>). Similar methods have also been applied for exploring the role of other signaling pathways in TBI, such as TREM2/DAP12, etc. (<xref ref-type="bibr" rid="B319">Saber et al., 2017</xref>). However, while these models could be beneficial in understanding the role of specific molecular pathways, it remains difficult to specify their cellular source, which could be microglial or peripheral macrophages (<xref ref-type="bibr" rid="B336">Sewell et al., 2004</xref>).</p>
<p>However, microglial signaling in neurodegeneration caused by TBI remains controversial (<xref ref-type="bibr" rid="B27">Bennett and Brody, 2014</xref>). A study by <xref ref-type="bibr" rid="B27">Bennett and Brody (2014)</xref> showed that in a mouse model of repetitive closed skull TBI (rcTBI) the partial depletion of Cd11b<sup>+</sup> microglia did not affect axon degeneration at 7 or 14 days post injury (<xref ref-type="bibr" rid="B27">Bennett and Brody, 2014</xref>). Another study observed a big therapeutic effect of deleting or inhibiting complement system proteins C3 and C5 after traumatic brain cryoinjury – which was not attributed directly to the activity of microglia – but instead to a lesser invasion of neutrophils (<xref ref-type="bibr" rid="B336">Sewell et al., 2004</xref>).</p>
<p>So far, four peer reviewed studies have investigated the effects of the absence or partial absence of fractalkine signaling after experimental TBI, with some conflicting results (<xref ref-type="bibr" rid="B110">Febinger et al., 2015</xref>; <xref ref-type="bibr" rid="B104">Erturk et al., 2016</xref>; <xref ref-type="bibr" rid="B418">Zanier et al., 2016</xref>; <xref ref-type="bibr" rid="B233">Makinde et al., 2017</xref>). In one study, CX3CR1<sup>GFP/GFP</sup> mice demonstrated a decrease of pro-inflammatory cytokines after the controlled cortical impact (CCI) model of TBI (<xref ref-type="bibr" rid="B110">Febinger et al., 2015</xref>). However, in another investigation with CX3CR1<sup>-/-</sup> mice subjected to CCI, the trends in cytokine expression were not as clear (<xref ref-type="bibr" rid="B418">Zanier et al., 2016</xref>), although in both studies, early after insult, the mice lacking CX3CR1 performed the neuroscore test better than WT controls (<xref ref-type="bibr" rid="B110">Febinger et al., 2015</xref>; <xref ref-type="bibr" rid="B418">Zanier et al., 2016</xref>). This effect was reversed at a later stage (<xref ref-type="bibr" rid="B110">Febinger et al., 2015</xref>; <xref ref-type="bibr" rid="B418">Zanier et al., 2016</xref>), indicating that fractalkine signaling might exert negative influence at an early stage, but protective at later stages after TBI. It should be noted that, while fractalkine signaling is important in microglia–neuron bidirectional communication, CX3CR1 is also expressed in peripheral macrophages, and could contribute to their infiltration into the CNS (<xref ref-type="bibr" rid="B104">Erturk et al., 2016</xref>). A third study examined the effects of CCI in mice missing one allele of CX3CR1 and found that the female mice, but not the male mice, showed significantly better symptoms post-injury, including less neurodegeneration, leukocyte infiltration and cognitive deficits (<xref ref-type="bibr" rid="B104">Erturk et al., 2016</xref>). Here it was also shown that WT mice revealed neurodegeneration one year after insult, even in areas far from the lesion, indicating that targeting chronic fractalkine signaling is a promising, albeit sex-specific, way of combating detrimental events after TBI (<xref ref-type="bibr" rid="B104">Erturk et al., 2016</xref>). A fourth study subjected CX3CR1 null mice to CCI and observed that neutrophil infiltration was significantly reduced (<xref ref-type="bibr" rid="B233">Makinde et al., 2017</xref>).</p>
<p>The receptor adaptor complex TREM2/DAP12, important in synapse formation (<xref ref-type="bibr" rid="B115">Filipello et al., 2018</xref>), is also involved in microglial activation and phagocytosis (<xref ref-type="bibr" rid="B241">Mecca et al., 2018</xref>). A massive upregulation of TREM2 has been demonstrated in a mouse model of TBI and the absence of TREM2 was shown to improve hippocampal survival and cognition, lower disinhibitory behavior, as well as to decrease the immune cell activation throughout the brain, except in proximity to the lesion (<xref ref-type="bibr" rid="B319">Saber et al., 2017</xref>). However, the TREM2-dependent immune cell activity, believed to be negative in the TBI setting, was not primarily associated with microglia, but rather with peripherally derived macrophages (<xref ref-type="bibr" rid="B319">Saber et al., 2017</xref>).</p>
<p>TBI is associated with a wide range of deleterious events for cerebral vasculature and tissues that cause immune reactions and leukocyte infiltration in the brain (<xref ref-type="bibr" rid="B319">Saber et al., 2017</xref>; <xref ref-type="bibr" rid="B251">Monson et al., 2018</xref>). The activity of macrophages appears to be a potential therapeutic target in different TBI settings in adult, but not young, rodents (<xref ref-type="bibr" rid="B110">Febinger et al., 2015</xref>; <xref ref-type="bibr" rid="B104">Erturk et al., 2016</xref>; <xref ref-type="bibr" rid="B149">Hanlon et al., 2016</xref>; <xref ref-type="bibr" rid="B418">Zanier et al., 2016</xref>; <xref ref-type="bibr" rid="B63">Chhor et al., 2017</xref>; <xref ref-type="bibr" rid="B319">Saber et al., 2017</xref>). However, it appears that the peripherally derived macrophages, rather than macrophages derived from the resident microglial population, are the primary targets for attenuating detrimental effects after TBI (<xref ref-type="bibr" rid="B27">Bennett and Brody, 2014</xref>; <xref ref-type="bibr" rid="B253">Morganti et al., 2015</xref>; <xref ref-type="bibr" rid="B319">Saber et al., 2017</xref>). More research is required to elucidate the specific role of microglia and microglial pathways in the very multi-facetted context of TBI.</p>
</sec>
<sec>
<title>Microglia–Neuron Communication in Brain Ischemia</title>
<p>Brain ischemia, or stroke, is one of the leading cause to death and disability in adults (<xref ref-type="bibr" rid="B7">American Heart Association, 2017</xref>). Brain ischemia is typically characterized as focal or global brain ischemia. The most common type of brain ischemia is stroke (focal ischemia), which to 85% is related to an occlusion of a cerebral artery or to less extent (15%) rupture of an cerebral artery and few treatment options is currently available and then related to clot removal or to resolve to clot in the immediate phase (<xref ref-type="bibr" rid="B338">Siegel et al., 2017</xref>). In global ischemia, the entire brain is ischemic, where most common condition leading to global brain ischemia is cardiac arrest with successful resuscitation (<xref ref-type="bibr" rid="B182">Joundi et al., 2016</xref>). In this section, we will focus on focal ischemia, which is characterized by an ischemic core, which in the acute phase is surrounded by a penumbra region, with impaired function, and injured tissue that is amenable for tissue protection. Neuroinflammation and microglia reactions are involved in all stages of the ischemic cascade: from the acute event leading to the first neuronal cell death to later stages of parenchymal processing including phagocytosis of cell debris and tissue remodeling. In this section, we will focus on the direct interaction between microglia–neuron, i.e., CD200 and fractalkine. Other recent reviews cover the broader aspect of inflammation in stroke and ischemia pathogenesis (<xref ref-type="bibr" rid="B93">Dirnagl, 2012</xref>; <xref ref-type="bibr" rid="B25">Benakis et al., 2014</xref>; <xref ref-type="bibr" rid="B56">Chamorro et al., 2016</xref>). As mentioned, several messengers are involved in the communication between microglia and neurons, for example cytokines and purines. The glycoprotein CD200 is mainly expressed by neurons and its receptor CD200R is expressed on myeloid cells including microglia. This interaction is involved in maintaining microglial cells in a quiescent homeostatic stage. Lower expression of CD200 has been related to proinflammatory activation of microglia and increased influx of inflammatory cells into the brain (<xref ref-type="bibr" rid="B87">Denieffe et al., 2013</xref>). Autocrine release of CD200 from microglia is also suggested to keep the microglia in an alternative/non-inflammatory activation state, involving IL-4 signaling (<xref ref-type="bibr" rid="B410">Yi et al., 2012</xref>). The endocannabinoid anandamide (AEA) which can be released by microglia in neuroinflammatory conditions and have an anti-inflammatory effect in stroke (<xref ref-type="bibr" rid="B53">Capettini et al., 2012</xref>), is also reported as a mechanism for upregulation of CD200R on microglia (<xref ref-type="bibr" rid="B160">Hernangomez et al., 2012</xref>). Additionally, peroxisome proliferator-activated receptor gamma (PPAR-γ), which is a transcription factor controlling the inflammatory response, has been reported to regulate CD200 and CD200R1 gene expression, which could be related to the neuroprotective action of PPAR-γ agonists (<xref ref-type="bibr" rid="B88">Dentesano et al., 2014</xref>). Recently, <xref ref-type="bibr" rid="B406">Yang et al. (2018b)</xref> investigated the acute effect, up to 48 h after ischemia, of CD200 following permanent focal ischemia in mice. They found CD200 expression on neurons, but not on microglia, and a negative correlation with neuronal death in cortical tissue. Injection of recombinant CD200 intracerebroventricular, performed right after pMCAO induction, reduced microglial activation and expression of cytokine TNF, IL-1β, and IL-10 (<xref ref-type="bibr" rid="B406">Yang et al., 2018b</xref>). To be able to use the beneficial effect of CD200 signaling in ischemic stroke, <xref ref-type="bibr" rid="B199">Kong et al. (2018)</xref> used human mesenchymal stem cells with high CD200 expression from human placenta which they transplanted intracerebrally 24 h after transient middle cerebral artery occlusion (tMCAO). Interestingly, they report reduced microglia activation in the infarct boundary area, smaller infarct and improved behavior. Silencing of CD200 in the mesenchymal stem cells also reduced the inflammatory response in BV2 microglia when applying a co-culture system (<xref ref-type="bibr" rid="B199">Kong et al., 2018</xref>). Using a similar rat stroke model, <xref ref-type="bibr" rid="B238">Matsumoto et al. (2015)</xref> investigated if the CD200 could be used to distinguish M1 or M2 macrophage/microglia in the infarct at 7 days after ischemia, but were not able to make this distinction in M1/M2 based on CD200 expression. However, using rat macrophages <xref ref-type="bibr" rid="B153">Hayakawa et al. (2016b)</xref> used CD200 stimulation induced alternative activation (M2) via CREB-C/EBP-beta signaling.</p>
<p>Focal white matter ischemia, where a small ischemic lesion can generate large neurological deficits, has also been studied in the context of CD200 signaling using endothelin injections in mice (<xref ref-type="bibr" rid="B152">Hayakawa et al., 2016a</xref>). <xref ref-type="bibr" rid="B152">Hayakawa et al. (2016a)</xref> used CD200-Fc treatment to target CD200R and found a reduction in the macrophage phagocytosis of oligodendrocyte progenitors, which was related to reduced TLR4 expression in macrophages. Indeed, they could even detect an enhancement of remyelination following CD200-Fc treatment (<xref ref-type="bibr" rid="B152">Hayakawa et al., 2016a</xref>). Microglia studies of CD200-deficient mice reveal increased classical activation, which could be related to increased infiltration of T cells and macrophages (<xref ref-type="bibr" rid="B87">Denieffe et al., 2013</xref>). Using CD200-deficient mice, or overexpression of CD200, using conditional systems in various experimental stroke models with long-term recovery would be interesting to further elucidate its function in neuroinflammation and potential as a therapeutic target.</p>
<p>CD200 signaling has been discussed for decades as an important mechanism in neuroinflammatory conditions (<xref ref-type="bibr" rid="B261">Neumann, 2001</xref>), but the jury is still out on whether CD200 could be important target to use in ischemic brain injury and neurodegenerative diseases.</p>
<p>Crosstalk between microglia and neuron via fractalkine/CXCR1 has also been studied in experimental stroke models and been a target for neuroprotection. CXCR1 knockout mice subjected to focal brain ischemia was reported by <xref ref-type="bibr" rid="B85">Denes et al. (2008)</xref> to surprisingly have reduced IL-1B and TNF production together with reduced infarct size, better recovery and ameliorated neuronal cell death.</p>
<p><xref ref-type="bibr" rid="B342">Soriano et al. (2002)</xref> used the CX3CL1 deficient mice and confirmed the results with the tMCAO model, showing reduced infarct size and reduced mortality when CX3CL1/CX3CR1 signaling was absent.</p>
<p>In stark contrast to these results, when CX3CL1 was administered to naive mice (wt) in combination with pMCAO a reduction in infarct size was reported. In this study, <xref ref-type="bibr" rid="B65">Cipriani et al. (2011)</xref> found that the adenosine receptor 1 (A<sub>1</sub>R) was implicate in this neuroprotection and using A1R antagonist or A<sub>1</sub>R<sup>-</sup>/<sup>-</sup> mice abolished the positive effect of CX3CL1 (<xref ref-type="bibr" rid="B65">Cipriani et al., 2011</xref>). However, when they administering CX3CL1 to the CX3CL1 deficient mice they found aggravated the brain ischemia, possibly related to the constitutive lack of CX3CL1 leading to a maladaptation of the CX3CL1/CX3CR1 signaling axis (<xref ref-type="bibr" rid="B65">Cipriani et al., 2011</xref>). Clinical data though suggest a potential protective role of CX3CL1, where patients with better clinical outcome after 6 months had higher levels of CX3CL1 in blood plasma (<xref ref-type="bibr" rid="B96">Donohue et al., 2012</xref>).</p>
<p>In a recent rat study, <xref ref-type="bibr" rid="B222">Liu et al. (2017)</xref> used a pMCAO model to study the effect of CXCR1 inhibitor (day 3–14 systemic administration) and found increased expression of BDNF and NGF, neuroprotection and improved neurology up to 14 days after ischemia.</p>
<p>In view of the dispersed data related to CX3CL1/CX3CR1 and ischemic stroke it is difficult to judge the neuroprotective role of CX3CL1/CX3CR1 signaling and the future possibility to manipulate this pathway pharmaceutically to reduce the sequel of stroke.</p>
</sec>
<sec>
<title>Microglia in Brain Tumors</title>
<p>Prolonged microglia activation has also been observed in the environment of malignant brain tumors. In contrast to what is known in neurodegenerative conditions, tumor-infiltrated microglia exhibit immunologically suppressed phenotypes and they have been demonstrated rather promoting tumor proliferation and progression than exert an anti-tumor activity (<xref ref-type="bibr" rid="B30">Bettinger et al., 2002</xref>; <xref ref-type="bibr" rid="B404">Yang et al., 2010</xref>; <xref ref-type="bibr" rid="B420">Zhai et al., 2011</xref>; <xref ref-type="bibr" rid="B329">Schiffer et al., 2017</xref>). The pathological hallmarks of malignant brain tumors involve rapid tumor proliferation, diffuse brain invasion, tumor-induced brain edema and neuronal cell death. Gliomas are the most common and aggressive primary brain tumors that are composed of neoplastic and non-neoplastic cells. The majority of the non-neoplastic cells are tumor-associated macrophages along with fibroblast and endothelial cells (<xref ref-type="bibr" rid="B252">Morantz et al., 1979</xref>; <xref ref-type="bibr" rid="B316">Rossi et al., 1987</xref>; <xref ref-type="bibr" rid="B340">Simmons et al., 2011</xref>). Histopathologic studies of glioblastomas have revealed high number of microglia and macrophages (with peripheral origin) in and around of glioma tissue. This is due to the local release of numerous factors by tumor cells which mediate microglia chemoattraction including chemokines, ligands of complement receptors, ATP and neurotransmitters. Monocyte chemoattractant protein-1 (MCP-1, also known CCL2) was among the first chemoattractant factors, which has been identified to contribute tumor proliferation and progression (<xref ref-type="bibr" rid="B295">Platten et al., 2003</xref>; <xref ref-type="bibr" rid="B376">Vakilian et al., 2017</xref>). The chemokine stromal-derived factor-1 (SDF-1, also known as CXCL12) has been described as another potent microglia and macrophage recruiting molecules (<xref ref-type="bibr" rid="B391">Wang et al., 2012</xref>; <xref ref-type="bibr" rid="B177">Jiang et al., 2013</xref>). The growth factor glial cell–derived neurotrophic factor (GDNF), is secreted in mouse and human gliomas, which serves as a strong chemoattractant for microglia (<xref ref-type="bibr" rid="B206">Ku et al., 2013</xref>). Colony stimulating factor-1 (CSF-1) is released by glioma cells and acts as a microglial chemoattractant. Blockade of CSF-1R signaling using RNA interference or pharmacological inhibitors have been shown to significantly reduce the number of tumor-associated microglia and glioblastoma invasion (<xref ref-type="bibr" rid="B72">Coniglio et al., 2012</xref>). Additionally, CSF-1 is also able to convert microglia into a pro-tumorigenic anti-inflammatory phenotype (<xref ref-type="bibr" rid="B301">Pyonteck et al., 2013</xref>). Furthermore, granulocyte- macrophage colony-stimulating factor (GM-CSF) can also serve as a chemoattractant for microglia, as GM-CSF knockdown reduces microglia-dependent invasion in organotypic brain slices and attenuates the gliomas growth <italic>in vivo</italic> (<xref ref-type="bibr" rid="B339">Sielska et al., 2013</xref>). Although the tumor-associated microglia are high in numbers, they exert suppressed functions that involves reduced phagocytic activity and defective antigen presentation for cytotoxic and helper T cells activation. Therefore, microglia associated with malignant gliomas appear incapable of inducing an effective anti-tumor T cell response (<xref ref-type="bibr" rid="B400">Wu et al., 2010</xref>; <xref ref-type="bibr" rid="B146">Hambardzumyan et al., 2016</xref>). Additionally, glioma cells produce numerous anti-inflammatory cytokines (e.g., IL-10, IL-6, TGF-β2, PGE2) that can revert activated microglia to an anti-inflammatory phenotype (<xref ref-type="bibr" rid="B162">Hishii et al., 1995</xref>; <xref ref-type="bibr" rid="B301">Pyonteck et al., 2013</xref>). For instance, TGF-β2 released by glioma cells inhibits proliferation and secretion of proinflammatory cytokines by microglia and lymphocytes (<xref ref-type="bibr" rid="B354">Suzumura et al., 1993</xref>).</p>
<p>In return, microglia secrete tumor proliferation promoting factors including epidermal growth factor (EGF) (<xref ref-type="bibr" rid="B72">Coniglio et al., 2012</xref>) and vascular endothelial growth factor (VEGF), TGF-β, arginase-1 (ARG1), and IL-10 (<xref ref-type="bibr" rid="B123">Gabrusiewicz et al., 2011</xref>; <xref ref-type="bibr" rid="B219">Li and Graeber, 2012</xref>). Additionally, TGF-β released predominantly from microglia are able to enhance tumor growth and invasion as the downregulation the TGF-β type II receptor expression with shRNAs abolished TGF-β-induced glioblastoma invasiveness and migratory responses <italic>in vitro</italic> (<xref ref-type="bibr" rid="B395">Wesolowska et al., 2008</xref>). Furthermore, microglia can help increase the spread of tumors by releasing of extracellular matrix degrading enzymes such as MMP-2, MMP-9, and MT1-MMP, into the tumor environment which support tissue remodeling and angiogenesis (<xref ref-type="bibr" rid="B22">Belien et al., 1999</xref>; <xref ref-type="bibr" rid="B235">Markovic et al., 2005</xref>; <xref ref-type="bibr" rid="B201">Konnecke and Bechmann, 2013</xref>).</p>
<p>Neurodegenerative actions of malignant gliomas resemble mechanisms also found in neurodegenerative diseases (e.g., AD, PD, ALS) and brain tumors can affect neuronal survival directly or by microglia-mediated factors. Tumor environments include elevated level of extracellular ATP, which can recruit microglia and macrophages into tumor regions and induce cellular release of inflammatory mediators initiating and sustaining tumor development. ATP is able to activate P2X7 purinergic receptors (P2X7R) expressed on glioma and immune responsive cells (microglia/macrophages). A critical point of ATP signaling in tumors is the prolonged duration in effect due to the inefficient hydrolysis of ATP. The high concentration of extracellular ATP is toxic for neurons and contributes to neuronal cell death (<xref ref-type="bibr" rid="B240">McLarnon, 2017</xref>). Additionally, the prolonged activation of microglial P2X7R leads to excessive inflammation by the release of inflammatory factors (IL-1β and TNF-α) and the activation of caspase activity in apoptosis, which can put neuronal survival at risk (<xref ref-type="bibr" rid="B111">Ferrari et al., 1997</xref>, <xref ref-type="bibr" rid="B112">1999</xref>). Furthermore, gliomas have been shown to seize neuronal glutamate signaling for their own growth advantage (<xref ref-type="bibr" rid="B325">Savaskan et al., 2015</xref>). The cystine/glutamate antiporter xCT is expressed in various malignant tumors including brain tumors (<xref ref-type="bibr" rid="B194">Kim et al., 2001</xref>). The protein complex transports Na<sup>+</sup>-independent glutamate out of cells in exchange for cysteine thereby, releases high amounts of glutamate in the extracellular microenvironment. Extracellular glutamate represents a potent signaling molecule and neurotransmitter in the bran tissue and triggers membrane depolarization. However, excessive glutamate release and hence glutamate receptor activation can lead to excitatory neuronal cell death. In brain tumors, the cystine/glutamate antiporter expression is elevated that is consequently causes an increased extracellular glutamate levels in the peritumoral zone. The high extracellular glutamate concentration results in tumor-associated seizures, brain swelling and neuronal damage (<xref ref-type="bibr" rid="B408">Ye and Sontheimer, 1999</xref>; <xref ref-type="bibr" rid="B326">Savaskan et al., 2008</xref>; <xref ref-type="bibr" rid="B48">Buckingham et al., 2011</xref>). In line with this, other experimental and clinical studies have demonstrated that glioma cells secrete high levels of the neurotransmitter glutamate, resulting in neuronal damage and antagonizing ionotropic glutamate receptors alleviate neuronal degeneration in the tumor vicinity and lessen glioma growth <italic>in vivo</italic> (<xref ref-type="bibr" rid="B21">Behrens et al., 2000</xref>; <xref ref-type="bibr" rid="B234">Marcus et al., 2010</xref>).</p>
</sec>
<sec>
<title>Microglia–Neuron Interaction in Psychiatric Diseases</title>
<p>As previously mentioned, microglia are one of the key mediators of neuroplasticity, acting in the remodeling of synaptic processes and circuitry formation during normal physiological conditions. Therefore, the bidirectional communication between neurons and microglia may be critical for preserving the homeostatic environment in the central nervous system and defects in microglia-neuronal activities have been suggested as potential contributors to neurodevelopmental alterations, resulting in psychiatric disorders such as schizophrenia, bipolar disorder (BD), and depression (<xref ref-type="bibr" rid="B411">Yirmiya et al., 2015</xref>; <xref ref-type="bibr" rid="B212">Laskaris et al., 2016</xref>).</p>
</sec>
<sec>
<title>Schizophrenia</title>
<p>Schizophrenia is a severe neurodevelopmental disorder characterized by psychosis, apathy and withdrawal, and cognitive impairment, which cause abnormal social behavior and self-care (<xref ref-type="bibr" rid="B256">Mueser and McGurk, 2004</xref>; <xref ref-type="bibr" rid="B38">Blank and Prinz, 2013</xref>). This disease affects ∼1% of the entire population (<xref ref-type="bibr" rid="B403">Yamamuro et al., 2015</xref>), emerges between 16 and 30 years and persists throughout the patient’s life (<xref ref-type="bibr" rid="B256">Mueser and McGurk, 2004</xref>). The origin of this disease is still unknown, but some evidences suggest that schizophrenia can arise from an interaction between neurodevelopmental processes, such as prenatal viral infections (<xref ref-type="bibr" rid="B6">Allswede and Cannon, 2018</xref>), and environmental factors (<xref ref-type="bibr" rid="B80">Davalieva et al., 2016</xref>). Brain structural irregularities have been reported in schizophrenic patients, such as the loss of gray matter in prefrontal, temporal and subcortical structures (<xref ref-type="bibr" rid="B103">Ellison-Wright and Bullmore, 2009</xref>; <xref ref-type="bibr" rid="B120">Fornito et al., 2009</xref>), the presence of white matter tracts connecting these areas (<xref ref-type="bibr" rid="B40">Bora et al., 2011</xref>; <xref ref-type="bibr" rid="B417">Zalesky et al., 2011</xref>), as well as an enlargement of ventricle (<xref ref-type="bibr" rid="B273">Olabi et al., 2011</xref>). Additionally, this disease presents multiple biochemical irregularities in the dopamine, serotonin, acetylcholine, glutamate, and GABA systems (<xref ref-type="bibr" rid="B256">Mueser and McGurk, 2004</xref>), as well as changes in the immune system (<xref ref-type="bibr" rid="B259">Nawa et al., 2000</xref>).</p>
<p>In the last few years, microglial cells have appeared as important players in the development of schizophrenia (<xref ref-type="bibr" rid="B47">Brown, 2011</xref>). Owing to their participation in inflammatory processes as well as in the modification of neuronal networks (<xref ref-type="bibr" rid="B368">Tremblay et al., 2010</xref>; <xref ref-type="bibr" rid="B62">Chew et al., 2013</xref>; <xref ref-type="bibr" rid="B421">Zhan et al., 2014</xref>b), microglial cells have been proposed as a possible mechanism that participate in the structural brain changes that appear in schizophrenia (<xref ref-type="bibr" rid="B257">Munn, 2000</xref>; <xref ref-type="bibr" rid="B250">Monji et al., 2009</xref>). Postmortem studies have shown an increased density of microglial cells in the brain of patients with schizophrenia specifically in frontal and temporal, but not in cingulate cortex (<xref ref-type="bibr" rid="B125">Garey, 2010</xref>). In addition, positron emission tomography (PET) imaging studies have shown that microglia are activated in these patients (<xref ref-type="bibr" rid="B379">van Berckel et al., 2008</xref>; <xref ref-type="bibr" rid="B159">Hercher et al., 2014</xref>). These microglia features have been also related with differences in behavior in animal studies, where specifically, schizophrenic rodent models present deficits in pre-pulse inhibition and working memory impairments (<xref ref-type="bibr" rid="B314">Ribeiro et al., 2013</xref>).</p>
<p>During the development of the nervous system, the communication between microglia and neuron is fundamental in the synaptic formation and maturation (<xref ref-type="bibr" rid="B288">Penzes et al., 2011</xref>) and persistent microglial activation has been used to explain how this process might cause neuronal degeneration and synaptic dysfunction (<xref ref-type="bibr" rid="B250">Monji et al., 2009</xref>). CX3CR1 is expressed on microglia during embryogenesis and throughout murine lifespan (<xref ref-type="bibr" rid="B129">Ginhoux et al., 2010</xref>; <xref ref-type="bibr" rid="B283">Paolicelli et al., 2011</xref>) and it has been proposed as a key mediator of neuron–microglia interactions. In fact, the CX3CR1-knockout mice model presents a reduction of microglia which resulted in deficits of synaptic pruning and a decreased functional brain connectivity (<xref ref-type="bibr" rid="B421">Zhan et al., 2014</xref>), as well as behavioral impairments measured by fear conditioning, Morris water maze and motor learning deficits (<xref ref-type="bibr" rid="B315">Rogers et al., 2011</xref>). Furthermore, meta-analysis using human blood and brain samples showed a significantly down-regulation of CX3CR1 in schizophrenic patients (<xref ref-type="bibr" rid="B28">Bergon et al., 2015</xref>), specifically individuals with Ala55Thr variant of this receptor present more susceptibility to develop this neurological disorder (<xref ref-type="bibr" rid="B173">Ishizuka et al., 2017</xref>). Apart from CX3CR1 receptors, secreted Neuregulin 1 (NRG1) can bind to NRG1 receptor on microglia and signal via a type of EGF receptor, ErbB2/3, leading to proliferation and activation of microglia (<xref ref-type="bibr" rid="B51">Calvo et al., 2010</xref>). Signaling deficits in NRG1/ErbB3 has been identified in schizophrenia patients (<xref ref-type="bibr" rid="B73">Corfas et al., 2004</xref>). Single nucleotide polymorphisms in NRG1; have been associated with psychosis and enlarged lateral ventricles and white matter disruption in schizophrenia (<xref ref-type="bibr" rid="B42">Bousman et al., 2018</xref>). Another important mediator between microglia and neuron communication is BDNF, where microglia is one of the central source of BDNF (<xref ref-type="bibr" rid="B113">Ferrini and De Koninck, 2013</xref>). Alterations in this gene have been pointed out as a responsible protein for the etiology of schizophrenia (<xref ref-type="bibr" rid="B425">Zhang et al., 2008</xref>). Moreover, a single polymorphism (Val66Met) in the BDNF gene has been related to the age of onset of this disorder and the manifestations that persist after durable antipsychotic treatment (<xref ref-type="bibr" rid="B270">Numata et al., 2006</xref>).</p>
</sec>
<sec>
<title>Bipolar Disorder</title>
<p>Bipolar disorder is a brain disorder that provokes intense emotion, changes in sleep patterns and activity levels and uncommon behaviors that may go along with mood episodes including symptoms of both manic and depression (<xref ref-type="bibr" rid="B23">Belmaker, 2004</xref>). This disorder affects approximately 1% of the population (<xref ref-type="bibr" rid="B265">Newman et al., 2002</xref>). The etiology of this psychiatric disorder is still unknown; however, as schizophrenia, the interaction between genes and environment have been related to the pathogenesis of BD (<xref ref-type="bibr" rid="B23">Belmaker, 2004</xref>). BD patients showed brain white matter abnormalities (<xref ref-type="bibr" rid="B124">Ganzola and Duchesne, 2017</xref>), as well as a decrease in hippocampal (<xref ref-type="bibr" rid="B52">Cao et al., 2016</xref>), corpus callosum (<xref ref-type="bibr" rid="B213">Lavagnino et al., 2015</xref>), and frontal cortical volumes, specifically in patients with manic (<xref ref-type="bibr" rid="B1">Abé et al., 2015</xref>).</p>
<p>Neuroinflammation has been suggested as a possible mechanism involved in mood disorders, such as BD (<xref ref-type="bibr" rid="B293">Perugi et al., 2015</xref>; <xref ref-type="bibr" rid="B313">Réus et al., 2015</xref>), and alterations in glial markers have been found in postmortem frontal cortex in BD subjects (<xref ref-type="bibr" rid="B310">Rao et al., 2010</xref>). Moreover, using PET imaging studies with the microglial tracer ([(11)C]-(R)-PK11195), <xref ref-type="bibr" rid="B144">Haarman et al. (2014)</xref> showed an intensification of neuroinflammation in the hippocampus of BD patients. After an insult, microglia can produce proinflammatory cytokines in response to activation via damage-associated molecular patterns (DAMPs) (<xref ref-type="bibr" rid="B157">Heneka et al., 2014</xref>). Indeed, numerous meta-analysis in patients with BD showed a significantly increase in peripheral cytokines, such as IL-6 or TNF-α (<xref ref-type="bibr" rid="B133">Goldsmith et al., 2016</xref>). Also, serum analysis of BD patients during acute manic/depressive episodes have shown an increased in DAMPs levels (<xref ref-type="bibr" rid="B350">Stertz et al., 2015</xref>).</p>
<p>As we have already mentioned, due to their participation in neuroinflammation and remodeling of synapses, microglial cells may contribute in the development of neuropsychiatric disorders, such as BD. Actually, postmortem studies showed a decreased in glial cells in the prefrontal cortex, especially in patients with familial history of mood disorders (<xref ref-type="bibr" rid="B276">Ongur et al., 1998</xref>). In particular, it has been suggested that the microglial function is altered in BD patients (<xref ref-type="bibr" rid="B313">Réus et al., 2015</xref>). The communication between microglial cells in the brain is mediated by purinergic signaling that includes the P2X purinergic receptor 7 for ATP (P2RX7) (for review, see <xref ref-type="bibr" rid="B114">Fields and Burnstock, 2006</xref>). In fact, a single nucleotide polymorphism in the gene that encodes for P2RX7 receptor has been associated with a highest susceptibility for BD pathology (<xref ref-type="bibr" rid="B13">Barden et al., 2006</xref>). Likewise, the role of fraktalkines mediated neuron–microglia interaction has been reported in BD (for review, see <xref ref-type="bibr" rid="B294">Pinto et al., 2018</xref>). Actually, CX3CR1 expression has been found reduced in monocytes of BD patients (<xref ref-type="bibr" rid="B279">Padmos et al., 2008</xref>).</p>
</sec>
<sec>
<title>Depression</title>
<p>Depression is a neuropsychiatric disorder characterized by psychophysiological alterations in affective symptoms (sadness, irritability, low mood, desperation, apathy, anhedonia) that decrease of interest in all daily activities and events (<xref ref-type="bibr" rid="B24">Belmaker and Agam, 2008</xref>). According to the World Health Organization, depression affects more than 300 million people worldwide. Conventionally, depressive symptoms have been attributed to an imbalance in the hypothalamic-pituitary-adrenal axis (<xref ref-type="bibr" rid="B343">Sousa et al., 2008</xref>) as well as a deregulation in the neuromodulation of neurotransmitters, specially by serotonin (<xref ref-type="bibr" rid="B205">Krishnan and Nestler, 2008</xref>). Brain abnormalities have also been found in depressed patients. Thus, postmortem brain studies showed reduced lobar volumes accompanied by a decreased number of synaptic contacts (<xref ref-type="bibr" rid="B211">Lampe et al., 2003</xref>; <xref ref-type="bibr" rid="B185">Kang et al., 2012</xref>). Moreover, it has been described a loss and a decrease in the size of GABAergic neurons, in occipital, prefrontal and limbic areas (<xref ref-type="bibr" rid="B75">Cotter et al., 2002</xref>; <xref ref-type="bibr" rid="B305">Rajkowska et al., 2007</xref>; <xref ref-type="bibr" rid="B230">Maciag et al., 2010</xref>).</p>
<p>Beyond the classical impairments in the HPA and/or in the neuromodulation by neurotransmitters, depression is also associated with alterations of microglia activity and inflammation (<xref ref-type="bibr" rid="B411">Yirmiya et al., 2015</xref>). Rodent models of depression showed significant variations in microglial function and morphology, specifically in brain areas sensitive to chronic stress leading depressive-like behavior, such as hippocampus, prefrontal cortex, amygdala and nucleus accumbens (<xref ref-type="bibr" rid="B373">Tynan et al., 2010</xref>; <xref ref-type="bibr" rid="B204">Kreisel et al., 2014</xref>). In depressive patients, PET imaging studies revealed a higher level of neuroinflammation in prefrontal cortex, anterior cingulate cortex and insula (<xref ref-type="bibr" rid="B335">Setiawan et al., 2015</xref>). Likewise, the communication between microglial cells also may participate in mood disorders. To note, in rodent models, excessive P2X7 receptor activation enhance depressive-like behavior (for review, see <xref ref-type="bibr" rid="B352">Stokes et al., 2015</xref>) and in humans, a single nucleotide polymorphism in this gene is associated with the develop of major depressive disorder (<xref ref-type="bibr" rid="B226">Lucae et al., 2006</xref>). Besides the alterations in the morphology and function, failures in the microglia–neuron communication may be involved in depression. Some authors showed that the manipulation of this interaction in the CX3CR1 pathway alters the stress reaction and depressive-like behavior (<xref ref-type="bibr" rid="B74">Corona et al., 2010</xref>; <xref ref-type="bibr" rid="B245">Milior et al., 2016</xref>). Furthermore, the CX3CR1-deficient mouse model showed resistance to stress-induced depressive-like behavior and changes in microglia morphology, suggesting that the hyper-ramification in microglia is controlled by neuron–microglia interaction (<xref ref-type="bibr" rid="B156">Hellwig et al., 2016</xref>). Another important mediator between microglia and neurons is BDNF, which has also been linked to depression (<xref ref-type="bibr" rid="B55">Castren, 2014</xref>; <xref ref-type="bibr" rid="B196">Kishi et al., 2017</xref>). Thus, in a rat model of chronic stress-induced depression, the infusion of this neurotrophin partially reverse the depressive-like behavior (<xref ref-type="bibr" rid="B407">Ye et al., 2011</xref>).</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The dynamics of microglia–neuron communication in the healthy brain has attracted great attention in the field of neurobiology/neuroimmunology during the past decades. The bidirectional communication between the two cell-types involves several immunomodulatory factors and signaling pathways including purinergic, neurotransmitter, chemokine, and complement signaling. Many observations indicate that microglia modulates neuronal activity and prune synaptic elements such as dendritic spines in the healthy brain and during neural development. In return, neurons contribute to immune modulation through secreted and membrane associated molecules control microglial phagocytosis, motility and activation. Elucidating the functional significance of the bidirectional microglial–neuronal communication in the healthy brain is important in comprehending how the defects in physiological microglia function could contribute to or even trigger diseases. In brain injuries such as TBI and brain ischemia, microglia–neuron communication is very likely important in both the acute phase, in terms of altered neuroinflammation and cell death, as well as in the chronic phase including the rewiring of neuronal circuits. In neurodegenerative and neuropsychiatric disorders, such as AD, PD, BD depression and schizophrenia, the chronic activation of microglia is likely affecting the pathogenesis and aberrant neuronal signaling. Thus, a deeper understanding of microglia–neuron communication would be important in future therapies for diseases of the brain.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>ZS, OM, SB, and TD have all designed and drafted sections of the manuscript, as well as significantly contributed to revisions and editing of the final version. OM has also prepared the figures.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> SparbankFärs and Frosta Foundation to the list of contributors.</p>
</fn>
</fn-group>
<ack>
<p>We gratefully acknowledge funding support from the Strategic Research Area MultiPark at Lund University, Lund, Sweden, the Swedish Research Council grant no. 2012-2229, the Basal Ganglia Disorders Linnaeus Consortium (BAGADILICO), and the Swedish Alzheimer Foundation, A.E. Berger Foundation, Olle Engkvist Byggmästare Foundation, Swedish Brain Foundation, Crafoord Foundation, Swedish Dementia Association, G&amp;J Kock Foundation, Swedish National Stroke Foundation, Swedish Parkinson Foundation, Stohnes Foundation, and the Royal Physiographic Society.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abé</surname><given-names>C.</given-names></name><name><surname>Carl-Johan</surname><given-names>E.</given-names></name><name><surname>Carl</surname><given-names>S.</given-names></name><name><surname>Predrag</surname><given-names>P.</given-names></name><name><surname>Martin</surname><given-names>I.</given-names></name><name><surname>Mikael</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Manic episodes are related to changes in frontal cortex: a longitudinal neuroimaging study of bipolar disorder 1.</article-title>
<source/><italic>Brain</italic>
<volume>138</volume>
<fpage>3440</fpage>–<lpage>3448</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awv266</pub-id>
<pub-id pub-id-type="pmid">26373602</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abels</surname><given-names>E. R.</given-names></name><name><surname>Breakefield</surname><given-names>X. O.</given-names></name></person-group> (<year>2016</year>). <article-title>Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake.</article-title>
<source/><italic>Cell Mol. Neurobiol.</italic>
<volume>36</volume>
<fpage>301</fpage>–<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-016-0366-z</pub-id>
<pub-id pub-id-type="pmid">27053351</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abutbul</surname><given-names>S.</given-names></name><name><surname>Shapiro</surname><given-names>J.</given-names></name><name><surname>Szaingurten-Solodkin</surname><given-names>I.</given-names></name><name><surname>Levy</surname><given-names>N.</given-names></name><name><surname>Carmy</surname><given-names>Y.</given-names></name><name><surname>Baron</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>TGF-beta signaling through SMAD2/3 induces the quiescent microglial phenotype within the CNS environment.</article-title>
<source/><italic>Glia</italic>
<volume>60</volume>
<fpage>1160</fpage>–<lpage>1171</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22343</pub-id>
<pub-id pub-id-type="pmid">22511296</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akassoglou</surname><given-names>K.</given-names></name><name><surname>Merlini</surname><given-names>M.</given-names></name><name><surname>Rafalski</surname><given-names>V. A.</given-names></name><name><surname>Real</surname><given-names>R.</given-names></name><name><surname>Liang</surname><given-names>L.</given-names></name><name><surname>Jin</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>In vivo imaging of CNS injury and disease.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>37</volume>
<fpage>10808</fpage>–<lpage>10816</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1826-17.2017</pub-id><pub-id pub-id-type="pmid">29118209</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Aoukaty</surname><given-names>A.</given-names></name><name><surname>Rolstad</surname><given-names>B.</given-names></name><name><surname>Giaid</surname><given-names>A.</given-names></name><name><surname>Maghazachi</surname><given-names>A. A.</given-names></name></person-group> (<year>1998</year>). <article-title>MIP-3alpha, MIP-3beta and fractalkine induce the locomotion and the mobilization of intracellular calcium, and activate the heterotrimeric G proteins in human natural killer cells.</article-title>
<source/><italic>Immunology</italic>
<volume>95</volume>
<fpage>618</fpage>–<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2567.1998.00603.x</pub-id>
<pub-id pub-id-type="pmid">9893054</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allswede</surname><given-names>D. M.</given-names></name><name><surname>Cannon</surname><given-names>T. D.</given-names></name></person-group> (<year>2018</year>). <article-title>Prenatal inflammation and risk for schizophrenia: a role for immune proteins in neurodevelopment.</article-title>
<source/><italic>Dev. Psychopathol.</italic>
<volume>30</volume>
<fpage>1157</fpage>–<lpage>1178</lpage>. <pub-id pub-id-type="doi">10.1017/S0954579418000317</pub-id>
<pub-id pub-id-type="pmid">30068405</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><collab>American Heart Association</collab> (<year>2017</year>). <article-title>Correction to: Heart disease, and stroke statistics—2017 update: A report from the american heart association.</article-title>
<source/><italic>Circulation</italic>
<volume>135</volume>:<issue>e646</issue>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000000491</pub-id>
<pub-id pub-id-type="pmid">28264899</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andjelkovic</surname><given-names>A. V.</given-names></name><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Dzenko</surname><given-names>K. A.</given-names></name><name><surname>Cong</surname><given-names>H.</given-names></name><name><surname>Pachter</surname><given-names>J. S.</given-names></name></person-group> (<year>2002</year>). <article-title>Functional expression of CCR2 by human fetal astrocytes.</article-title>
<source/><italic>J. Neurosci. Res.</italic>
<volume>70</volume>
<fpage>219</fpage>–<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.10372</pub-id>
<pub-id pub-id-type="pmid">12271471</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonucci</surname><given-names>F.</given-names></name><name><surname>Turola</surname><given-names>E.</given-names></name><name><surname>Riganti</surname><given-names>L.</given-names></name><name><surname>Caleo</surname><given-names>M.</given-names></name><name><surname>Gabrielli</surname><given-names>M.</given-names></name><name><surname>Perrotta</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism.</article-title>
<source/><italic>EMBO J.</italic>
<volume>31</volume>
<fpage>1231</fpage>–<lpage>1240</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2011.489</pub-id>
<pub-id pub-id-type="pmid">22246184</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asai</surname><given-names>H.</given-names></name><name><surname>Ikezu</surname><given-names>S.</given-names></name><name><surname>Tsunoda</surname><given-names>S.</given-names></name><name><surname>Medalla</surname><given-names>M.</given-names></name><name><surname>Luebke</surname><given-names>J.</given-names></name><name><surname>Haydar</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Depletion of microglia and inhibition of exosome synthesis halt tau propagation.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>18</volume>
<fpage>1584</fpage>–<lpage>1593</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4132</pub-id>
<pub-id pub-id-type="pmid">26436904</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banisadr</surname><given-names>G.</given-names></name><name><surname>Gosselin</surname><given-names>R. D.</given-names></name><name><surname>Mechighel</surname><given-names>P.</given-names></name><name><surname>Rostene</surname><given-names>W.</given-names></name><name><surname>Kitabgi</surname><given-names>P.</given-names></name><name><surname>Melik Parsadaniantz</surname><given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons.</article-title>
<source/><italic>J. Comp. Neurol.</italic>
<volume>492</volume>
<fpage>178</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1002/cne.20729</pub-id>
<pub-id pub-id-type="pmid">16196033</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barclay</surname><given-names>A. N.</given-names></name><name><surname>Wright</surname><given-names>G. J.</given-names></name><name><surname>Brooke</surname><given-names>G.</given-names></name><name><surname>Brown</surname><given-names>M. H.</given-names></name></person-group> (<year>2002</year>). <article-title>CD200 and membrane protein interactions in the control of myeloid cells.</article-title>
<source/><italic>Trends Immunol.</italic>
<volume>23</volume>
<fpage>285</fpage>–<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1016/S1471-4906(02)02223-8</pub-id><pub-id pub-id-type="pmid">12072366</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barden</surname><given-names>N.</given-names></name><name><surname>Harvey</surname><given-names>M.</given-names></name><name><surname>Gagne</surname><given-names>B.</given-names></name><name><surname>Shink</surname><given-names>E.</given-names></name><name><surname>Tremblay</surname><given-names>M.</given-names></name><name><surname>Raymond</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder.</article-title>
<source/><italic>Am. J. Med. Genet. B Neuropsychiatr. Genet.</italic>
<volume>141B</volume>, <fpage>374</fpage>–<lpage>382</lpage>. <pub-id pub-id-type="pmid">16673375</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barna</surname><given-names>B. P.</given-names></name><name><surname>Pettay</surname><given-names>J.</given-names></name><name><surname>Barnett</surname><given-names>G. H.</given-names></name><name><surname>Zhou</surname><given-names>P.</given-names></name><name><surname>Iwasaki</surname><given-names>K.</given-names></name><name><surname>Estes</surname><given-names>M. L.</given-names></name></person-group> (<year>1994</year>). <article-title>Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor.</article-title>
<source/><italic>J. Neuroimmunol.</italic>
<volume>50</volume>
<fpage>101</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/0165-5728(94)90220-8</pub-id><pub-id pub-id-type="pmid">8300851</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron</surname><given-names>P.</given-names></name><name><surname>Bussini</surname><given-names>S.</given-names></name><name><surname>Cardin</surname><given-names>V.</given-names></name><name><surname>Corbo</surname><given-names>M.</given-names></name><name><surname>Conti</surname><given-names>G.</given-names></name><name><surname>Galimberti</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Muscle Nerve</italic>
<volume>32</volume>
<fpage>541</fpage>–<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1002/mus.20376</pub-id>
<pub-id pub-id-type="pmid">15962273</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basso</surname><given-names>M.</given-names></name><name><surname>Bonetto</surname><given-names>V.</given-names></name></person-group> (<year>2016</year>). <article-title>Extracellular vesicles and a novel form of communication in the brain.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>10</volume>:<issue>127</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2016.00127</pub-id>
<pub-id pub-id-type="pmid">27065789</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basso</surname><given-names>M.</given-names></name><name><surname>Pozzi</surname><given-names>S.</given-names></name><name><surname>Tortarolo</surname><given-names>M.</given-names></name><name><surname>Fiordaliso</surname><given-names>F.</given-names></name><name><surname>Bisighini</surname><given-names>C.</given-names></name><name><surname>Pasetto</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>288</volume>
<fpage>15699</fpage>–<lpage>15711</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.425066</pub-id>
<pub-id pub-id-type="pmid">23592792</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batchelor</surname><given-names>P. E.</given-names></name><name><surname>Liberatore</surname><given-names>G. T.</given-names></name><name><surname>Wong</surname><given-names>J. Y.</given-names></name><name><surname>Porritt</surname><given-names>M. J.</given-names></name><name><surname>Frerichs</surname><given-names>F.</given-names></name><name><surname>Donnan</surname><given-names>G. A.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>19</volume>
<fpage>1708</fpage>–<lpage>1716</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-05-01708.1999</pub-id>
<pub-id pub-id-type="pmid">10024357</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazan</surname><given-names>J. F.</given-names></name><name><surname>Bacon</surname><given-names>K. B.</given-names></name><name><surname>Hardiman</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Soo</surname><given-names>K.</given-names></name><name><surname>Rossi</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>A new class of membrane-bound chemokine with a CX3C motif.</article-title>
<source/><italic>Nature</italic>
<volume>385</volume>
<fpage>640</fpage>–<lpage>644</lpage>. <pub-id pub-id-type="doi">10.1038/385640a0</pub-id>
<pub-id pub-id-type="pmid">9024663</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beattie</surname><given-names>E. C.</given-names></name><name><surname>Stellwagen</surname><given-names>D.</given-names></name><name><surname>Morishita</surname><given-names>W.</given-names></name><name><surname>Bresnahan</surname><given-names>J. C.</given-names></name><name><surname>Ha</surname><given-names>B. K.</given-names></name><name><surname>Von Zastrow</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Control of synaptic strength by glial TNFalpha.</article-title>
<source/><italic>Science</italic>
<volume>295</volume>
<fpage>2282</fpage>–<lpage>2285</lpage>. <pub-id pub-id-type="doi">10.1126/science.1067859</pub-id>
<pub-id pub-id-type="pmid">11910117</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behrens</surname><given-names>P. F.</given-names></name><name><surname>Langemann</surname><given-names>H.</given-names></name><name><surname>Strohschein</surname><given-names>R.</given-names></name><name><surname>Draeger</surname><given-names>J.</given-names></name><name><surname>Hennig</surname><given-names>J.</given-names></name></person-group> (<year>2000</year>). <article-title>Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study.</article-title>
<source/><italic>J. Neurooncol.</italic>
<volume>47</volume>
<fpage>11</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1023/A:1006426917654</pub-id>
<pub-id pub-id-type="pmid">10930095</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belien</surname><given-names>A. T.</given-names></name><name><surname>Paganetti</surname><given-names>P. A.</given-names></name><name><surname>Schwab</surname><given-names>M. E.</given-names></name></person-group> (<year>1999</year>). <article-title>Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>144</volume>
<fpage>373</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.144.2.373</pub-id>
<pub-id pub-id-type="pmid">9922462</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belmaker</surname><given-names>R. H.</given-names></name></person-group> (<year>2004</year>). <article-title>Bipolar disorder.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>351</volume>
<fpage>476</fpage>–<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra035354</pub-id>
<pub-id pub-id-type="pmid">15282355</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belmaker</surname><given-names>R. H.</given-names></name><name><surname>Agam</surname><given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>Mechanisms of disease: major depressive disorder.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>358</volume>
<fpage>55</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra073096</pub-id>
<pub-id pub-id-type="pmid">18172175</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benakis</surname><given-names>C.</given-names></name><name><surname>Garcia-Bonilla</surname><given-names>L.</given-names></name><name><surname>Iadecola</surname><given-names>C.</given-names></name><name><surname>Anrather</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of microglia and myeloid immune cells in acute cerebral ischemia.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>8</volume>:<issue>461</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00461</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benilova</surname><given-names>I.</given-names></name><name><surname>Karran</surname><given-names>E.</given-names></name><name><surname>De Strooper</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>The toxic Abeta oligomer and Alzheimer’s disease: an emperor in need of clothes.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>15</volume>
<fpage>349</fpage>–<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3028</pub-id>
<pub-id pub-id-type="pmid">22286176</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>R. E.</given-names></name><name><surname>Brody</surname><given-names>D. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Acute reduction of microglia does not alter axonal injury in a mouse model of repetitive concussive traumatic brain injury.</article-title>
<source/><italic>J. Neurotrauma</italic>
<volume>31</volume>
<fpage>1647</fpage>–<lpage>1663</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2013.3320</pub-id>
<pub-id pub-id-type="pmid">24797413</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergon</surname><given-names>A.</given-names></name><name><surname>Belzeaux</surname><given-names>R.</given-names></name><name><surname>Comte</surname><given-names>M.</given-names></name><name><surname>Pelletier</surname><given-names>F.</given-names></name><name><surname>Herve</surname><given-names>M.</given-names></name><name><surname>Gardiner</surname><given-names>E. J.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>CX3CR1 is dysregulated in blood and brain from schizophrenia patients.</article-title>
<source/><italic>Schizophr. Res.</italic>
<volume>168</volume>
<fpage>434</fpage>–<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2015.08.010</pub-id>
<pub-id pub-id-type="pmid">26285829</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertollini</surname><given-names>C.</given-names></name><name><surname>Ragozzino</surname><given-names>D.</given-names></name><name><surname>Gross</surname><given-names>C.</given-names></name><name><surname>Limatola</surname><given-names>C.</given-names></name><name><surname>Eusebi</surname><given-names>F.</given-names></name></person-group> (<year>2006</year>). <article-title>Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>51</volume>
<fpage>816</fpage>–<lpage>821</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2006.05.027</pub-id>
<pub-id pub-id-type="pmid">16815480</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bettinger</surname><given-names>I.</given-names></name><name><surname>Thanos</surname><given-names>S.</given-names></name><name><surname>Paulus</surname><given-names>W.</given-names></name></person-group> (<year>2002</year>). <article-title>Microglia promote glioma migration.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>103</volume>
<fpage>351</fpage>–<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-001-0472-x</pub-id>
<pub-id pub-id-type="pmid">11904754</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhaskar</surname><given-names>K.</given-names></name><name><surname>Konerth</surname><given-names>M.</given-names></name><name><surname>Kokiko-Cochran</surname><given-names>O. N.</given-names></name><name><surname>Cardona</surname><given-names>A.</given-names></name><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name><name><surname>Lamb</surname><given-names>B. T.</given-names></name></person-group> (<year>2010</year>). <article-title>Regulation of tau pathology by the microglial fractalkine receptor.</article-title>
<source/><italic>Neuron</italic>
<volume>68</volume>
<fpage>19</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.08.023</pub-id>
<pub-id pub-id-type="pmid">20920788</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bialas</surname><given-names>A. R.</given-names></name><name><surname>Stevens</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>TGF-beta signaling regulates neuronal C1q expression and developmental synaptic refinement.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>16</volume>
<fpage>1773</fpage>–<lpage>1782</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3560</pub-id>
<pub-id pub-id-type="pmid">24162655</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianco</surname><given-names>F.</given-names></name><name><surname>Perrotta</surname><given-names>C.</given-names></name><name><surname>Novellino</surname><given-names>L.</given-names></name><name><surname>Francolini</surname><given-names>M.</given-names></name><name><surname>Riganti</surname><given-names>L.</given-names></name><name><surname>Menna</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Acid sphingomyelinase activity triggers microparticle release from glial cells.</article-title>
<source/><italic>EMBO J.</italic>
<volume>28</volume>
<fpage>1043</fpage>–<lpage>1054</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2009.45</pub-id>
<pub-id pub-id-type="pmid">19300439</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianco</surname><given-names>F.</given-names></name><name><surname>Pravettoni</surname><given-names>E.</given-names></name><name><surname>Colombo</surname><given-names>A.</given-names></name><name><surname>Schenk</surname><given-names>U.</given-names></name><name><surname>Moller</surname><given-names>T.</given-names></name><name><surname>Matteoli</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>174</volume>
<fpage>7268</fpage>–<lpage>7277</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.174.11.7268</pub-id>
<pub-id pub-id-type="pmid">15905573</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biber</surname><given-names>K.</given-names></name><name><surname>Laurie</surname><given-names>D. J.</given-names></name><name><surname>Berthele</surname><given-names>A.</given-names></name><name><surname>Sommer</surname><given-names>B.</given-names></name><name><surname>Tolle</surname><given-names>T. R.</given-names></name><name><surname>Gebicke-Harter</surname><given-names>P. J.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>72</volume>
<fpage>1671</fpage>–<lpage>1680</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.1999.721671.x</pub-id>
<pub-id pub-id-type="pmid">10098876</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biber</surname><given-names>K.</given-names></name><name><surname>Neumann</surname><given-names>H.</given-names></name><name><surname>Inoue</surname><given-names>K.</given-names></name><name><surname>Boddeke</surname><given-names>H. W.</given-names></name></person-group> (<year>2007</year>). <article-title>Neuronal ‘On’ and ‘Off’ signals control microglia.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>30</volume>
<fpage>596</fpage>–<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2007.08.007</pub-id>
<pub-id pub-id-type="pmid">17950926</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biber</surname><given-names>K.</given-names></name><name><surname>Sauter</surname><given-names>A.</given-names></name><name><surname>Brouwer</surname><given-names>N.</given-names></name><name><surname>Copray</surname><given-names>S. C.</given-names></name><name><surname>Boddeke</surname><given-names>H. W.</given-names></name></person-group> (<year>2001</year>). <article-title>Ischemia-induced neuronal expression of the microglia attracting chemokine secondary lymphoid-tissue chemokine (SLC).</article-title>
<source/><italic>Glia</italic>
<volume>34</volume>
<fpage>121</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1002/glia.1047</pub-id>
<pub-id pub-id-type="pmid">11307161</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blank</surname><given-names>T.</given-names></name><name><surname>Prinz</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Microglia as modulators of cognition and neuropsychiatric disorders.</article-title>
<source/><italic>Glia</italic>
<volume>61</volume>
<fpage>62</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22372</pub-id>
<pub-id pub-id-type="pmid">22740320</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boche</surname><given-names>D.</given-names></name><name><surname>Perry</surname><given-names>V. H.</given-names></name><name><surname>Nicoll</surname><given-names>J. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Review: activation patterns of microglia and their identification in the human brain.</article-title>
<source/><italic>Neuropathol. Appl. Neurobiol.</italic>
<volume>39</volume>
<fpage>3</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1111/nan.12011</pub-id>
<pub-id pub-id-type="pmid">23252647</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bora</surname><given-names>E.</given-names></name><name><surname>Fornito</surname><given-names>A.</given-names></name><name><surname>Radua</surname><given-names>J.</given-names></name><name><surname>Walterfang</surname><given-names>M.</given-names></name><name><surname>Seal</surname><given-names>M.</given-names></name><name><surname>Wood</surname><given-names>S. J.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis.</article-title>
<source/><italic>Schizophr. Res.</italic>
<volume>127</volume>
<fpage>46</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2010.12.020</pub-id>
<pub-id pub-id-type="pmid">21300524</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bose</surname><given-names>S.</given-names></name><name><surname>Cho</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.</article-title>
<source/><italic>Arch. Pharm. Res.</italic>
<volume>36</volume>
<fpage>1039</fpage>–<lpage>1050</lpage>. <pub-id pub-id-type="doi">10.1007/s12272-013-0161-z</pub-id>
<pub-id pub-id-type="pmid">23771498</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bousman</surname><given-names>C. A.</given-names></name><name><surname>Cropley</surname><given-names>V.</given-names></name><name><surname>Klauser</surname><given-names>P.</given-names></name><name><surname>Hess</surname><given-names>J. L.</given-names></name><name><surname>Pereira</surname><given-names>A.</given-names></name><name><surname>Idrizi</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Neuregulin-1 (NRG1) polymorphisms linked with psychosis transition are associated with enlarged lateral ventricles and white matter disruption in schizophrenia.</article-title>
<source/><italic>Psychol. Med.</italic>
<volume>48</volume>
<fpage>801</fpage>–<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1017/S0033291717002173</pub-id>
<pub-id pub-id-type="pmid">28826413</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boza-Serrano</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Paulus</surname><given-names>A.</given-names></name><name><surname>Deierborg</surname><given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer’s disease mouse model 5xFAD.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>8</volume>:<issue>1550</issue>. <pub-id pub-id-type="doi">10.1038/s41598-018-19699-y</pub-id>
<pub-id pub-id-type="pmid">29367720</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>M.</given-names></name><name><surname>Vaibhav</surname><given-names>K.</given-names></name><name><surname>Saad</surname><given-names>N. M.</given-names></name><name><surname>Fatima</surname><given-names>S.</given-names></name><name><surname>Vender</surname><given-names>J. R.</given-names></name><name><surname>Baban</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>White matter damage after traumatic brain injury: a role for damage associated molecular patterns.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1863</volume>
<fpage>2614</fpage>–<lpage>2626</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2017.05.020</pub-id>
<pub-id pub-id-type="pmid">28533056</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brionne</surname><given-names>T. C.</given-names></name><name><surname>Tesseur</surname><given-names>I.</given-names></name><name><surname>Masliah</surname><given-names>E.</given-names></name><name><surname>Wyss-Coray</surname><given-names>T.</given-names></name></person-group> (<year>2003</year>). <article-title>Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain.</article-title>
<source/><italic>Neuron</italic>
<volume>40</volume>
<fpage>1133</fpage>–<lpage>1145</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(03)00766-9</pub-id>
<pub-id pub-id-type="pmid">14687548</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Britschgi</surname><given-names>M.</given-names></name><name><surname>Wyss-Coray</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Systemic and acquired immune responses in Alzheimer’s disease.</article-title>
<source/><italic>Int. Rev. Neurobiol.</italic>
<volume>82</volume>
<fpage>205</fpage>–<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1016/S0074-7742(07)82011-3</pub-id>
<pub-id pub-id-type="pmid">17678963</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A. S.</given-names></name></person-group> (<year>2011</year>). <article-title>The environment and susceptibility to schizophrenia.</article-title>
<source/><italic>Progr. Neurobiol.</italic>
<volume>93</volume>
<fpage>23</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2010.09.003</pub-id>
<pub-id pub-id-type="pmid">20955757</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckingham</surname><given-names>S. C.</given-names></name><name><surname>Campbell</surname><given-names>S. L.</given-names></name><name><surname>Haas</surname><given-names>B. R.</given-names></name><name><surname>Montana</surname><given-names>V.</given-names></name><name><surname>Robel</surname><given-names>S.</given-names></name><name><surname>Ogunrinu</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Glutamate release by primary brain tumors induces epileptic activity.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>17</volume>
<fpage>1269</fpage>–<lpage>1274</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2453</pub-id>
<pub-id pub-id-type="pmid">21909104</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Budnik</surname><given-names>V.</given-names></name><name><surname>Ruiz-Canada</surname><given-names>C.</given-names></name><name><surname>Wendler</surname><given-names>F.</given-names></name></person-group> (<year>2016</year>). <article-title>Extracellular vesicles round off communication in the nervous system.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>17</volume>
<fpage>160</fpage>–<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2015.29</pub-id>
<pub-id pub-id-type="pmid">26891626</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butovsky</surname><given-names>O.</given-names></name><name><surname>Jedrychowski</surname><given-names>M. P.</given-names></name><name><surname>Moore</surname><given-names>C. S.</given-names></name><name><surname>Cialic</surname><given-names>R.</given-names></name><name><surname>Lanser</surname><given-names>A. J.</given-names></name><name><surname>Gabriely</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Identification of a unique TGF-beta-dependent molecular and functional signature in microglia.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>17</volume>
<fpage>131</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3599</pub-id>
<pub-id pub-id-type="pmid">24316888</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvo</surname><given-names>M.</given-names></name><name><surname>Zhu</surname><given-names>N.</given-names></name><name><surname>Tsantoulas</surname><given-names>C.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Grist</surname><given-names>J.</given-names></name><name><surname>Loeb</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Neuregulin-ErbB signaling promotes microglial proliferation and chemotaxis contributing to microgliosis and pain after peripheral nerve injury.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>30</volume>
<fpage>5437</fpage>–<lpage>5450</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5169-09.2010</pub-id>
<pub-id pub-id-type="pmid">20392965</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>B.</given-names></name><name><surname>Bauer</surname><given-names>I. E.</given-names></name><name><surname>Sharma</surname><given-names>A. N.</given-names></name><name><surname>Mwangi</surname><given-names>B.</given-names></name><name><surname>Frazier</surname><given-names>T.</given-names></name><name><surname>Lavagnino</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele.</article-title>
<source/><italic>J. Affect. Disord.</italic>
<volume>198</volume>
<fpage>198</fpage>–<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2016.03.044</pub-id>
<pub-id pub-id-type="pmid">27018938</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capettini</surname><given-names>L. S.</given-names></name><name><surname>Savergnini</surname><given-names>S. Q.</given-names></name><name><surname>da Silva</surname><given-names>R. F.</given-names></name><name><surname>Stergiopulos</surname><given-names>N.</given-names></name><name><surname>Santos</surname><given-names>R. A.</given-names></name><name><surname>Mach</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Update on the role of cannabinoid receptors after ischemic stroke.</article-title>
<source/><italic>Mediat. Inflamm.</italic>
<volume>2012</volume>:<issue>824093</issue>. <pub-id pub-id-type="doi">10.1155/2012/824093</pub-id>
<pub-id pub-id-type="pmid">22577257</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardona</surname><given-names>A. E.</given-names></name><name><surname>Pioro</surname><given-names>E. P.</given-names></name><name><surname>Sasse</surname><given-names>M. E.</given-names></name><name><surname>Kostenko</surname><given-names>V.</given-names></name><name><surname>Cardona</surname><given-names>S. M.</given-names></name><name><surname>Dijkstra</surname><given-names>I. M.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Control of microglial neurotoxicity by the fractalkine receptor.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>9</volume>
<fpage>917</fpage>–<lpage>924</lpage>. <pub-id pub-id-type="doi">10.1038/nn1715</pub-id>
<pub-id pub-id-type="pmid">16732273</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castren</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Neurotrophins and psychiatric disorders.</article-title>
<source/><italic>Handb. Exp. Pharmacol.</italic>
<volume>220</volume>
<fpage>461</fpage>–<lpage>479</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-642-45106-5_17</pub-id>
<pub-id pub-id-type="pmid">24668483</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamorro</surname><given-names>A.</given-names></name><name><surname>Dirnagl</surname><given-names>U.</given-names></name><name><surname>Urra</surname><given-names>X.</given-names></name><name><surname>Planas</surname><given-names>A. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>15</volume>
<fpage>869</fpage>–<lpage>881</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(16)00114-9</pub-id>
<pub-id pub-id-type="pmid">27180033</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrasekar</surname><given-names>B.</given-names></name><name><surname>Mummidi</surname><given-names>S.</given-names></name><name><surname>Perla</surname><given-names>R. P.</given-names></name><name><surname>Bysani</surname><given-names>S.</given-names></name><name><surname>Dulin</surname><given-names>N. O.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway.</article-title>
<source/><italic>Biochem. J.</italic>
<volume>373</volume>
<fpage>547</fpage>–<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1042/bj20030207</pub-id>
<pub-id pub-id-type="pmid">12729461</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>C.</given-names></name><name><surname>Lang</surname><given-names>H.</given-names></name><name><surname>Geng</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group> (<year>2013</year>). <article-title>Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>548</volume>
<fpage>190</fpage>–<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2013.06.009</pub-id>
<pub-id pub-id-type="pmid">23792198</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Che</surname><given-names>X.</given-names></name><name><surname>Ye</surname><given-names>W.</given-names></name><name><surname>Panga</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>D. C.</given-names></name><name><surname>Yang</surname><given-names>G. Y.</given-names></name></person-group> (<year>2001</year>). <article-title>Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice.</article-title>
<source/><italic>Brain Res.</italic>
<volume>902</volume>
<fpage>171</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(01)02328-9</pub-id><pub-id pub-id-type="pmid">11384610</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>P.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Yin</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>CX3CL1/CX3CR1 in Alzheimer’s disease: a target for neuroprotection.</article-title>
<source/><italic>Biomed. Res. Int.</italic>
<volume>2016</volume>:<issue>8090918</issue>. <pub-id pub-id-type="doi">10.1155/2016/8090918</pub-id>
<pub-id pub-id-type="pmid">27429982</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Koga</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>X. Y.</given-names></name><name><surname>Zhuo</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Spinal microglial motility is independent of neuronal activity and plasticity in adult mice.</article-title>
<source/><italic>Mol. Pain</italic>
<volume>6</volume>:<issue>19</issue>. <pub-id pub-id-type="doi">10.1186/1744-8069-6-19</pub-id>
<pub-id pub-id-type="pmid">20380706</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chew</surname><given-names>L. J.</given-names></name><name><surname>Fusar-Poli</surname><given-names>P.</given-names></name><name><surname>Schmitz</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.</article-title>
<source/><italic>Dev. Neurosci.</italic>
<volume>35</volume>
<fpage>102</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1159/000346157</pub-id>
<pub-id pub-id-type="pmid">23446060</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chhor</surname><given-names>V.</given-names></name><name><surname>Moretti</surname><given-names>R.</given-names></name><name><surname>Le Charpentier</surname><given-names>T.</given-names></name><name><surname>Sigaut</surname><given-names>S.</given-names></name><name><surname>Lebon</surname><given-names>S.</given-names></name><name><surname>Schwendimann</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Role of microglia in a mouse model of paediatric traumatic brain injury.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>63</volume>
<fpage>197</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2016.11.001</pub-id>
<pub-id pub-id-type="pmid">27818218</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>S. H.</given-names></name><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Kauppinen</surname><given-names>T. M.</given-names></name><name><surname>Halabisky</surname><given-names>B.</given-names></name><name><surname>Wes</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>286</volume>
<fpage>32713</fpage>–<lpage>32722</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.254268</pub-id>
<pub-id pub-id-type="pmid">21771791</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cipriani</surname><given-names>R.</given-names></name><name><surname>Villa</surname><given-names>P.</given-names></name><name><surname>Chece</surname><given-names>G.</given-names></name><name><surname>Lauro</surname><given-names>C.</given-names></name><name><surname>Paladini</surname><given-names>A.</given-names></name><name><surname>Micotti</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>16327</fpage>–<lpage>16335</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3611-11.2011</pub-id>
<pub-id pub-id-type="pmid">22072684</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cocucci</surname><given-names>E.</given-names></name><name><surname>Meldolesi</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Ectosomes and exosomes: shedding the confusion between extracellular vesicles.</article-title>
<source/><italic>Trends Cell Biol.</italic>
<volume>25</volume>
<fpage>364</fpage>–<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2015.01.004</pub-id>
<pub-id pub-id-type="pmid">25683921</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cocucci</surname><given-names>E.</given-names></name><name><surname>Racchetti</surname><given-names>G.</given-names></name><name><surname>Meldolesi</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Shedding microvesicles: artefacts no more.</article-title>
<source/><italic>Trends Cell Biol.</italic>
<volume>19</volume>
<fpage>43</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2008.11.003</pub-id>
<pub-id pub-id-type="pmid">19144520</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombo</surname><given-names>M.</given-names></name><name><surname>Raposo</surname><given-names>G.</given-names></name><name><surname>Thery</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles.</article-title>
<source/><italic>Annu. Rev. Cell. Dev. Biol.</italic>
<volume>30</volume>
<fpage>255</fpage>–<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-cellbio-101512-122326</pub-id>
<pub-id pub-id-type="pmid">25288114</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colonna</surname><given-names>M.</given-names></name><name><surname>Facchetti</surname><given-names>F.</given-names></name></person-group> (<year>2003</year>). <article-title>TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses.</article-title>
<source/><italic>J. Infect. Dis.</italic>
<volume>187(Suppl. 2)</volume>, <fpage>S397</fpage>–<lpage>S401</lpage>. <pub-id pub-id-type="doi">10.1086/374754</pub-id>
<pub-id pub-id-type="pmid">12792857</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Condello</surname><given-names>C.</given-names></name><name><surname>Yuan</surname><given-names>P.</given-names></name><name><surname>Schain</surname><given-names>A.</given-names></name><name><surname>Grutzendler</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Microglia constitute a barrier that prevents neurotoxic protofibrillar Abeta42 hotspots around plaques.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>6</volume>:<issue>6176</issue>. <pub-id pub-id-type="doi">10.1038/ncomms7176</pub-id>
<pub-id pub-id-type="pmid">25630253</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conductier</surname><given-names>G.</given-names></name><name><surname>Blondeau</surname><given-names>N.</given-names></name><name><surname>Guyon</surname><given-names>A.</given-names></name><name><surname>Nahon</surname><given-names>J. L.</given-names></name><name><surname>Rovere</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases.</article-title>
<source/><italic>J. Neuroimmunol.</italic>
<volume>224</volume>
<fpage>93</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2010.05.010</pub-id>
<pub-id pub-id-type="pmid">20681057</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coniglio</surname><given-names>S. J.</given-names></name><name><surname>Eugenin</surname><given-names>E.</given-names></name><name><surname>Dobrenis</surname><given-names>K.</given-names></name><name><surname>Stanley</surname><given-names>E. R.</given-names></name><name><surname>West</surname><given-names>B. L.</given-names></name><name><surname>Symons</surname><given-names>M. H.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling.</article-title>
<source/><italic>Mol. Med.</italic>
<volume>18</volume>
<fpage>519</fpage>–<lpage>527</lpage>. <pub-id pub-id-type="doi">10.2119/molmed.2011.00217</pub-id>
<pub-id pub-id-type="pmid">22294205</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corfas</surname><given-names>G.</given-names></name><name><surname>Roy</surname><given-names>K.</given-names></name><name><surname>Buxbaum</surname><given-names>J. D.</given-names></name></person-group> (<year>2004</year>). <article-title>Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>7</volume>
<fpage>575</fpage>–<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1038/nn1258</pub-id>
<pub-id pub-id-type="pmid">15162166</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corona</surname><given-names>A. W.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>O’Connor</surname><given-names>J. C.</given-names></name><name><surname>Dantzer</surname><given-names>R.</given-names></name><name><surname>Kelley</surname><given-names>K. W.</given-names></name><name><surname>Popovich</surname><given-names>P. G.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide.</article-title>
<source/><italic>J. Neuroinflamm.</italic>
<volume>7</volume>:<issue>93</issue>. <pub-id pub-id-type="doi">10.1186/1742-2094-7-93</pub-id>
<pub-id pub-id-type="pmid">21167054</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotter</surname><given-names>D.</given-names></name><name><surname>Mackay</surname><given-names>D.</given-names></name><name><surname>Chana</surname><given-names>G.</given-names></name><name><surname>Beasley</surname><given-names>C.</given-names></name><name><surname>Landau</surname><given-names>S.</given-names></name><name><surname>Everall</surname><given-names>I. P.</given-names></name></person-group> (<year>2002</year>). <article-title>Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder.</article-title>
<source/><italic>Cereb. Cortex</italic>
<volume>12</volume>
<fpage>386</fpage>–<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/12.4.386</pub-id>
<pub-id pub-id-type="pmid">11884354</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coughlan</surname><given-names>C. M.</given-names></name><name><surname>McManus</surname><given-names>C. M.</given-names></name><name><surname>Sharron</surname><given-names>M.</given-names></name><name><surname>Gao</surname><given-names>Z.</given-names></name><name><surname>Murphy</surname><given-names>D.</given-names></name><name><surname>Jaffer</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons.</article-title>
<source/><italic>Neuroscience</italic>
<volume>97</volume>
<fpage>591</fpage>–<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1016/S0306-4522(00)00024-5</pub-id>
<pub-id pub-id-type="pmid">10828541</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croese</surname><given-names>T.</given-names></name><name><surname>Furlan</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Extracellular vesicles in neurodegenerative diseases.</article-title>
<source/><italic>Mol. Aspects Med.</italic>
<volume>60</volume>
<fpage>52</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2017.11.006</pub-id>
<pub-id pub-id-type="pmid">29137922</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>C. L.</given-names></name><name><surname>Martinez-Cerdeno</surname><given-names>V.</given-names></name><name><surname>Noctor</surname><given-names>S. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Microglia regulate the number of neural precursor cells in the developing cerebral cortex.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>33</volume>
<fpage>4216</fpage>–<lpage>4233</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3441-12.2013</pub-id><pub-id pub-id-type="pmid">23467340</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalmau</surname><given-names>I.</given-names></name><name><surname>Vela</surname><given-names>J. M.</given-names></name><name><surname>Gonzalez</surname><given-names>B.</given-names></name><name><surname>Finsen</surname><given-names>B.</given-names></name><name><surname>Castellano</surname><given-names>B.</given-names></name></person-group> (<year>2003</year>). <article-title>Dynamics of microglia in the developing rat brain.</article-title>
<source/><italic>J. Comp. Neurol.</italic>
<volume>458</volume>
<fpage>144</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1002/cne.10572</pub-id>
<pub-id pub-id-type="pmid">12596255</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davalieva</surname><given-names>K.</given-names></name><name><surname>Maleva Kostovska</surname><given-names>I.</given-names></name><name><surname>Dwork</surname><given-names>A. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Proteomics research in schizophrenia.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>10</volume>:<issue>18</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2016.00018</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davalos</surname><given-names>D.</given-names></name><name><surname>Grutzendler</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Kim</surname><given-names>J. V.</given-names></name><name><surname>Zuo</surname><given-names>Y.</given-names></name><name><surname>Jung</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>ATP mediates rapid microglial response to local brain injury in vivo.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>8</volume>
<fpage>752</fpage>–<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1038/nn1472</pub-id>
<pub-id pub-id-type="pmid">15895084</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Biase</surname><given-names>L. M.</given-names></name><name><surname>Schuebel</surname><given-names>K. E.</given-names></name><name><surname>Fusfeld</surname><given-names>Z. H.</given-names></name><name><surname>Jair</surname><given-names>K.</given-names></name><name><surname>Hawes</surname><given-names>I. A.</given-names></name><name><surname>Cimbro</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Local cues establish and maintain region-specific phenotypes of basal ganglia microglia.</article-title>
<source/><italic>Neuron</italic>
<volume>95</volume>:<issue>e6</issue>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.06.020</pub-id>
<pub-id pub-id-type="pmid">28689984</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deczkowska</surname><given-names>A.</given-names></name><name><surname>Amit</surname><given-names>I.</given-names></name><name><surname>Schwartz</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Microglial immune checkpoint mechanisms.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>21</volume>
<fpage>779</fpage>–<lpage>786</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0145-x</pub-id>
<pub-id pub-id-type="pmid">29735982</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLeo</surname><given-names>A. M.</given-names></name><name><surname>Ikezu</surname><given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>Extracellular vesicle biology in alzheimer’s disease and related tauopathy.</article-title>
<source/><italic>J. Neuroimmune Pharmacol.</italic>
<volume>13</volume>
<fpage>292</fpage>–<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1007/s11481-017-9768-z</pub-id>
<pub-id pub-id-type="pmid">29185187</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denes</surname><given-names>A.</given-names></name><name><surname>Ferenczi</surname><given-names>S.</given-names></name><name><surname>Halasz</surname><given-names>J.</given-names></name><name><surname>Kornyei</surname><given-names>Z.</given-names></name><name><surname>Kovacs</surname><given-names>K. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse.</article-title>
<source/><italic>J. Cereb. Blood Flow Metab.</italic>
<volume>28</volume>
<fpage>1707</fpage>–<lpage>1721</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2008.64</pub-id>
<pub-id pub-id-type="pmid">18575457</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Koutras</surname><given-names>C.</given-names></name><name><surname>Donnelier</surname><given-names>J.</given-names></name><name><surname>Alshehri</surname><given-names>M.</given-names></name><name><surname>Fotouhi</surname><given-names>M.</given-names></name><name><surname>Girard</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Neurons export extracellular vesicles enriched in cysteine string protein and misfolded protein cargo.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>956</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-01115-6</pub-id>
<pub-id pub-id-type="pmid">28424476</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denieffe</surname><given-names>S.</given-names></name><name><surname>Kelly</surname><given-names>R. J.</given-names></name><name><surname>McDonald</surname><given-names>C.</given-names></name><name><surname>Lyons</surname><given-names>A.</given-names></name><name><surname>Lynch</surname><given-names>M. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Classical activation of microglia in CD200-deficient mice is a consequence of blood brain barrier permeability and infiltration of peripheral cells.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>34</volume>
<fpage>86</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2013.07.174</pub-id>
<pub-id pub-id-type="pmid">23916893</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dentesano</surname><given-names>G.</given-names></name><name><surname>Serratosa</surname><given-names>J.</given-names></name><name><surname>Tusell</surname><given-names>J. M.</given-names></name><name><surname>Ramon</surname><given-names>P.</given-names></name><name><surname>Valente</surname><given-names>T.</given-names></name><name><surname>Saura</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>CD200R1 and CD200 expression are regulated by PPAR-gamma in activated glial cells.</article-title>
<source/><italic>Glia</italic>
<volume>62</volume>
<fpage>982</fpage>–<lpage>998</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22656</pub-id>
<pub-id pub-id-type="pmid">24639050</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derynck</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>Y. E.</given-names></name></person-group> (<year>2003</year>). <article-title>Smad-dependent and smad-independent pathways in TGF-beta family signalling.</article-title>
<source/><italic>Nature</italic>
<volume>425</volume>
<fpage>577</fpage>–<lpage>584</lpage>. <pub-id pub-id-type="doi">10.1038/nature02006</pub-id>
<pub-id pub-id-type="pmid">14534577</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dibaj</surname><given-names>P.</given-names></name><name><surname>Nadrigny</surname><given-names>F.</given-names></name><name><surname>Steffens</surname><given-names>H.</given-names></name><name><surname>Scheller</surname><given-names>A.</given-names></name><name><surname>Hirrlinger</surname><given-names>J.</given-names></name><name><surname>Schomburg</surname><given-names>E. D.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>NO mediates microglial response to acute spinal cord injury under ATP control in vivo.</article-title>
<source/><italic>Glia</italic>
<volume>58</volume>
<fpage>1133</fpage>–<lpage>1144</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20993</pub-id>
<pub-id pub-id-type="pmid">20468054</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickens</surname><given-names>A. M.</given-names></name><name><surname>Romo Tovar</surname><given-names>L. B.</given-names></name><name><surname>Yoo</surname><given-names>S. W.</given-names></name><name><surname>Trout</surname><given-names>A. L.</given-names></name><name><surname>Bae</surname><given-names>M.</given-names></name><name><surname>Kanmogne</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Astrocyte-shed extracellular vesicles regulate the peripheral leukocyte response to inflammatory brain lesions.</article-title>
<source/><italic>Sci. Signal.</italic>
<volume>10</volume>:<issue>eaai7696</issue>. <pub-id pub-id-type="pmid">28377412</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dijkstra</surname><given-names>I. M.</given-names></name><name><surname>Hulshof</surname><given-names>S.</given-names></name><name><surname>van der Valk</surname><given-names>P.</given-names></name><name><surname>Boddeke</surname><given-names>H. W.</given-names></name><name><surname>Biber</surname><given-names>K.</given-names></name></person-group> (<year>2004</year>). <article-title>Cutting edge: activity of human adult microglia in response to CC chemokine ligand 21.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>172</volume>
<fpage>2744</fpage>–<lpage>2747</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.172.5.2744</pub-id>
<pub-id pub-id-type="pmid">14978072</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dirnagl</surname><given-names>U.</given-names></name></person-group> (<year>2012</year>). <article-title>Pathobiology of injury after stroke: the neurovascular unit and beyond.</article-title>
<source/><italic>Ann. N. Y. Acad. Sci.</italic>
<volume>1268</volume>
<fpage>21</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2012.06691.x</pub-id>
<pub-id pub-id-type="pmid">22994217</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dissing-Olesen</surname><given-names>L.</given-names></name><name><surname>LeDue</surname><given-names>J. M.</given-names></name><name><surname>Rungta</surname><given-names>R. L.</given-names></name><name><surname>Hefendehl</surname><given-names>J. K.</given-names></name><name><surname>Choi</surname><given-names>H. B.</given-names></name><name><surname>MacVicar</surname><given-names>B. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Activation of neuronal NMDA receptors triggers transient ATP-mediated microglial process outgrowth.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>34</volume>
<fpage>10511</fpage>–<lpage>10527</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0405-14.2014</pub-id>
<pub-id pub-id-type="pmid">25100586</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donat</surname><given-names>C. K.</given-names></name><name><surname>Scott</surname><given-names>G.</given-names></name><name><surname>Gentleman</surname><given-names>S. M.</given-names></name><name><surname>Sastre</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Microglial activation in traumatic brain injury.</article-title>
<source/><italic>Front. Aging Neurosci.</italic>
<volume>9</volume>:<issue>208</issue>
<pub-id pub-id-type="doi">10.3389/fnagi.2017.00208</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donohue</surname><given-names>M. M.</given-names></name><name><surname>Cain</surname><given-names>K.</given-names></name><name><surname>Zierath</surname><given-names>D.</given-names></name><name><surname>Shibata</surname><given-names>D.</given-names></name><name><surname>Tanzi</surname><given-names>P. M.</given-names></name><name><surname>Becker</surname><given-names>K. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Higher plasma fractalkine is associated with better 6-month outcome from ischemic stroke.</article-title>
<source/><italic>Stroke</italic>
<volume>43</volume>
<fpage>2300</fpage>–<lpage>2306</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.112.657411</pub-id>
<pub-id pub-id-type="pmid">22798324</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doorn</surname><given-names>K. J.</given-names></name><name><surname>Breve</surname><given-names>J. J.</given-names></name><name><surname>Drukarch</surname><given-names>B.</given-names></name><name><surname>Boddeke</surname><given-names>H. W.</given-names></name><name><surname>Huitinga</surname><given-names>I.</given-names></name><name><surname>Lucassen</surname><given-names>P. J.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Brain region-specific gene expression profiles in freshly isolated rat microglia.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>9</volume>:<issue>84</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00084</pub-id>
<pub-id pub-id-type="pmid">25814934</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dozio</surname><given-names>V.</given-names></name><name><surname>Sanchez</surname><given-names>J. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Characterisation of extracellular vesicle-subsets derived from brain endothelial cells and analysis of their protein cargo modulation after TNF exposure.</article-title>
<source/><italic>J. Extracell. Vesicles</italic>
<volume>6</volume>:<issue>1302705</issue>. <pub-id pub-id-type="doi">10.1080/20013078.2017.1302705</pub-id>
<pub-id pub-id-type="pmid">28473883</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drago</surname><given-names>F.</given-names></name><name><surname>Lombardi</surname><given-names>M.</given-names></name><name><surname>Prada</surname><given-names>I.</given-names></name><name><surname>Gabrielli</surname><given-names>M.</given-names></name><name><surname>Joshi</surname><given-names>P.</given-names></name><name><surname>Cojoc</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>ATP modifies the proteome of extracellular vesicles released by microglia and influences their action on astrocytes.</article-title>
<source/><italic>Front. Pharmacol.</italic>
<volume>8</volume>:<issue>910</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2017.00910</pub-id>
<pub-id pub-id-type="pmid">29321741</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>H. L.</given-names></name></person-group> (<year>2017</year>). <article-title>Role of microglia in neurological disorders and their potentials as a therapeutic target.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>54</volume>
<fpage>7567</fpage>–<lpage>7584</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-016-0245-0</pub-id>
<pub-id pub-id-type="pmid">27830532</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dworzak</surname><given-names>J.</given-names></name><name><surname>Renvoise</surname><given-names>B.</given-names></name><name><surname>Habchi</surname><given-names>J.</given-names></name><name><surname>Yates</surname><given-names>E. V.</given-names></name><name><surname>Combadiere</surname><given-names>C.</given-names></name><name><surname>Knowles</surname><given-names>T. P.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Neuronal Cx3cr1 deficiency protects against amyloid beta-induced neurotoxicity.</article-title>
<source/><italic>PLoS One</italic>
<volume>10</volume>:<issue>e0127730</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0127730</pub-id>
<pub-id pub-id-type="pmid">26038823</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elkabes</surname><given-names>S.</given-names></name><name><surname>DiCicco-Bloom</surname><given-names>E. M.</given-names></name><name><surname>Black</surname><given-names>I. B.</given-names></name></person-group> (<year>1996</year>). <article-title>Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>16</volume>
<fpage>2508</fpage>–<lpage>2521</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-08-02508.1996</pub-id>
<pub-id pub-id-type="pmid">8786427</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellison-Wright</surname><given-names>I.</given-names></name><name><surname>Bullmore</surname><given-names>E. T.</given-names></name></person-group> (<year>2009</year>). <article-title>Meta-analysis of diffusion tensor imaging studies in schizophrenia.</article-title>
<source/><italic>Schizophr. Res.</italic>
<volume>108</volume>
<fpage>3</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2008.11.021</pub-id>
<pub-id pub-id-type="pmid">19128945</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erturk</surname><given-names>A.</given-names></name><name><surname>Mentz</surname><given-names>S.</given-names></name><name><surname>Stout</surname><given-names>E. E.</given-names></name><name><surname>Hedehus</surname><given-names>M.</given-names></name><name><surname>Dominguez</surname><given-names>S. L.</given-names></name><name><surname>Neumaier</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Interfering with the chronic immune response rescues chronic degeneration after traumatic brain injury.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>36</volume>
<fpage>9962</fpage>–<lpage>9975</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1898-15.2016</pub-id>
<pub-id pub-id-type="pmid">27656033</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eyo</surname><given-names>U. B.</given-names></name><name><surname>Wu</surname><given-names>L. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Bidirectional microglia-neuron communication in the healthy brain.</article-title>
<source/><italic>Neural Plast.</italic>
<volume>2013</volume>:<issue>456857</issue>. <pub-id pub-id-type="doi">10.1155/2013/456857</pub-id>
<pub-id pub-id-type="pmid">24078884</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>K. M.</given-names></name><name><surname>Yang</surname><given-names>C. S.</given-names></name><name><surname>Sun</surname><given-names>S. H.</given-names></name><name><surname>Tzeng</surname><given-names>S. F.</given-names></name></person-group> (<year>2009</year>). <article-title>Microglial phagocytosis attenuated by short-term exposure to exogenous ATP through P2X receptor action.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>111</volume>
<fpage>1225</fpage>–<lpage>1237</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06409.x</pub-id>
<pub-id pub-id-type="pmid">19860838</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farhy-Tselnicker</surname><given-names>I.</given-names></name><name><surname>Allen</surname><given-names>N. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Astrocytes, neurons, synapses: a tripartite view on cortical circuit development.</article-title>
<source/><italic>Neural Dev.</italic>
<volume>13</volume>:<issue>7</issue>. <pub-id pub-id-type="doi">10.1186/s13064-018-0104-y</pub-id>
<pub-id pub-id-type="pmid">29712572</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faure</surname><given-names>J.</given-names></name><name><surname>Lachenal</surname><given-names>G.</given-names></name><name><surname>Court</surname><given-names>M.</given-names></name><name><surname>Hirrlinger</surname><given-names>J.</given-names></name><name><surname>Chatellard-Causse</surname><given-names>C.</given-names></name><name><surname>Blot</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Exosomes are released by cultured cortical neurones.</article-title>
<source/><italic>Mol. Cell Neurosci.</italic>
<volume>31</volume>
<fpage>642</fpage>–<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2005.12.003</pub-id>
<pub-id pub-id-type="pmid">16446100</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fazio</surname><given-names>F.</given-names></name><name><surname>Ulivieri</surname><given-names>M.</given-names></name><name><surname>Volpi</surname><given-names>C.</given-names></name><name><surname>Gargaro</surname><given-names>M.</given-names></name><name><surname>Fallarino</surname><given-names>F.</given-names></name></person-group> (<year>2018</year>). <article-title>Targeting metabotropic glutamate receptors for the treatment of neuroinflammation.</article-title>
<source/><italic>Curr. Opin. Pharmacol.</italic>
<volume>38</volume>
<fpage>16</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2018.01.010</pub-id>
<pub-id pub-id-type="pmid">29471184</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Febinger</surname><given-names>H. Y.</given-names></name><name><surname>Thomasy</surname><given-names>H. E.</given-names></name><name><surname>Pavlova</surname><given-names>M. N.</given-names></name><name><surname>Ringgold</surname><given-names>K. M.</given-names></name><name><surname>Barf</surname><given-names>P. R.</given-names></name><name><surname>George</surname><given-names>A. M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury.</article-title>
<source/><italic>J. Neuroinflamm.</italic>
<volume>12</volume>:<issue>154</issue>. <pub-id pub-id-type="doi">10.1186/s12974-015-0386-5</pub-id>
<pub-id pub-id-type="pmid">26329692</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>D.</given-names></name><name><surname>Chiozzi</surname><given-names>P.</given-names></name><name><surname>Falzoni</surname><given-names>S.</given-names></name><name><surname>Hanau</surname><given-names>S.</given-names></name><name><surname>Di Virgilio</surname><given-names>F.</given-names></name></person-group> (<year>1997</year>). <article-title>Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin.</article-title>
<source/><italic>J. Exp. Med.</italic>
<volume>185</volume>
<fpage>579</fpage>–<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1084/jem.185.3.579</pub-id>
<pub-id pub-id-type="pmid">9053458</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>D.</given-names></name><name><surname>Los</surname><given-names>M.</given-names></name><name><surname>Bauer</surname><given-names>M. K.</given-names></name><name><surname>Vandenabeele</surname><given-names>P.</given-names></name><name><surname>Wesselborg</surname><given-names>S.</given-names></name><name><surname>Schulze-Osthoff</surname><given-names>K.</given-names></name></person-group> (<year>1999</year>). <article-title>P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death.</article-title>
<source/><italic>FEBS Lett.</italic>
<volume>447</volume>
<fpage>71</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(99)00270-7</pub-id>
<pub-id pub-id-type="pmid">10218585</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrini</surname><given-names>F.</given-names></name><name><surname>De Koninck</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Microglia control neuronal network excitability via BDNF signalling.</article-title>
<source/><italic>Neural Plast.</italic>
<volume>2013</volume>:<issue>429815</issue>. <pub-id pub-id-type="doi">10.1155/2013/429815</pub-id>
<pub-id pub-id-type="pmid">24089642</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fields</surname><given-names>R. D.</given-names></name><name><surname>Burnstock</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>Purinergic signalling in neuron-glia interactions.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>7</volume>
<fpage>423</fpage>–<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1928</pub-id>
<pub-id pub-id-type="pmid">16715052</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filipello</surname><given-names>F.</given-names></name><name><surname>Morini</surname><given-names>R.</given-names></name><name><surname>Corradini</surname><given-names>I.</given-names></name><name><surname>Zerbi</surname><given-names>V.</given-names></name><name><surname>Canzi</surname><given-names>A.</given-names></name><name><surname>Michalski</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity.</article-title>
<source/><italic>Immunity</italic>
<volume>48</volume>:<issue>e8</issue>. <pub-id pub-id-type="doi">10.1016/j.immuni.2018.04.016</pub-id>
<pub-id pub-id-type="pmid">29752066</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzner</surname><given-names>D.</given-names></name><name><surname>Schnaars</surname><given-names>M.</given-names></name><name><surname>van Rossum</surname><given-names>D.</given-names></name><name><surname>Krishnamoorthy</surname><given-names>G.</given-names></name><name><surname>Dibaj</surname><given-names>P.</given-names></name><name><surname>Bakhti</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis.</article-title>
<source/><italic>J. Cell. Sci.</italic>
<volume>124</volume>
<fpage>447</fpage>–<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.074088</pub-id>
<pub-id pub-id-type="pmid">21242314</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonseca</surname><given-names>M. I.</given-names></name><name><surname>Ager</surname><given-names>R. R.</given-names></name><name><surname>Chu</surname><given-names>S. H.</given-names></name><name><surname>Yazan</surname><given-names>O.</given-names></name><name><surname>Sanderson</surname><given-names>S. D.</given-names></name><name><surname>LaFerla</surname><given-names>F. M.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer’s disease.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>183</volume>
<fpage>1375</fpage>–<lpage>1383</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0901005</pub-id>
<pub-id pub-id-type="pmid">19561098</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonseca</surname><given-names>M. I.</given-names></name><name><surname>Chu</surname><given-names>S. H.</given-names></name><name><surname>Hernandez</surname><given-names>M. X.</given-names></name><name><surname>Fang</surname><given-names>M. J.</given-names></name><name><surname>Modarresi</surname><given-names>L.</given-names></name><name><surname>Selvan</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain.</article-title>
<source/><italic>J. Neuroinflamm.</italic>
<volume>14</volume>:<issue>48</issue>. <pub-id pub-id-type="doi">10.1186/s12974-017-0814-9</pub-id>
<pub-id pub-id-type="pmid">28264694</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontainhas</surname><given-names>A. M.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Liang</surname><given-names>K. J.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Mettu</surname><given-names>P.</given-names></name><name><surname>Damani</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Microglial morphology and dynamic behavior is regulated by ionotropic glutamatergic and GABAergic neurotransmission.</article-title>
<source/><italic>PLoS One</italic>
<volume>6</volume>:<issue>e15973</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0015973</pub-id>
<pub-id pub-id-type="pmid">21283568</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fornito</surname><given-names>A.</given-names></name><name><surname>Yucel</surname><given-names>M.</given-names></name><name><surname>Patti</surname><given-names>J.</given-names></name><name><surname>Wood</surname><given-names>S. J.</given-names></name><name><surname>Pantelis</surname><given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies.</article-title>
<source/><italic>Schizophr. Res.</italic>
<volume>108</volume>
<fpage>104</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2008.12.011</pub-id>
<pub-id pub-id-type="pmid">19157788</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fruhbeis</surname><given-names>C.</given-names></name><name><surname>Frohlich</surname><given-names>D.</given-names></name><name><surname>Kuo</surname><given-names>W. P.</given-names></name><name><surname>Amphornrat</surname><given-names>J.</given-names></name><name><surname>Thilemann</surname><given-names>S.</given-names></name><name><surname>Saab</surname><given-names>A. S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication.</article-title>
<source/><italic>PLoS Biol.</italic>
<volume>11</volume>:<issue>e1001604</issue>. <pub-id pub-id-type="doi">10.1371/journal.pbio.1001604</pub-id>
<pub-id pub-id-type="pmid">23874151</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabrielli</surname><given-names>M.</given-names></name><name><surname>Battista</surname><given-names>N.</given-names></name><name><surname>Riganti</surname><given-names>L.</given-names></name><name><surname>Prada</surname><given-names>I.</given-names></name><name><surname>Antonucci</surname><given-names>F.</given-names></name><name><surname>Cantone</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Active endocannabinoids are secreted on extracellular membrane vesicles.</article-title>
<source/><italic>EMBO Rep.</italic>
<volume>16</volume>
<fpage>213</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.15252/embr.201439668</pub-id>
<pub-id pub-id-type="pmid">25568329</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabrusiewicz</surname><given-names>K.</given-names></name><name><surname>Ellert-Miklaszewska</surname><given-names>A.</given-names></name><name><surname>Lipko</surname><given-names>M.</given-names></name><name><surname>Sielska</surname><given-names>M.</given-names></name><name><surname>Frankowska</surname><given-names>M.</given-names></name><name><surname>Kaminska</surname><given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title>Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas.</article-title>
<source/><italic>PLoS One</italic>
<volume>6</volume>:<issue>e23902</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0023902</pub-id>
<pub-id pub-id-type="pmid">21901144</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganzola</surname><given-names>R.</given-names></name><name><surname>Duchesne</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Voxel-based morphometry meta-analysis of gray and white matter finds significant areas of differences in bipolar patients from healthy controls.</article-title>
<source/><italic>Bipolar. Disord.</italic>
<volume>19</volume>
<fpage>74</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1111/bdi.12488</pub-id>
<pub-id pub-id-type="pmid">28444949</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garey</surname><given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>When cortical development goes wrong: schizophrenia as a neurodevelopmental disease of microcircuits.</article-title>
<source/><italic>J. Anat.</italic>
<volume>217</volume>
<fpage>324</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7580.2010.01231.x</pub-id>
<pub-id pub-id-type="pmid">20408906</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garton</surname><given-names>K. J.</given-names></name><name><surname>Gough</surname><given-names>P. J.</given-names></name><name><surname>Blobel</surname><given-names>C. P.</given-names></name><name><surname>Murphy</surname><given-names>G.</given-names></name><name><surname>Greaves</surname><given-names>D. R.</given-names></name><name><surname>Dempsey</surname><given-names>P. J.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>276</volume>
<fpage>37993</fpage>–<lpage>38001</lpage>. <pub-id pub-id-type="pmid">11495925</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garzetti</surname><given-names>L.</given-names></name><name><surname>Menon</surname><given-names>R.</given-names></name><name><surname>Finardi</surname><given-names>A.</given-names></name><name><surname>Bergami</surname><given-names>A.</given-names></name><name><surname>Sica</surname><given-names>A.</given-names></name><name><surname>Martino</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs.</article-title>
<source/><italic>J. Leukoc. Biol.</italic>
<volume>95</volume>
<fpage>817</fpage>–<lpage>825</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0913485</pub-id>
<pub-id pub-id-type="pmid">24379213</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gertig</surname><given-names>U.</given-names></name><name><surname>Hanisch</surname><given-names>U. K.</given-names></name></person-group> (<year>2014</year>). <article-title>Microglial diversity by responses and responders.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>8</volume>:<issue>101</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00101</pub-id>
<pub-id pub-id-type="pmid">24744702</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname><given-names>F.</given-names></name><name><surname>Greter</surname><given-names>M.</given-names></name><name><surname>Leboeuf</surname><given-names>M.</given-names></name><name><surname>Nandi</surname><given-names>S.</given-names></name><name><surname>See</surname><given-names>P.</given-names></name><name><surname>Gokhan</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Fate mapping analysis reveals that adult microglia derive from primitive macrophages.</article-title>
<source/><italic>Science</italic>
<volume>330</volume>
<fpage>841</fpage>–<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1126/science.1194637</pub-id>
<pub-id pub-id-type="pmid">20966214</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname><given-names>F.</given-names></name><name><surname>Lim</surname><given-names>S.</given-names></name><name><surname>Hoeffel</surname><given-names>G.</given-names></name><name><surname>Low</surname><given-names>D.</given-names></name><name><surname>Huber</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Origin and differentiation of microglia.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>7</volume>:<issue>45</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2013.00045</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname><given-names>F.</given-names></name><name><surname>Prinz</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Origin of microglia: current concepts and past controversies.</article-title>
<source/><italic>Cold Spring Harb. Perspect. Biol.</italic>
<volume>7</volume>:<issue>a020537</issue>. <pub-id pub-id-type="doi">10.1101/cshperspect.a020537</pub-id>
<pub-id pub-id-type="pmid">26134003</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glebov</surname><given-names>K.</given-names></name><name><surname>Lochner</surname><given-names>M.</given-names></name><name><surname>Jabs</surname><given-names>R.</given-names></name><name><surname>Lau</surname><given-names>T.</given-names></name><name><surname>Merkel</surname><given-names>O.</given-names></name><name><surname>Schloss</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Serotonin stimulates secretion of exosomes from microglia cells.</article-title>
<source/><italic>Glia</italic>
<volume>63</volume>
<fpage>626</fpage>–<lpage>634</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22772</pub-id>
<pub-id pub-id-type="pmid">25451814</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldsmith</surname><given-names>D. R.</given-names></name><name><surname>Rapaport</surname><given-names>M. H.</given-names></name><name><surname>Miller</surname><given-names>B. J.</given-names></name></person-group> (<year>2016</year>). <article-title>A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>21</volume>
<fpage>1696</fpage>–<lpage>1709</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.3</pub-id>
<pub-id pub-id-type="pmid">26903267</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottmann</surname><given-names>K.</given-names></name><name><surname>Mittmann</surname><given-names>T.</given-names></name><name><surname>Lessmann</surname><given-names>V.</given-names></name></person-group> (<year>2009</year>). <article-title>BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses.</article-title>
<source/><italic>Exp. Brain Res.</italic>
<volume>199</volume>
<fpage>203</fpage>–<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1007/s00221-009-1994-z</pub-id>
<pub-id pub-id-type="pmid">19777221</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabert</surname><given-names>K.</given-names></name><name><surname>Michoel</surname><given-names>T.</given-names></name><name><surname>Karavolos</surname><given-names>M. H.</given-names></name><name><surname>Clohisey</surname><given-names>S.</given-names></name><name><surname>Baillie</surname><given-names>J. K.</given-names></name><name><surname>Stevens</surname><given-names>M. P.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Microglial brain region-dependent diversity and selective regional sensitivities to aging.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>19</volume>
<fpage>504</fpage>–<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4222</pub-id>
<pub-id pub-id-type="pmid">26780511</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graeber</surname><given-names>M. B.</given-names></name><name><surname>Streit</surname><given-names>W. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Microglia: biology and pathology.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>119</volume>
<fpage>89</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-009-0622-0</pub-id>
<pub-id pub-id-type="pmid">20012873</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grathwohl</surname><given-names>S. A.</given-names></name><name><surname>Kalin</surname><given-names>R. E.</given-names></name><name><surname>Bolmont</surname><given-names>T.</given-names></name><name><surname>Prokop</surname><given-names>S.</given-names></name><name><surname>Winkelmann</surname><given-names>G.</given-names></name><name><surname>Kaeser</surname><given-names>S. A.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Formation and maintenance of Alzheimer’s disease beta-amyloid plaques in the absence of microglia.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>12</volume>
<fpage>1361</fpage>–<lpage>1363</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2432</pub-id>
<pub-id pub-id-type="pmid">19838177</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greco</surname><given-names>V.</given-names></name><name><surname>Hannus</surname><given-names>M.</given-names></name><name><surname>Eaton</surname><given-names>S.</given-names></name></person-group> (<year>2001</year>). <article-title>Argosomes: a potential vehicle for the spread of morphogens through epithelia.</article-title>
<source/><italic>Cell</italic>
<volume>106</volume>
<fpage>633</fpage>–<lpage>645</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(01)00484-6</pub-id>
<pub-id pub-id-type="pmid">11551510</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>M.</given-names></name><name><surname>Neal</surname><given-names>J. W.</given-names></name><name><surname>Gasque</surname><given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins.</article-title>
<source/><italic>Int. Rev. Neurobiol.</italic>
<volume>82</volume>
<fpage>29</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/S0074-7742(07)82002-2</pub-id>
<pub-id pub-id-type="pmid">17678954</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimmig</surname><given-names>B.</given-names></name><name><surname>Morganti</surname><given-names>J.</given-names></name><name><surname>Nash</surname><given-names>K.</given-names></name><name><surname>Bickford</surname><given-names>P. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Immunomodulators as therapeutic agents in mitigating the progression of Parkinson’s disease.</article-title>
<source/><italic>Brain Sci.</italic>
<volume>6</volume>:<issue>E41</issue>. <pub-id pub-id-type="doi">10.3390/brainsci6040041</pub-id>
<pub-id pub-id-type="pmid">27669315</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillemin</surname><given-names>G. J.</given-names></name><name><surname>Croitoru-Lamoury</surname><given-names>J.</given-names></name><name><surname>Dormont</surname><given-names>D.</given-names></name><name><surname>Armati</surname><given-names>P. J.</given-names></name><name><surname>Brew</surname><given-names>B. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes.</article-title>
<source/><italic>Glia</italic>
<volume>41</volume>
<fpage>371</fpage>–<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1002/glia.10175</pub-id>
<pub-id pub-id-type="pmid">12555204</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guix</surname><given-names>F. X.</given-names></name><name><surname>Corbett</surname><given-names>G. T.</given-names></name><name><surname>Cha</surname><given-names>D. J.</given-names></name><name><surname>Mustapic</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Mengel</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Detection of aggregation-competent tau in neuron-derived extracellular vesicles.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>19</volume>:<issue>E663</issue>. <pub-id pub-id-type="doi">10.3390/ijms19030663</pub-id>
<pub-id pub-id-type="pmid">29495441</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyorgy</surname><given-names>B.</given-names></name><name><surname>Szabo</surname><given-names>T. G.</given-names></name><name><surname>Pasztoi</surname><given-names>M.</given-names></name><name><surname>Pal</surname><given-names>Z.</given-names></name><name><surname>Misjak</surname><given-names>P.</given-names></name><name><surname>Aradi</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles.</article-title>
<source/><italic>Cell Mol. Life Sci.</italic>
<volume>68</volume>
<fpage>2667</fpage>–<lpage>2688</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-011-0689-3</pub-id>
<pub-id pub-id-type="pmid">21560073</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haarman</surname><given-names>B. C.</given-names></name><name><surname>Riemersma-Van</surname></name><name><surname>der Lek</surname><given-names>R. F.</given-names></name><name><surname>de Groot</surname></name><name><surname>Ruhe</surname><given-names>J. C. H. G.</given-names></name><name><surname>Klein</surname><given-names>H. C.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Neuroinflammation in bipolar disorder – A [(11)C]-(R)-PK11195 positron emission tomography study.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>40</volume>
<fpage>219</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2014.03.016</pub-id>
<pub-id pub-id-type="pmid">24703991</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagino</surname><given-names>Y.</given-names></name><name><surname>Kariura</surname><given-names>Y.</given-names></name><name><surname>Manago</surname><given-names>Y.</given-names></name><name><surname>Amano</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Sekiguchi</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia.</article-title>
<source/><italic>Glia</italic>
<volume>47</volume>
<fpage>68</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20034</pub-id>
<pub-id pub-id-type="pmid">15139014</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hambardzumyan</surname><given-names>D.</given-names></name><name><surname>Gutmann</surname><given-names>D. H.</given-names></name><name><surname>Kettenmann</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>The role of microglia and macrophages in glioma maintenance and progression.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>19</volume>
<fpage>20</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4185</pub-id>
<pub-id pub-id-type="pmid">26713745</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanisch</surname><given-names>U. K.</given-names></name></person-group> (<year>2002</year>). <article-title>Microglia as a source and target of cytokines.</article-title>
<source/><italic>Glia</italic>
<volume>40</volume>
<fpage>140</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1002/glia.10161</pub-id>
<pub-id pub-id-type="pmid">12379902</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanisch</surname><given-names>U. K.</given-names></name><name><surname>Kettenmann</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Microglia: active sensor and versatile effector cells in the normal and pathologic brain.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>10</volume>
<fpage>1387</fpage>–<lpage>1394</lpage>. <pub-id pub-id-type="doi">10.1038/nn1997</pub-id>
<pub-id pub-id-type="pmid">17965659</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanlon</surname><given-names>L. A.</given-names></name><name><surname>Huh</surname><given-names>J. W.</given-names></name><name><surname>Raghupathi</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Minocycline transiently reduces microglia/macrophage activation but exacerbates cognitive deficits following repetitive traumatic brain injury in the neonatal rat.</article-title>
<source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>75</volume>
<fpage>214</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1093/jnen/nlv021</pub-id>
<pub-id pub-id-type="pmid">26825312</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>J. K.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Xia</surname><given-names>Y.</given-names></name><name><surname>Maciejewski</surname><given-names>D.</given-names></name><name><surname>McNamara</surname><given-names>R. K.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>95</volume>
<fpage>10896</fpage>–<lpage>10901</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.18.10896</pub-id>
<pub-id pub-id-type="pmid">9724801</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatori</surname><given-names>K.</given-names></name><name><surname>Nagai</surname><given-names>A.</given-names></name><name><surname>Heisel</surname><given-names>R.</given-names></name><name><surname>Ryu</surname><given-names>J. K.</given-names></name><name><surname>Kim</surname><given-names>S. U.</given-names></name></person-group> (<year>2002</year>). <article-title>Fractalkine and fractalkine receptors in human neurons and glial cells.</article-title>
<source/><italic>J. Neurosci. Res.</italic>
<volume>69</volume>
<fpage>418</fpage>–<lpage>426</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.10304</pub-id>
<pub-id pub-id-type="pmid">12125082</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayakawa</surname><given-names>K.</given-names></name><name><surname>Pham</surname><given-names>L. D.</given-names></name><name><surname>Seo</surname><given-names>J. H.</given-names></name><name><surname>Miyamoto</surname><given-names>N.</given-names></name><name><surname>Maki</surname><given-names>T.</given-names></name><name><surname>Terasaki</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2016a</year>). <article-title>CD200 restrains macrophage attack on oligodendrocyte precursors via toll-like receptor 4 downregulation.</article-title>
<source/><italic>J. Cereb. Blood Flow Metab.</italic>
<volume>36</volume>
<fpage>781</fpage>–<lpage>793</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X15606148</pub-id>
<pub-id pub-id-type="pmid">26661156</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayakawa</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Lo</surname><given-names>E. H.</given-names></name></person-group> (<year>2016b</year>). <article-title>CD200 increases alternatively activated macrophages through cAMP-response element binding protein – C/EBP-beta signaling.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>136</volume>
<fpage>900</fpage>–<lpage>906</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13492</pub-id>
<pub-id pub-id-type="pmid">26670206</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haynes</surname><given-names>S. E.</given-names></name><name><surname>Hollopeter</surname><given-names>G.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Kurpius</surname><given-names>D.</given-names></name><name><surname>Dailey</surname><given-names>M. E.</given-names></name><name><surname>Gan</surname><given-names>W. B.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>The P2Y12 receptor regulates microglial activation by extracellular nucleotides.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>9</volume>
<fpage>1512</fpage>–<lpage>1519</lpage>. <pub-id pub-id-type="doi">10.1038/nn1805</pub-id>
<pub-id pub-id-type="pmid">17115040</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Qian</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Astrocyte-derived CCL2 is associated with M1 activation and recruitment of cultured microglial cells.</article-title>
<source/><italic>Cell Physiol. Biochem.</italic>
<volume>38</volume>
<fpage>859</fpage>–<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1159/000443040</pub-id>
<pub-id pub-id-type="pmid">26910882</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hellwig</surname><given-names>S.</given-names></name><name><surname>Brioschi</surname><given-names>S.</given-names></name><name><surname>Dieni</surname><given-names>S.</given-names></name><name><surname>Frings</surname><given-names>L.</given-names></name><name><surname>Masuch</surname><given-names>A.</given-names></name><name><surname>Blank</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Altered microglia morphology and higher resilience to stress-induced depression-like behavior in CX3CR1-deficient mice.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>55</volume>
<fpage>126</fpage>–<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2015.11.008</pub-id>
<pub-id pub-id-type="pmid">26576722</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heneka</surname><given-names>M. T.</given-names></name><name><surname>Kummer</surname><given-names>M. P.</given-names></name><name><surname>Latz</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Innate immune activation in neurodegenerative disease.</article-title>
<source/><italic>Nat. Rev. Immunol.</italic>
<volume>14</volume>
<fpage>463</fpage>–<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1038/nri3705</pub-id>
<pub-id pub-id-type="pmid">24962261</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heneka</surname><given-names>M. T.</given-names></name><name><surname>Kummer</surname><given-names>M. P.</given-names></name><name><surname>Stutz</surname><given-names>A.</given-names></name><name><surname>Delekate</surname><given-names>A.</given-names></name><name><surname>Schwartz</surname><given-names>S.</given-names></name><name><surname>Vieira-Saecker</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice.</article-title>
<source/><italic>Nature</italic>
<volume>493</volume>
<fpage>674</fpage>–<lpage>678</lpage>. <pub-id pub-id-type="doi">10.1038/nature11729</pub-id>
<pub-id pub-id-type="pmid">23254930</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hercher</surname><given-names>C.</given-names></name><name><surname>Chopra</surname><given-names>V.</given-names></name><name><surname>Beasley</surname><given-names>C. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder.</article-title>
<source/><italic>J. Psychiatry Neurosci.</italic>
<volume>39</volume>
<fpage>376</fpage>–<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1503/jpn.130277</pub-id>
<pub-id pub-id-type="pmid">24936776</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernangomez</surname><given-names>M.</given-names></name><name><surname>Mestre</surname><given-names>L.</given-names></name><name><surname>Correa</surname><given-names>F. G.</given-names></name><name><surname>Loria</surname><given-names>F.</given-names></name><name><surname>Mecha</surname><given-names>M.</given-names></name><name><surname>Inigo</surname><given-names>P. M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.</article-title>
<source/><italic>Glia</italic>
<volume>60</volume>
<fpage>1437</fpage>–<lpage>1450</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22366</pub-id>
<pub-id pub-id-type="pmid">22653796</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinwood</surname><given-names>M.</given-names></name><name><surname>Morandini</surname><given-names>J.</given-names></name><name><surname>Day</surname><given-names>T. A.</given-names></name><name><surname>Walker</surname><given-names>F. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex.</article-title>
<source/><italic>Cereb. Cortex</italic>
<volume>22</volume>
<fpage>1442</fpage>–<lpage>1454</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhr229</pub-id>
<pub-id pub-id-type="pmid">21878486</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hishii</surname><given-names>M.</given-names></name><name><surname>Nitta</surname><given-names>T.</given-names></name><name><surname>Ishida</surname><given-names>H.</given-names></name><name><surname>Ebato</surname><given-names>M.</given-names></name><name><surname>Kurosu</surname><given-names>A.</given-names></name><name><surname>Yagita</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>1995</year>). <article-title>Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro.</article-title>
<source/><italic>Neurosurgery</italic>
<volume>37</volume>
<fpage>1160</fpage>–<lpage>1166</lpage>; <comment>discussion</comment>
<fpage>66</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1227/00006123-199512000-00016</pub-id>
<pub-id pub-id-type="pmid">8584157</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeffel</surname><given-names>G.</given-names></name><name><surname>Ginhoux</surname><given-names>F.</given-names></name></person-group> (<year>2018</year>). <article-title>Fetal monocytes and the origins of tissue-resident macrophages.</article-title>
<source/><italic>Cell Immunol.</italic>
<volume>330</volume>
<fpage>5</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellimm.2018.01.001</pub-id>
<pub-id pub-id-type="pmid">29475558</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoek</surname><given-names>R. M.</given-names></name><name><surname>Ruuls</surname><given-names>S. R.</given-names></name><name><surname>Murphy</surname><given-names>C. A.</given-names></name><name><surname>Wright</surname><given-names>G. J.</given-names></name><name><surname>Goddard</surname><given-names>R.</given-names></name><name><surname>Zurawski</surname><given-names>S. M.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Down-regulation of the macrophage lineage through interaction with OX2 (CD200).</article-title>
<source/><italic>Science</italic>
<volume>290</volume>
<fpage>1768</fpage>–<lpage>1771</lpage>. <pub-id pub-id-type="doi">10.1126/science.290.5497.1768</pub-id>
<pub-id pub-id-type="pmid">11099416</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>S.</given-names></name><name><surname>Beja-Glasser</surname><given-names>V. F.</given-names></name><name><surname>Nfonoyim</surname><given-names>B. M.</given-names></name><name><surname>Frouin</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Ramakrishnan</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Complement and microglia mediate early synapse loss in Alzheimer mouse models.</article-title>
<source/><italic>Science</italic>
<volume>352</volume>
<fpage>712</fpage>–<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad8373</pub-id>
<pub-id pub-id-type="pmid">27033548</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname><given-names>C.</given-names></name><name><surname>Sainz-Fuertes</surname><given-names>R.</given-names></name><name><surname>Lynham</surname><given-names>S.</given-names></name><name><surname>Hye</surname><given-names>A.</given-names></name><name><surname>Killick</surname><given-names>R.</given-names></name><name><surname>Warley</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Wnt3a induces exosome secretion from primary cultured rat microglia.</article-title>
<source/><italic>BMC Neurosci.</italic>
<volume>13</volume>:<issue>144</issue>. <pub-id pub-id-type="doi">10.1186/1471-2202-13-144</pub-id>
<pub-id pub-id-type="pmid">23173708</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoshiko</surname><given-names>M.</given-names></name><name><surname>Arnoux</surname><given-names>I.</given-names></name><name><surname>Avignone</surname><given-names>E.</given-names></name><name><surname>Yamamoto</surname><given-names>N.</given-names></name><name><surname>Audinat</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Deficiency of the microglial receptor CX3CR1 impairs postnatal functional development of thalamocortical synapses in the barrel cortex.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>15106</fpage>–<lpage>15111</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1167-12.2012</pub-id>
<pub-id pub-id-type="pmid">23100431</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>C. L.</given-names></name><name><surname>Koike</surname><given-names>M.</given-names></name><name><surname>Spusta</surname><given-names>S. C.</given-names></name><name><surname>Niemi</surname><given-names>E. C.</given-names></name><name><surname>Yenari</surname><given-names>M.</given-names></name><name><surname>Nakamura</surname><given-names>M. C.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>109</volume>
<fpage>1144</fpage>–<lpage>1156</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06042.x</pub-id>
<pub-id pub-id-type="pmid">19302484</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Leak</surname><given-names>R. K.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia.</article-title>
<source/><italic>Stroke</italic>
<volume>43</volume>
<fpage>3063</fpage>–<lpage>3070</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.112.659656</pub-id>
<pub-id pub-id-type="pmid">22933588</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Ge</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>Z.</given-names></name><name><surname>Yin</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons.</article-title>
<source/><italic>FASEB J.</italic>
<volume>32</volume>
<fpage>512</fpage>–<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201700673R</pub-id>
<pub-id pub-id-type="pmid">28935818</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>P. M.</given-names></name><name><surname>Botham</surname><given-names>M. S.</given-names></name><name><surname>Frentzel</surname><given-names>S.</given-names></name><name><surname>Mir</surname><given-names>A.</given-names></name><name><surname>Perry</surname><given-names>V. H.</given-names></name></person-group> (<year>2002</year>). <article-title>Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS.</article-title>
<source/><italic>Glia</italic>
<volume>37</volume>
<fpage>314</fpage>–<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1002/glia.10037</pub-id>
<pub-id pub-id-type="pmid">11870871</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>T.</given-names></name><name><surname>Hieshima</surname><given-names>K.</given-names></name><name><surname>Haskell</surname><given-names>C.</given-names></name><name><surname>Baba</surname><given-names>M.</given-names></name><name><surname>Nagira</surname><given-names>M.</given-names></name><name><surname>Nishimura</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.</article-title>
<source/><italic>Cell</italic>
<volume>91</volume>
<fpage>521</fpage>–<lpage>530</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80438-9</pub-id>
<pub-id pub-id-type="pmid">9390561</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishizuka</surname><given-names>K.</given-names></name><name><surname>Fujita</surname><given-names>Y.</given-names></name><name><surname>Kawabata</surname><given-names>T.</given-names></name><name><surname>Kimura</surname><given-names>H.</given-names></name><name><surname>Iwayama</surname><given-names>Y.</given-names></name><name><surname>Inada</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>7</volume>:<issue>e1184</issue>. <pub-id pub-id-type="doi">10.1038/tp.2017.173</pub-id>
<pub-id pub-id-type="pmid">28763059</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jablonski</surname><given-names>K. A.</given-names></name><name><surname>Gaudet</surname><given-names>A. D.</given-names></name><name><surname>Amici</surname><given-names>S. A.</given-names></name><name><surname>Popovich</surname><given-names>P. G.</given-names></name><name><surname>Guerau-de-Arellano</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Control of the inflammatory macrophage transcriptional signature by miR-155.</article-title>
<source/><italic>PLoS One</italic>
<volume>11</volume>:<issue>e0159724</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0159724</pub-id>
<pub-id pub-id-type="pmid">27447824</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>S.</given-names></name><name><surname>Bhaskar</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Dynamics of the complement, cytokine, and chemokine systems in the regulation of synaptic function and dysfunction relevant to Alzheimer’s disease.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>57</volume>
<fpage>1123</fpage>–<lpage>1135</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-161123</pub-id>
<pub-id pub-id-type="pmid">28372329</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Jiang</surname><given-names>J. X.</given-names></name><name><surname>Zhang</surname><given-names>G. X.</given-names></name></person-group> (<year>2014</year>). <article-title>Macrophages: a double-edged sword in experimental autoimmune encephalomyelitis.</article-title>
<source/><italic>Immunol. Lett.</italic>
<volume>160</volume>
<fpage>17</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.imlet.2014.03.006</pub-id>
<pub-id pub-id-type="pmid">24698730</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Guan</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Liang</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Contribution of SDF-1alpha/CXCR4 signaling to brain development and glioma progression.</article-title>
<source/><italic>Neurosignals</italic>
<volume>21</volume>
<fpage>240</fpage>–<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1159/000339091</pub-id>
<pub-id pub-id-type="pmid">22922481</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>N.</given-names></name><name><surname>Gao</surname><given-names>L.</given-names></name><name><surname>Fan</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Friend or Foe? Resident microglia vs bone marrow-derived microglia and their roles in the retinal degeneration.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>54</volume>
<fpage>4094</fpage>–<lpage>4112</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-016-9960-9</pub-id>
<pub-id pub-id-type="pmid">27318678</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joe</surname><given-names>E. H.</given-names></name><name><surname>Choi</surname><given-names>D. J.</given-names></name><name><surname>An</surname><given-names>J.</given-names></name><name><surname>Eun</surname><given-names>J. H.</given-names></name><name><surname>Jou</surname><given-names>I.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Astrocytes, microglia, and Parkinson’s disease.</article-title>
<source/><italic>Exp. Neurobiol.</italic>
<volume>27</volume>
<fpage>77</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.5607/en.2018.27.2.77</pub-id>
<pub-id pub-id-type="pmid">29731673</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname><given-names>G. R.</given-names></name><name><surname>Lee</surname><given-names>S. C.</given-names></name><name><surname>Brosnan</surname><given-names>C. F.</given-names></name></person-group> (<year>2003</year>). <article-title>Cytokines: powerful regulators of glial cell activation.</article-title>
<source/><italic>Neuroscientist</italic>
<volume>9</volume>
<fpage>10</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1177/1073858402239587</pub-id>
<pub-id pub-id-type="pmid">12580336</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>P.</given-names></name><name><surname>Turola</surname><given-names>E.</given-names></name><name><surname>Ruiz</surname><given-names>A.</given-names></name><name><surname>Bergami</surname><given-names>A.</given-names></name><name><surname>Libera</surname><given-names>D. D.</given-names></name><name><surname>Benussi</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Microglia convert aggregated amyloid-beta into neurotoxic forms through the shedding of microvesicles.</article-title>
<source/><italic>Cell Death Differ.</italic>
<volume>21</volume>
<fpage>582</fpage>–<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2013.180</pub-id>
<pub-id pub-id-type="pmid">24336048</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joundi</surname><given-names>R. A.</given-names></name><name><surname>Rabinstein</surname><given-names>A. A.</given-names></name><name><surname>Nikneshan</surname><given-names>D.</given-names></name><name><surname>Tu</surname><given-names>J. V.</given-names></name><name><surname>Fang</surname><given-names>J.</given-names></name><name><surname>Holloway</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Cardiac arrest in acute ischemic stroke: incidence, predisposing factors, and clinical outcomes.</article-title>
<source/><italic>J. Stroke Cerebrovasc. Dis.</italic>
<volume>25</volume>
<fpage>1644</fpage>–<lpage>1652</lpage>. <pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2016.03.010</pub-id>
<pub-id pub-id-type="pmid">27067880</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>S.</given-names></name><name><surname>Aliberti</surname><given-names>J.</given-names></name><name><surname>Graemmel</surname><given-names>P.</given-names></name><name><surname>Sunshine</surname><given-names>M. J.</given-names></name><name><surname>Kreutzberg</surname><given-names>G. W.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion.</article-title>
<source/><italic>Mol. Cell Biol.</italic>
<volume>20</volume>
<fpage>4106</fpage>–<lpage>4114</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.20.11.4106-4114.2000</pub-id>
<pub-id pub-id-type="pmid">10805752</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>Y. J.</given-names></name><name><surname>Chung</surname><given-names>W. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Phagocytic roles of glial cells in healthy and diseased brains.</article-title>
<source/><italic>Biomol. Ther. (Seoul)</italic>
<volume>26</volume>
<fpage>350</fpage>–<lpage>357</lpage>. <pub-id pub-id-type="doi">10.4062/biomolther.2017.133</pub-id>
<pub-id pub-id-type="pmid">29316776</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>H. J.</given-names></name><name><surname>Voleti</surname><given-names>B.</given-names></name><name><surname>Hajszan</surname><given-names>T.</given-names></name><name><surname>Rajkowska</surname><given-names>G.</given-names></name><name><surname>Stockmeier</surname><given-names>C. A.</given-names></name><name><surname>Licznerski</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Decreased expression of synapse-related genes and loss of synapses in major depressive disorder.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>18</volume>
<fpage>1413</fpage>–<lpage>1417</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2886</pub-id>
<pub-id pub-id-type="pmid">22885997</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlstetter</surname><given-names>M.</given-names></name><name><surname>Scholz</surname><given-names>R.</given-names></name><name><surname>Rutar</surname><given-names>M.</given-names></name><name><surname>Wong</surname><given-names>W. T.</given-names></name><name><surname>Provis</surname><given-names>J. M.</given-names></name><name><surname>Langmann</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>Retinal microglia: just bystander or target for therapy?</article-title>
<source/><italic>Prog. Retin. Eye Res.</italic>
<volume>45</volume>
<fpage>30</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.preteyeres.2014.11.004</pub-id>
<pub-id pub-id-type="pmid">25476242</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>A.</given-names></name><name><surname>Lynch</surname><given-names>A.</given-names></name><name><surname>Vereker</surname><given-names>E.</given-names></name><name><surname>Nolan</surname><given-names>Y.</given-names></name><name><surname>Queenan</surname><given-names>P.</given-names></name><name><surname>Whittaker</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>The anti-inflammatory cytokine, interleukin (IL)-10, blocks the inhibitory effect of IL-1 beta on long term potentiation, a role for JNK.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>276</volume>
<fpage>45564</fpage>–<lpage>45572</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M108757200</pub-id>
<pub-id pub-id-type="pmid">11581275</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerschensteiner</surname><given-names>M.</given-names></name><name><surname>Meinl</surname><given-names>E.</given-names></name><name><surname>Hohlfeld</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Neuro-immune crosstalk in CNS diseases.</article-title>
<source/><italic>Neuroscience</italic>
<volume>158</volume>
<fpage>1122</fpage>–<lpage>1132</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.09.009</pub-id>
<pub-id pub-id-type="pmid">18848864</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kettenmann</surname><given-names>H.</given-names></name><name><surname>Hanisch</surname><given-names>U. K.</given-names></name><name><surname>Noda</surname><given-names>M.</given-names></name><name><surname>Verkhratsky</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Physiology of microglia.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>91</volume>
<fpage>461</fpage>–<lpage>553</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00011.2010</pub-id>
<pub-id pub-id-type="pmid">21527731</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kierdorf</surname><given-names>K.</given-names></name><name><surname>Erny</surname><given-names>D.</given-names></name><name><surname>Goldmann</surname><given-names>T.</given-names></name><name><surname>Sander</surname><given-names>V.</given-names></name><name><surname>Schulz</surname><given-names>C.</given-names></name><name><surname>Perdiguero</surname><given-names>E. G.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>16</volume>
<fpage>273</fpage>–<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3318</pub-id>
<pub-id pub-id-type="pmid">23334579</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kierdorf</surname><given-names>K.</given-names></name><name><surname>Prinz</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Factors regulating microglia activation.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>7</volume>:<issue>44</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2013.00044</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kierdorf</surname><given-names>K.</given-names></name><name><surname>Prinz</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Microglia in steady state.</article-title>
<source/><italic>J. Clin. Invest</italic>
<volume>127</volume>
<fpage>3201</fpage>–<lpage>3209</lpage>. <pub-id pub-id-type="doi">10.1172/JCI90602</pub-id>
<pub-id pub-id-type="pmid">28714861</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiialainen</surname><given-names>A.</given-names></name><name><surname>Hovanes</surname><given-names>K.</given-names></name><name><surname>Paloneva</surname><given-names>J.</given-names></name><name><surname>Kopra</surname><given-names>O.</given-names></name><name><surname>Peltonen</surname><given-names>L.</given-names></name></person-group> (<year>2005</year>). <article-title>Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>18</volume>
<fpage>314</fpage>–<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2004.09.007</pub-id>
<pub-id pub-id-type="pmid">15686960</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. Y.</given-names></name><name><surname>Kanai</surname><given-names>Y.</given-names></name><name><surname>Chairoungdua</surname><given-names>A.</given-names></name><name><surname>Cha</surname><given-names>S. H.</given-names></name><name><surname>Matsuo</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>D. K.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1512</volume>
<fpage>335</fpage>–<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1016/S0005-2736(01)00338-8</pub-id>
<pub-id pub-id-type="pmid">11406111</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>T. S.</given-names></name><name><surname>Lim</surname><given-names>H. K.</given-names></name><name><surname>Lee</surname><given-names>J. Y.</given-names></name><name><surname>Kim</surname><given-names>D. J.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer’s disease.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>436</volume>
<fpage>196</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2008.03.019</pub-id>
<pub-id pub-id-type="pmid">18378084</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishi</surname><given-names>T.</given-names></name><name><surname>Yoshimura</surname><given-names>R.</given-names></name><name><surname>Ikuta</surname><given-names>T.</given-names></name><name><surname>Iwata</surname><given-names>N.</given-names></name></person-group> (<year>2017</year>). <article-title>Brain-derived neurotrophic factor and major depressive disorder: evidence from meta-analyses.</article-title>
<source/><italic>Front. Psychiatry</italic>
<volume>8</volume>:<issue>308</issue>. <pub-id pub-id-type="doi">10.3389/fpsyt.2017.00308</pub-id>
<pub-id pub-id-type="pmid">29387021</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knott</surname><given-names>C.</given-names></name><name><surname>Stern</surname><given-names>G.</given-names></name><name><surname>Kingsbury</surname><given-names>A.</given-names></name><name><surname>Welcher</surname><given-names>A. A.</given-names></name><name><surname>Wilkin</surname><given-names>G. P.</given-names></name></person-group> (<year>2002</year>). <article-title>Elevated glial brain-derived neurotrophic factor in Parkinson’s diseased nigra.</article-title>
<source/><italic>Parkinsonism Relat. Disord.</italic>
<volume>8</volume>
<fpage>329</fpage>–<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1016/S1353-8020(02)00008-1</pub-id><pub-id pub-id-type="pmid">15177062</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koizumi</surname><given-names>S.</given-names></name><name><surname>Shigemoto-Mogami</surname><given-names>Y.</given-names></name><name><surname>Nasu-Tada</surname><given-names>K.</given-names></name><name><surname>Shinozaki</surname><given-names>Y.</given-names></name><name><surname>Ohsawa</surname><given-names>K.</given-names></name><name><surname>Tsuda</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.</article-title>
<source/><italic>Nature</italic>
<volume>446</volume>
<fpage>1091</fpage>–<lpage>1095</lpage>. <pub-id pub-id-type="doi">10.1038/nature05704</pub-id>
<pub-id pub-id-type="pmid">17410128</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>T.</given-names></name><name><surname>Park</surname><given-names>J. M.</given-names></name><name><surname>Jang</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>C. Y.</given-names></name><name><surname>Bae</surname><given-names>S. H.</given-names></name><name><surname>Choi</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Immunomodulatory effect of CD200-positive human placenta-derived stem cells in the early phase of stroke.</article-title>
<source/><italic>Exp. Mol. Med.</italic>
<volume>50</volume>:<issue>e425</issue>. <pub-id pub-id-type="doi">10.1038/emm.2017.233</pub-id>
<pub-id pub-id-type="pmid">29328072</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koning</surname><given-names>N.</given-names></name><name><surname>Swaab</surname><given-names>D. F.</given-names></name><name><surname>Hoek</surname><given-names>R. M.</given-names></name><name><surname>Huitinga</surname><given-names>I.</given-names></name></person-group> (<year>2009</year>). <article-title>Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.</article-title>
<source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>68</volume>
<fpage>159</fpage>–<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0b013e3181964113</pub-id>
<pub-id pub-id-type="pmid">19151626</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konnecke</surname><given-names>H.</given-names></name><name><surname>Bechmann</surname><given-names>I.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas.</article-title>
<source/><italic>Clin. Dev. Immunol.</italic>
<volume>2013</volume>:<issue>914104</issue>. <pub-id pub-id-type="doi">10.1155/2013/914104</pub-id>
<pub-id pub-id-type="pmid">24023566</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer-Albers</surname><given-names>E. M.</given-names></name><name><surname>Bretz</surname><given-names>N.</given-names></name><name><surname>Tenzer</surname><given-names>S.</given-names></name><name><surname>Winterstein</surname><given-names>C.</given-names></name><name><surname>Mobius</surname><given-names>W.</given-names></name><name><surname>Berger</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: trophic support for axons?</article-title>
<source/><italic>Proteomics Clin. Appl.</italic>
<volume>1</volume>
<fpage>1446</fpage>–<lpage>1461</lpage>. <pub-id pub-id-type="doi">10.1002/prca.200700522</pub-id>
<pub-id pub-id-type="pmid">21136642</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer-Albers</surname><given-names>E. M.</given-names></name><name><surname>Hill</surname><given-names>A. F.</given-names></name></person-group> (<year>2016</year>). <article-title>Extracellular vesicles: interneural shuttles of complex messages.</article-title>
<source/><italic>Curr. Opin. Neurobiol.</italic>
<volume>39</volume>
<fpage>101</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2016.04.016</pub-id>
<pub-id pub-id-type="pmid">27183381</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreisel</surname><given-names>T.</given-names></name><name><surname>Frank</surname><given-names>M. G.</given-names></name><name><surname>Licht</surname><given-names>T.</given-names></name><name><surname>Reshef</surname><given-names>R.</given-names></name><name><surname>Ben-Menachem-Zidon</surname><given-names>O.</given-names></name><name><surname>Baratta</surname><given-names>M. V.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>19</volume>
<fpage>699</fpage>–<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.155</pub-id>
<pub-id pub-id-type="pmid">24342992</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>V.</given-names></name><name><surname>Nestler</surname><given-names>E. J.</given-names></name></person-group> (<year>2008</year>). <article-title>The molecular neurobiology of depression.</article-title>
<source/><italic>Nature</italic>
<volume>455</volume>
<fpage>894</fpage>–<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1038/nature07455</pub-id>
<pub-id pub-id-type="pmid">18923511</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ku</surname><given-names>M. C.</given-names></name><name><surname>Wolf</surname><given-names>S. A.</given-names></name><name><surname>Respondek</surname><given-names>D.</given-names></name><name><surname>Matyash</surname><given-names>V.</given-names></name><name><surname>Pohlmann</surname><given-names>A.</given-names></name><name><surname>Waiczies</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>125</volume>
<fpage>609</fpage>–<lpage>620</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-013-1079-8</pub-id>
<pub-id pub-id-type="pmid">23344256</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>S. A.</given-names></name><name><surname>van Landeghem</surname><given-names>F. K.</given-names></name><name><surname>Zacharias</surname><given-names>R.</given-names></name><name><surname>Farber</surname><given-names>K.</given-names></name><name><surname>Rappert</surname><given-names>A.</given-names></name><name><surname>Pavlovic</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Microglia express GABA(B) receptors to modulate interleukin release.</article-title>
<source/><italic>Mol. Cell Neurosci.</italic>
<volume>25</volume>
<fpage>312</fpage>–<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2003.10.023</pub-id>
<pub-id pub-id-type="pmid">15019947</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Stoica</surname><given-names>B. A.</given-names></name><name><surname>Loane</surname><given-names>D. J.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Abulwerdi</surname><given-names>G.</given-names></name><name><surname>Khan</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury.</article-title>
<source/><italic>J. Neuroinflamm.</italic>
<volume>14</volume>:<issue>47</issue>. <pub-id pub-id-type="doi">10.1186/s12974-017-0819-4</pub-id>
<pub-id pub-id-type="pmid">28292310</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachenal</surname><given-names>G.</given-names></name><name><surname>Pernet-Gallay</surname><given-names>K.</given-names></name><name><surname>Chivet</surname><given-names>M.</given-names></name><name><surname>Hemming</surname><given-names>F. J.</given-names></name><name><surname>Belly</surname><given-names>A.</given-names></name><name><surname>Bodon</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity.</article-title>
<source/><italic>Mol. Cell Neurosci.</italic>
<volume>46</volume>
<fpage>409</fpage>–<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2010.11.004</pub-id>
<pub-id pub-id-type="pmid">21111824</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>C. P.</given-names></name><name><surname>Tannous</surname><given-names>B. A.</given-names></name><name><surname>Breakefield</surname><given-names>X. O.</given-names></name></person-group> (<year>2014</year>). <article-title>Noninvasive in vivo monitoring of extracellular vesicles.</article-title>
<source/><italic>Methods Mol. Biol.</italic>
<volume>1098</volume>
<fpage>249</fpage>–<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-62703-718-1_19</pub-id>
<pub-id pub-id-type="pmid">24166382</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lampe</surname><given-names>I. K.</given-names></name><name><surname>Hulshoff Pol</surname><given-names>H. E.</given-names></name><name><surname>Janssen</surname><given-names>J.</given-names></name><name><surname>Schnack</surname><given-names>H. G.</given-names></name><name><surname>Kahn</surname><given-names>R. S.</given-names></name><name><surname>Heeren</surname><given-names>T. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Association of depression duration with reduction of global cerebral gray matter volume in female patients with recurrent major depressive disorder.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>160</volume>
<fpage>2052</fpage>–<lpage>2054</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.160.11.2052</pub-id>
<pub-id pub-id-type="pmid">14594756</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laskaris</surname><given-names>L. E.</given-names></name><name><surname>Di Biase</surname><given-names>M. A.</given-names></name><name><surname>Everall</surname><given-names>I.</given-names></name><name><surname>Chana</surname><given-names>G.</given-names></name><name><surname>Christopoulos</surname><given-names>A.</given-names></name><name><surname>Skafidas</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Microglial activation and progressive brain changes in schizophrenia.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>173</volume>
<fpage>666</fpage>–<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1111/bph.13364</pub-id>
<pub-id pub-id-type="pmid">26455353</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavagnino</surname><given-names>L.</given-names></name><name><surname>Cao</surname><given-names>B.</given-names></name><name><surname>Mwangi</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>M. J.</given-names></name><name><surname>Sanches</surname><given-names>M.</given-names></name><name><surname>Zunta-Soares</surname><given-names>G. B.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Changes in the corpus callosum in women with late-stage bipolar disorder.</article-title>
<source/><italic>Acta Psychiatr. Scand.</italic>
<volume>131</volume>
<fpage>458</fpage>–<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1111/acps.12397</pub-id>
<pub-id pub-id-type="pmid">25640667</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>L. J.</given-names></name><name><surname>Perry</surname><given-names>V. H.</given-names></name><name><surname>Dri</surname><given-names>P.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group> (<year>1990</year>). <article-title>Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain.</article-title>
<source/><italic>Neuroscience</italic>
<volume>39</volume>
<fpage>151</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(90)90229-W</pub-id><pub-id pub-id-type="pmid">2089275</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M. K.</given-names></name><name><surname>Pardoux</surname><given-names>C.</given-names></name><name><surname>Hall</surname><given-names>M. C.</given-names></name><name><surname>Lee</surname><given-names>P. S.</given-names></name><name><surname>Warburton</surname><given-names>D.</given-names></name><name><surname>Qing</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA.</article-title>
<source/><italic>EMBO J.</italic>
<volume>26</volume>
<fpage>3957</fpage>–<lpage>3967</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601818</pub-id>
<pub-id pub-id-type="pmid">17673906</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Varvel</surname><given-names>N. H.</given-names></name><name><surname>Konerth</surname><given-names>M. E.</given-names></name><name><surname>Xu</surname><given-names>G.</given-names></name><name><surname>Cardona</surname><given-names>A. E.</given-names></name><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer’s disease mouse models.</article-title>
<source/><italic>Am. J. Pathol.</italic>
<volume>177</volume>
<fpage>2549</fpage>–<lpage>2562</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2010.100265</pub-id>
<pub-id pub-id-type="pmid">20864679</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Jiang</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>R.</given-names></name><name><surname>Burnstock</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Microvesicles shed from microglia activated by the P2X7-p38 pathway are involved in neuropathic pain induced by spinal nerve ligation in rats.</article-title>
<source/><italic>Purinergic. Signal.</italic>
<volume>13</volume>
<fpage>13</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1007/s11302-016-9537-0</pub-id>
<pub-id pub-id-type="pmid">27683228</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Pang</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Guo</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Proliferation of parenchymal microglia is the main source of microgliosis after ischaemic stroke.</article-title>
<source/><italic>Brain</italic>
<volume>136</volume>
<fpage>3578</fpage>–<lpage>3588</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awt287</pub-id>
<pub-id pub-id-type="pmid">24154617</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Graeber</surname><given-names>M. B.</given-names></name></person-group> (<year>2012</year>). <article-title>The molecular profile of microglia under the influence of glioma.</article-title>
<source/><italic>Neuro Oncol.</italic>
<volume>14</volume>
<fpage>958</fpage>–<lpage>978</lpage>. <pub-id pub-id-type="doi">10.1093/neuonc/nos116</pub-id>
<pub-id pub-id-type="pmid">22573310</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Du</surname><given-names>X. F.</given-names></name><name><surname>Liu</surname><given-names>C. S.</given-names></name><name><surname>Wen</surname><given-names>Z. L.</given-names></name><name><surname>Du</surname><given-names>J. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo.</article-title>
<source/><italic>Dev. Cell</italic>
<volume>23</volume>
<fpage>1189</fpage>–<lpage>1202</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2012.10.027</pub-id>
<pub-id pub-id-type="pmid">23201120</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>S. H.</given-names></name><name><surname>Park</surname><given-names>E.</given-names></name><name><surname>You</surname><given-names>B.</given-names></name><name><surname>Jung</surname><given-names>Y.</given-names></name><name><surname>Park</surname><given-names>A. R.</given-names></name><name><surname>Park</surname><given-names>S. G.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Neuronal synapse formation induced by microglia and interleukin 10.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e81218</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0081218</pub-id>
<pub-id pub-id-type="pmid">24278397</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y. Z.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Lin</surname><given-names>Y. Z.</given-names></name><name><surname>Ge</surname><given-names>Y. S.</given-names></name><name><surname>Li</surname><given-names>D. M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Role of fractalkine/CX3CR1 signaling pathway in the recovery of neurological function after early ischemic stroke in a rat model.</article-title>
<source/><italic>Life Sci.</italic>
<volume>184</volume>
<fpage>87</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2017.06.012</pub-id>
<pub-id pub-id-type="pmid">28624392</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Condello</surname><given-names>C.</given-names></name><name><surname>Schain</surname><given-names>A.</given-names></name><name><surname>Harb</surname><given-names>R.</given-names></name><name><surname>Grutzendler</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-beta phagocytosis.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>30</volume>
<fpage>17091</fpage>–<lpage>17101</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4403-10.2010</pub-id><pub-id pub-id-type="pmid">21159979</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loane</surname><given-names>D. J.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Microglia in the TBI brain: the good, the bad, and the dysregulated.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>275(Pt 3)</volume>, <fpage>316</fpage>–<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2015.08.018</pub-id>
<pub-id pub-id-type="pmid">26342753</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>London</surname><given-names>A.</given-names></name><name><surname>Benhar</surname><given-names>I.</given-names></name><name><surname>Schwartz</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>The retina as a window to the brain-from eye research to CNS disorders.</article-title>
<source/><italic>Nat. Rev. Neurol.</italic>
<volume>9</volume>
<fpage>44</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2012.227</pub-id>
<pub-id pub-id-type="pmid">23165340</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucae</surname><given-names>S.</given-names></name><name><surname>Salyakina</surname><given-names>D.</given-names></name><name><surname>Barden</surname><given-names>N.</given-names></name><name><surname>Harvey</surname><given-names>M.</given-names></name><name><surname>Gagne</surname><given-names>B.</given-names></name><name><surname>Labbe</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>15</volume>
<fpage>2438</fpage>–<lpage>2445</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddl166</pub-id>
<pub-id pub-id-type="pmid">16822851</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>A. M.</given-names></name><name><surname>Murphy</surname><given-names>K. J.</given-names></name><name><surname>Deighan</surname><given-names>B. F.</given-names></name><name><surname>O’Reilly</surname><given-names>J. A.</given-names></name><name><surname>Gun’ko</surname><given-names>Y. K.</given-names></name><name><surname>Cowley</surname><given-names>T. R.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>The impact of glial activation in the aging brain.</article-title>
<source/><italic>Aging Dis.</italic>
<volume>1</volume>
<fpage>262</fpage>–<lpage>278</lpage>.<pub-id pub-id-type="pmid">22396865</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>M. A.</given-names></name></person-group> (<year>2009</year>). <article-title>The multifaceted profile of activated microglia.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>40</volume>
<fpage>139</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-009-8077-9</pub-id>
<pub-id pub-id-type="pmid">19629762</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>M. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Neuroinflammatory changes negatively impact on LTP: a focus on IL-1beta.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1621</volume>
<fpage>197</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2014.08.040</pub-id>
<pub-id pub-id-type="pmid">25193603</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maciag</surname><given-names>D.</given-names></name><name><surname>Hughes</surname><given-names>J.</given-names></name><name><surname>O’Dwyer</surname><given-names>G.</given-names></name><name><surname>Pride</surname><given-names>Y.</given-names></name><name><surname>Stockmeier</surname><given-names>C. A.</given-names></name><name><surname>Sanacora</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>67</volume>
<fpage>465</fpage>–<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.10.027</pub-id>
<pub-id pub-id-type="pmid">20004363</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maciejewski-Lenoir</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Feng</surname><given-names>L.</given-names></name><name><surname>Maki</surname><given-names>R.</given-names></name><name><surname>Bacon</surname><given-names>K. B.</given-names></name></person-group> (<year>1999</year>). <article-title>Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>163</volume>
<fpage>1628</fpage>–<lpage>1635</lpage>. <pub-id pub-id-type="pmid">10415068</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>C. R.</given-names></name></person-group> (<year>2001</year>). <article-title>Chemokines: immunology’s high impact factors.</article-title>
<source/><italic>Nat. Immunol.</italic>
<volume>2</volume>
<fpage>95</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1038/84298</pub-id>
<pub-id pub-id-type="pmid">11175800</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makinde</surname><given-names>H. M.</given-names></name><name><surname>Cuda</surname><given-names>C. M.</given-names></name><name><surname>Just</surname><given-names>T. B.</given-names></name><name><surname>Perlman</surname><given-names>H. R.</given-names></name><name><surname>Schwulst</surname><given-names>S. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Nonclassical monocytes mediate secondary injury, neurocognitive outcome, and neutrophil infiltration after traumatic brain injury.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>199</volume>
<fpage>3583</fpage>–<lpage>3591</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1700896</pub-id>
<pub-id pub-id-type="pmid">28993515</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcus</surname><given-names>H. J.</given-names></name><name><surname>Carpenter</surname><given-names>K. L.</given-names></name><name><surname>Price</surname><given-names>S. J.</given-names></name><name><surname>Hutchinson</surname><given-names>P. J.</given-names></name></person-group> (<year>2010</year>). <article-title>In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines.</article-title>
<source/><italic>J. Neurooncol.</italic>
<volume>97</volume>
<fpage>11</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1007/s11060-009-9990-5</pub-id>
<pub-id pub-id-type="pmid">19714445</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markovic</surname><given-names>D. S.</given-names></name><name><surname>Glass</surname><given-names>R.</given-names></name><name><surname>Synowitz</surname><given-names>M.</given-names></name><name><surname>Rooijen</surname><given-names>N.</given-names></name><name><surname>Kettenmann</surname><given-names>H.</given-names></name></person-group> (<year>2005</year>). <article-title>Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2.</article-title>
<source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>64</volume>
<fpage>754</fpage>–<lpage>762</lpage>. <pub-id pub-id-type="doi">10.1097/01.jnen.0000178445.33972.a9</pub-id>
<pub-id pub-id-type="pmid">16141784</pub-id></mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marzesco</surname><given-names>A. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Prominin-1-containing membrane vesicles: origins, formation, and utility.</article-title>
<source/><italic>Adv. Exp. Med. Biol.</italic>
<volume>777</volume>
<fpage>41</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4614-5894-4_3</pub-id>
<pub-id pub-id-type="pmid">23161074</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marzesco</surname><given-names>A. M.</given-names></name><name><surname>Janich</surname><given-names>P.</given-names></name><name><surname>Wilsch-Brauninger</surname><given-names>M.</given-names></name><name><surname>Dubreuil</surname><given-names>V.</given-names></name><name><surname>Langenfeld</surname><given-names>K.</given-names></name><name><surname>Corbeil</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells.</article-title>
<source/><italic>J. Cell Sci.</italic>
<volume>118</volume>
<fpage>2849</fpage>–<lpage>2858</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.02439</pub-id>
<pub-id pub-id-type="pmid">15976444</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>S.</given-names></name><name><surname>Tanaka</surname><given-names>J.</given-names></name><name><surname>Yano</surname><given-names>H.</given-names></name><name><surname>Takahashi</surname><given-names>H.</given-names></name><name><surname>Sugimoto</surname><given-names>K.</given-names></name><name><surname>Ohue</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>CD200+ and CD200- macrophages accumulated in ischemic lesions of rat brain: the two populations cannot be classified as either M1 or M2 macrophages.</article-title>
<source/><italic>J. Neuroimmunol.</italic>
<volume>282</volume>
<fpage>7</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2015.03.013</pub-id>
<pub-id pub-id-type="pmid">25903723</pub-id></mixed-citation>
</ref>
<ref id="B239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCluskey</surname><given-names>L. P.</given-names></name><name><surname>Lampson</surname><given-names>L. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Local immune regulation in the central nervous system by substance P vs. glutamate.</article-title>
<source/><italic>J. Neuroimmunol.</italic>
<volume>116</volume>
<fpage>136</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-5728(01)00295-8</pub-id>
<pub-id pub-id-type="pmid">11438168</pub-id></mixed-citation>
</ref>
<ref id="B240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLarnon</surname><given-names>J. G.</given-names></name></person-group> (<year>2017</year>). <article-title>Roles of purinergic P2X7 receptor in glioma and microglia in brain tumors.</article-title>
<source/><italic>Cancer Lett.</italic>
<volume>402</volume>
<fpage>93</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2017.05.004</pub-id>
<pub-id pub-id-type="pmid">28536012</pub-id></mixed-citation>
</ref>
<ref id="B241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mecca</surname><given-names>C.</given-names></name><name><surname>Giambanco</surname><given-names>I.</given-names></name><name><surname>Donato</surname><given-names>R.</given-names></name><name><surname>Arcuri</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Microglia and aging: the role of the TREM2-DAP12 and CX3CL1-CX3CR1 axes.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>19</volume>:<issue>E318</issue>. <pub-id pub-id-type="doi">10.3390/ijms19010318</pub-id>
<pub-id pub-id-type="pmid">29361745</pub-id></mixed-citation>
</ref>
<ref id="B242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname><given-names>M.</given-names></name><name><surname>Avila</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of extracellular Tau in the spreading of neurofibrillary pathology.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>8</volume>:<issue>113</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00113</pub-id></mixed-citation>
</ref>
<ref id="B243">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellado</surname><given-names>M.</given-names></name><name><surname>Rodriguez-Frade</surname><given-names>J. M.</given-names></name><name><surname>Vila-Coro</surname><given-names>A. J.</given-names></name><name><surname>Fernandez</surname><given-names>S.</given-names></name><name><surname>Martin</surname></name><name><surname>de Ana</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Chemokine receptor homo- or heterodimerization activates distinct signaling pathways.</article-title>
<source/><italic>EMBO J.</italic>
<volume>20</volume>
<fpage>2497</fpage>–<lpage>2507</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/20.10.2497</pub-id><pub-id pub-id-type="pmid">11350939</pub-id></mixed-citation>
</ref>
<ref id="B244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meucci</surname><given-names>O.</given-names></name><name><surname>Fatatis</surname><given-names>A.</given-names></name><name><surname>Simen</surname><given-names>A. A.</given-names></name><name><surname>Miller</surname><given-names>R. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>97</volume>
<fpage>8075</fpage>–<lpage>8080</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.090017497</pub-id>
<pub-id pub-id-type="pmid">10869418</pub-id></mixed-citation>
</ref>
<ref id="B245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milior</surname><given-names>G.</given-names></name><name><surname>Lecours</surname><given-names>C.</given-names></name><name><surname>Samson</surname><given-names>L.</given-names></name><name><surname>Bisht</surname><given-names>K.</given-names></name><name><surname>Poggini</surname><given-names>S.</given-names></name><name><surname>Pagani</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Fractalkine receptor deficiency impairs microglial and neuronal responsiveness to chronic stress.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>55</volume>
<fpage>114</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2015.07.024</pub-id>
<pub-id pub-id-type="pmid">26231972</pub-id></mixed-citation>
</ref>
<ref id="B246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittelbronn</surname><given-names>M.</given-names></name><name><surname>Dietz</surname><given-names>K.</given-names></name><name><surname>Schluesener</surname><given-names>H. J.</given-names></name><name><surname>Meyermann</surname><given-names>R.</given-names></name></person-group> (<year>2001</year>). <article-title>Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>101</volume>
<fpage>249</fpage>–<lpage>255</lpage>. <pub-id pub-id-type="pmid">11307625</pub-id></mixed-citation>
</ref>
<ref id="B247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizoue</surname><given-names>L. S.</given-names></name><name><surname>Sullivan</surname><given-names>S. K.</given-names></name><name><surname>King</surname><given-names>D. S.</given-names></name><name><surname>Kledal</surname><given-names>T. N.</given-names></name><name><surname>Schwartz</surname><given-names>T. W.</given-names></name><name><surname>Bacon</surname><given-names>K. B.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Molecular determinants of receptor binding and signaling by the CX3C chemokine fractalkine.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>276</volume>
<fpage>33906</fpage>–<lpage>33914</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M101348200</pub-id>
<pub-id pub-id-type="pmid">11432858</pub-id></mixed-citation>
</ref>
<ref id="B248">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizutani</surname><given-names>M.</given-names></name><name><surname>Pino</surname><given-names>P. A.</given-names></name><name><surname>Saederup</surname><given-names>N.</given-names></name><name><surname>Charo</surname><given-names>I. F.</given-names></name><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name><name><surname>Cardona</surname><given-names>A. E.</given-names></name></person-group> (<year>2012</year>). <article-title>The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>188</volume>
<fpage>29</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1100421</pub-id><pub-id pub-id-type="pmid">22079990</pub-id></mixed-citation>
</ref>
<ref id="B249">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondello</surname><given-names>S.</given-names></name><name><surname>Thelin</surname><given-names>E. P.</given-names></name><name><surname>Shaw</surname><given-names>G.</given-names></name><name><surname>Salzet</surname><given-names>M.</given-names></name><name><surname>Visalli</surname><given-names>C.</given-names></name><name><surname>Cizkova</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Extracellular vesicles: pathogenetic, diagnostic and therapeutic value in traumatic brain injury.</article-title>
<source/><italic>Exp. Rev. Proteom.</italic>
<volume>15</volume>
<fpage>451</fpage>–<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1080/14789450.2018.1464914</pub-id>
<pub-id pub-id-type="pmid">29671356</pub-id></mixed-citation>
</ref>
<ref id="B250">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monji</surname><given-names>A.</given-names></name><name><surname>Kato</surname><given-names>T.</given-names></name><name><surname>Kanba</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Cytokines and schizophrenia: microglia hypothesis of schizophrenia.</article-title>
<source/><italic>Psychiatry Clin. Neurosci.</italic>
<volume>63</volume>
<fpage>257</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1819.2009.01945.x</pub-id><pub-id pub-id-type="pmid">19579286</pub-id></mixed-citation>
</ref>
<ref id="B251">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Monson</surname><given-names>K. L.</given-names></name><name><surname>Converse</surname><given-names>M. I.</given-names></name><name><surname>Manley</surname><given-names>G. T.</given-names></name></person-group> (<year>2018</year>). <article-title>Cerebral blood vessel damage in traumatic brain injury.</article-title>
<source/><italic>Clin. Biomech.</italic> (<publisher-loc>Bristol, Avon</publisher-loc>). <comment>[Epub ahead of print]</comment>.</mixed-citation>
</ref>
<ref id="B252">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morantz</surname><given-names>R. A.</given-names></name><name><surname>Wood</surname><given-names>G. W.</given-names></name><name><surname>Foster</surname><given-names>M.</given-names></name><name><surname>Clark</surname><given-names>M.</given-names></name><name><surname>Gollahon</surname><given-names>K.</given-names></name></person-group> (<year>1979</year>). <article-title>Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors.</article-title>
<source/><italic>J. Neurosurg.</italic>
<volume>50</volume>
<fpage>305</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.3171/jns.1979.50.3.0305</pub-id>
<pub-id pub-id-type="pmid">422981</pub-id></mixed-citation>
</ref>
<ref id="B253">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morganti</surname><given-names>J. M.</given-names></name><name><surname>Jopson</surname><given-names>T. D.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Riparip</surname><given-names>L. K.</given-names></name><name><surname>Guandique</surname><given-names>C. K.</given-names></name><name><surname>Gupta</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>CCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injury.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>35</volume>
<fpage>748</fpage>–<lpage>760</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2405-14.2015</pub-id>
<pub-id pub-id-type="pmid">25589768</pub-id></mixed-citation>
</ref>
<ref id="B254">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morganti</surname><given-names>J. M.</given-names></name><name><surname>Nash</surname><given-names>K. R.</given-names></name><name><surname>Grimmig</surname><given-names>B. A.</given-names></name><name><surname>Ranjit</surname><given-names>S.</given-names></name><name><surname>Small</surname><given-names>B.</given-names></name><name><surname>Bickford</surname><given-names>P. C.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson’s disease.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>14592</fpage>–<lpage>14601</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0539-12.2012</pub-id><pub-id pub-id-type="pmid">23077045</pub-id></mixed-citation>
</ref>
<ref id="B255">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mott</surname><given-names>R. T.</given-names></name><name><surname>Ait-Ghezala</surname><given-names>G.</given-names></name><name><surname>Town</surname><given-names>T.</given-names></name><name><surname>Mori</surname><given-names>T.</given-names></name><name><surname>Vendrame</surname><given-names>M.</given-names></name><name><surname>Zeng</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production.</article-title>
<source/><italic>Glia</italic>
<volume>46</volume>
<fpage>369</fpage>–<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20009</pub-id>
<pub-id pub-id-type="pmid">15095367</pub-id></mixed-citation>
</ref>
<ref id="B256">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueser</surname><given-names>K. T.</given-names></name><name><surname>McGurk</surname><given-names>S. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Schizophrenia.</article-title>
<source/><italic>Lancet</italic>
<volume>363</volume>
<fpage>2063</fpage>–<lpage>2072</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(04)16458-1</pub-id><pub-id pub-id-type="pmid">15207959</pub-id></mixed-citation>
</ref>
<ref id="B257">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munn</surname><given-names>N. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Microglia dysfunction in schizophrenia: an integrative theory.</article-title>
<source/><italic>Med. Hypotheses</italic>
<volume>54</volume>
<fpage>198</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1054/mehy.1999.0018</pub-id>
<pub-id pub-id-type="pmid">10790752</pub-id></mixed-citation>
</ref>
<ref id="B258">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nash</surname><given-names>K. R.</given-names></name><name><surname>Moran</surname><given-names>P.</given-names></name><name><surname>Finneran</surname><given-names>D. J.</given-names></name><name><surname>Hudson</surname><given-names>C.</given-names></name><name><surname>Robinson</surname><given-names>J.</given-names></name><name><surname>Morgan</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Fractalkine over expression suppresses alpha-synuclein-mediated neurodegeneration.</article-title>
<source/><italic>Mol. Ther.</italic>
<volume>23</volume>
<fpage>17</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1038/mt.2014.175</pub-id>
<pub-id pub-id-type="pmid">25195598</pub-id></mixed-citation>
</ref>
<ref id="B259">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nawa</surname><given-names>H.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Patterson</surname><given-names>P. H.</given-names></name></person-group> (<year>2000</year>). <article-title>Cytokine and growth factor involvement in schizophrenia–support for the developmental model.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>5</volume>
<fpage>594</fpage>–<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4000730</pub-id><pub-id pub-id-type="pmid">11126390</pub-id></mixed-citation>
</ref>
<ref id="B260">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neiva</surname><given-names>I.</given-names></name><name><surname>Malva</surname><given-names>J. O.</given-names></name><name><surname>Valero</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Can we talk about microglia without neurons? A discussion of microglial cell autonomous properties in culture.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>8</volume>:<issue>202</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00202</pub-id>
<pub-id pub-id-type="pmid">25104923</pub-id></mixed-citation>
</ref>
<ref id="B261">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>H.</given-names></name></person-group> (<year>2001</year>). <article-title>Control of glial immune function by neurons.</article-title>
<source/><italic>Glia</italic>
<volume>36</volume>
<fpage>191</fpage>–<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1002/glia.1108</pub-id>
<pub-id pub-id-type="pmid">11596127</pub-id></mixed-citation>
</ref>
<ref id="B262">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>H.</given-names></name><name><surname>Boucraut</surname><given-names>J.</given-names></name><name><surname>Hahnel</surname><given-names>C.</given-names></name><name><surname>Misgeld</surname><given-names>T.</given-names></name><name><surname>Wekerle</surname><given-names>H.</given-names></name></person-group> (<year>1996</year>). <article-title>Neuronal control of MHC class II inducibility in rat astrocytes and microglia.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>8</volume>
<fpage>2582</fpage>–<lpage>2590</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.1996.tb01552.x</pub-id>
<pub-id pub-id-type="pmid">8996807</pub-id></mixed-citation>
</ref>
<ref id="B263">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>H.</given-names></name><name><surname>Misgeld</surname><given-names>T.</given-names></name><name><surname>Matsumuro</surname><given-names>K.</given-names></name><name><surname>Wekerle</surname><given-names>H.</given-names></name></person-group> (<year>1998</year>). <article-title>Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>95</volume>
<fpage>5779</fpage>–<lpage>5784</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.10.5779</pub-id>
<pub-id pub-id-type="pmid">9576961</pub-id></mixed-citation>
</ref>
<ref id="B264">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>H.</given-names></name><name><surname>Takahashi</surname><given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis.</article-title>
<source/><italic>J. Neuroimmunol.</italic>
<volume>184</volume>
<fpage>92</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2006.11.032</pub-id>
<pub-id pub-id-type="pmid">17239445</pub-id></mixed-citation>
</ref>
<ref id="B265">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>C. F.</given-names></name><name><surname>Robert</surname><given-names>L. L.</given-names></name><name><surname>Aaron</surname><given-names>B. T.</given-names></name><name><surname>Noreen</surname><given-names>A.</given-names></name><name><surname>Reilly</surname><given-names>H.</given-names></name><name><surname>Laszlo</surname><given-names>G.</given-names></name></person-group>
<role>(eds)</role> (<year>2002</year>). <article-title>“Bipolar disorder: diagnostic, epidemiologic, etiologic, and prognostic issues,” in</article-title>
<source/><italic>Bipolar Disorder: A Cognitive Therapy Approach</italic>, (<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychological Association</publisher-name>).</mixed-citation>
</ref>
<ref id="B266">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngolab</surname><given-names>J.</given-names></name><name><surname>Trinh</surname><given-names>I.</given-names></name><name><surname>Rockenstein</surname><given-names>E.</given-names></name><name><surname>Mante</surname><given-names>M.</given-names></name><name><surname>Florio</surname><given-names>J.</given-names></name><name><surname>Trejo</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Brain-derived exosomes from dementia with Lewy bodies propagate alpha-synuclein pathology.</article-title>
<source/><italic>Acta Neuropathol. Commun.</italic>
<volume>5</volume>:<issue>46</issue>. <pub-id pub-id-type="doi">10.1186/s40478-017-0445-5</pub-id>
<pub-id pub-id-type="pmid">28599681</pub-id></mixed-citation>
</ref>
<ref id="B267">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nimmerjahn</surname><given-names>A.</given-names></name><name><surname>Kirchhoff</surname><given-names>F.</given-names></name><name><surname>Helmchen</surname><given-names>F.</given-names></name></person-group> (<year>2005</year>). <article-title>Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.</article-title>
<source/><italic>Science</italic>
<volume>308</volume>
<fpage>1314</fpage>–<lpage>1318</lpage>. <pub-id pub-id-type="doi">10.1126/science.1110647</pub-id>
<pub-id pub-id-type="pmid">15831717</pub-id></mixed-citation>
</ref>
<ref id="B268">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiyori</surname><given-names>A.</given-names></name><name><surname>Minami</surname><given-names>M.</given-names></name><name><surname>Ohtani</surname><given-names>Y.</given-names></name><name><surname>Takami</surname><given-names>S.</given-names></name><name><surname>Yamamoto</surname><given-names>J.</given-names></name><name><surname>Kawaguchi</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia?</article-title>
<source/><italic>FEBS Lett.</italic>
<volume>429</volume>
<fpage>167</fpage>–<lpage>172</lpage>. <pub-id pub-id-type="pmid">9650583</pub-id></mixed-citation>
</ref>
<ref id="B269">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nistico</surname><given-names>R.</given-names></name><name><surname>Salter</surname><given-names>E.</given-names></name><name><surname>Nicolas</surname><given-names>C.</given-names></name><name><surname>Feligioni</surname><given-names>M.</given-names></name><name><surname>Mango</surname><given-names>D.</given-names></name><name><surname>Bortolotto</surname><given-names>Z. A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Synaptoimmunology – Roles in health and disease.</article-title>
<source/><italic>Mol. Brain</italic>
<volume>10</volume>:<issue>26</issue>. <pub-id pub-id-type="doi">10.1186/s13041-017-0308-9</pub-id>
<pub-id pub-id-type="pmid">28637489</pub-id></mixed-citation>
</ref>
<ref id="B270">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Numata</surname><given-names>S.</given-names></name><name><surname>Ueno</surname><given-names>S.</given-names></name><name><surname>Iga</surname><given-names>J.</given-names></name><name><surname>Yamauchi</surname><given-names>K.</given-names></name><name><surname>Hongwei</surname><given-names>S.</given-names></name><name><surname>Ohta</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>401</volume>
<fpage>1</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2006.02.054</pub-id>
<pub-id pub-id-type="pmid">16533563</pub-id></mixed-citation>
</ref>
<ref id="B271">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Donnell</surname><given-names>E.</given-names></name><name><surname>Vereker</surname><given-names>E.</given-names></name><name><surname>Lynch</surname><given-names>M. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Age-related impairment in LTP is accompanied by enhanced activity of stress-activated protein kinases: analysis of underlying mechanisms.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>12</volume>
<fpage>345</fpage>–<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.2000.00900.x</pub-id>
<pub-id pub-id-type="pmid">10651889</pub-id></mixed-citation>
</ref>
<ref id="B272">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohsawa</surname><given-names>K.</given-names></name><name><surname>Sanagi</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Suzuki</surname><given-names>E.</given-names></name><name><surname>Inoue</surname><given-names>K.</given-names></name><name><surname>Kohsaka</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Adenosine A3 receptor is involved in ADP-induced microglial process extension and migration.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>121</volume>
<fpage>217</fpage>–<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2012.07693.x</pub-id>
<pub-id pub-id-type="pmid">22335470</pub-id></mixed-citation>
</ref>
<ref id="B273">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olabi</surname><given-names>B.</given-names></name><name><surname>Ellison-Wright</surname><given-names>I.</given-names></name><name><surname>McIntosh</surname><given-names>A. M.</given-names></name><name><surname>Wood</surname><given-names>S. J.</given-names></name><name><surname>Bullmore</surname><given-names>E. T.</given-names></name><name><surname>Lawrie</surname><given-names>S. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>70</volume>
<fpage>88</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2011.01.032</pub-id>
<pub-id pub-id-type="pmid">21457946</pub-id></mixed-citation>
</ref>
<ref id="B274">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olmos-Alonso</surname><given-names>A.</given-names></name><name><surname>Schetters</surname><given-names>S. T.</given-names></name><name><surname>Sri</surname><given-names>S.</given-names></name><name><surname>Askew</surname><given-names>K.</given-names></name><name><surname>Mancuso</surname><given-names>R.</given-names></name><name><surname>Vargas-Caballero</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology.</article-title>
<source/><italic>Brain</italic>
<volume>139</volume>
<fpage>891</fpage>–<lpage>907</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awv379</pub-id>
<pub-id pub-id-type="pmid">26747862</pub-id></mixed-citation>
</ref>
<ref id="B275">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omalu</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Chronic traumatic encephalopathy.</article-title>
<source/><italic>Prog Neurol. Surg.</italic>
<volume>28</volume>
<fpage>38</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1159/000358761</pub-id>
<pub-id pub-id-type="pmid">24923391</pub-id></mixed-citation>
</ref>
<ref id="B276">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ongur</surname><given-names>D.</given-names></name><name><surname>Drevets</surname><given-names>W. C.</given-names></name><name><surname>Price</surname><given-names>J. L.</given-names></name></person-group> (<year>1998</year>). <article-title>Glial reduction in the subgenual prefrontal cortex in mood disorders.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>95</volume>
<fpage>13290</fpage>–<lpage>13295</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.22.13290</pub-id>
<pub-id pub-id-type="pmid">9789081</pub-id></mixed-citation>
</ref>
<ref id="B277">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osier</surname><given-names>N.</given-names></name><name><surname>Motamedi</surname><given-names>V.</given-names></name><name><surname>Edwards</surname><given-names>K.</given-names></name><name><surname>Puccio</surname><given-names>A.</given-names></name><name><surname>Diaz-Arrastia</surname><given-names>R.</given-names></name><name><surname>Kenney</surname><given-names>K.</given-names></name><name><surname>Gill</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Exosomes in acquired neurological disorders: new insights into pathophysiology and treatment.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="doi">10.1007/s12035-018-1054-4</pub-id>
<pub-id pub-id-type="pmid">29663285</pub-id></mixed-citation>
</ref>
<ref id="B278">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pabon</surname><given-names>M. M.</given-names></name><name><surname>Bachstetter</surname><given-names>A. D.</given-names></name><name><surname>Hudson</surname><given-names>C. E.</given-names></name><name><surname>Gemma</surname><given-names>C.</given-names></name><name><surname>Bickford</surname><given-names>P. C.</given-names></name></person-group> (<year>2011</year>). <article-title>CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson’s disease.</article-title>
<source/><italic>J. Neuroinflamm.</italic>
<volume>8</volume>:<issue>9</issue>. <pub-id pub-id-type="doi">10.1186/1742-2094-8-9</pub-id>
<pub-id pub-id-type="pmid">21266082</pub-id></mixed-citation>
</ref>
<ref id="B279">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padmos</surname><given-names>R. C.</given-names></name><name><surname>Hillegers</surname><given-names>M. H.</given-names></name><name><surname>Knijff</surname><given-names>E. M.</given-names></name><name><surname>Vonk</surname><given-names>R.</given-names></name><name><surname>Bouvy</surname><given-names>A.</given-names></name><name><surname>Staal</surname><given-names>F. J.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>65</volume>
<fpage>395</fpage>–<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.65.4.395</pub-id>
<pub-id pub-id-type="pmid">18391128</pub-id></mixed-citation>
</ref>
<ref id="B280">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>L.</given-names></name><name><surname>Ye</surname><given-names>W.</given-names></name><name><surname>Che</surname><given-names>X. M.</given-names></name><name><surname>Roessler</surname><given-names>B. J.</given-names></name><name><surname>Betz</surname><given-names>A. L.</given-names></name><name><surname>Yang</surname><given-names>G. Y.</given-names></name></person-group> (<year>2001</year>). <article-title>Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression.</article-title>
<source/><italic>Stroke</italic>
<volume>32</volume>
<fpage>544</fpage>–<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1161/01.STR.32.2.544</pub-id>
<pub-id pub-id-type="pmid">11157195</pub-id></mixed-citation>
</ref>
<ref id="B281">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Bergamini</surname><given-names>G.</given-names></name><name><surname>Rajendran</surname><given-names>L.</given-names></name></person-group> (<year>2018</year>). <article-title>Cell-to-cell communication by extracellular vesicles: focus on microglia.</article-title>
<source/><italic>Neuroscience</italic>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2018.04.003</pub-id>
<pub-id pub-id-type="pmid">29660443</pub-id></mixed-citation>
</ref>
<ref id="B282">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Bisht</surname><given-names>K.</given-names></name><name><surname>Tremblay</surname><given-names>M. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Fractalkine regulation of microglial physiology and consequences on the brain and behavior.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>8</volume>:<issue>129</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00129</pub-id>
<pub-id pub-id-type="pmid">24860431</pub-id></mixed-citation>
</ref>
<ref id="B283">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Bolasco</surname><given-names>G.</given-names></name><name><surname>Pagani</surname><given-names>F.</given-names></name><name><surname>Maggi</surname><given-names>L.</given-names></name><name><surname>Scianni</surname><given-names>M.</given-names></name><name><surname>Panzanelli</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Synaptic pruning by microglia is necessary for normal brain development.</article-title>
<source/><italic>Science</italic>
<volume>333</volume>
<fpage>1456</fpage>–<lpage>1458</lpage>. <pub-id pub-id-type="doi">10.1126/science.1202529</pub-id>
<pub-id pub-id-type="pmid">21778362</pub-id></mixed-citation>
</ref>
<ref id="B284">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Gross</surname><given-names>C. T.</given-names></name></person-group> (<year>2011</year>). <article-title>Microglia in development: linking brain wiring to brain environment.</article-title>
<source/><italic>Neuron Glia Biol.</italic>
<volume>7</volume>
<fpage>77</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1017/S1740925X12000105</pub-id>
<pub-id pub-id-type="pmid">22857738</pub-id></mixed-citation>
</ref>
<ref id="B285">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkhurst</surname><given-names>C. N.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Ninan</surname><given-names>I.</given-names></name><name><surname>Savas</surname><given-names>J. N.</given-names></name><name><surname>Yates</surname><given-names>J. R.</given-names><suffix>III</suffix></name><name><surname>Lafaille</surname><given-names>J. J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.</article-title>
<source/><italic>Cell</italic>
<volume>155</volume>
<fpage>1596</fpage>–<lpage>1609</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.11.030</pub-id>
<pub-id pub-id-type="pmid">24360280</pub-id></mixed-citation>
</ref>
<ref id="B286">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascual</surname><given-names>O.</given-names></name><name><surname>Ben Achour</surname><given-names>S.</given-names></name><name><surname>Rostaing</surname><given-names>P.</given-names></name><name><surname>Triller</surname><given-names>A.</given-names></name><name><surname>Bessis</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>109</volume>
<fpage>E197</fpage>–<lpage>E205</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1111098109</pub-id>
<pub-id pub-id-type="pmid">22167804</pub-id></mixed-citation>
</ref>
<ref id="B287">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pena-Altamira</surname><given-names>L. E.</given-names></name><name><surname>Polazzi</surname><given-names>E.</given-names></name><name><surname>Giuliani</surname><given-names>P.</given-names></name><name><surname>Beraudi</surname><given-names>A.</given-names></name><name><surname>Massenzio</surname><given-names>F.</given-names></name><name><surname>Mengoni</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Release of soluble and vesicular purine nucleoside phosphorylase from rat astrocytes and microglia induced by pro-inflammatory stimulation with extracellular ATP via P2X7 receptors.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>115</volume>
<fpage>37</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2017.10.010</pub-id>
<pub-id pub-id-type="pmid">29061383</pub-id></mixed-citation>
</ref>
<ref id="B288">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penzes</surname><given-names>P.</given-names></name><name><surname>Cahill</surname><given-names>M. E.</given-names></name><name><surname>Jones</surname><given-names>K. A.</given-names></name><name><surname>VanLeeuwen</surname><given-names>J. E.</given-names></name><name><surname>Woolfrey</surname><given-names>K. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Dendritic spine pathology in neuropsychiatric disorders.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>14</volume>
<fpage>285</fpage>–<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2741</pub-id>
<pub-id pub-id-type="pmid">21346746</pub-id></mixed-citation>
</ref>
<ref id="B289">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perea</surname><given-names>G.</given-names></name><name><surname>Navarrete</surname><given-names>M.</given-names></name><name><surname>Araque</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Tripartite synapses: astrocytes process and control synaptic information.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>32</volume>
<fpage>421</fpage>–<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2009.05.001</pub-id>
<pub-id pub-id-type="pmid">19615761</pub-id></mixed-citation>
</ref>
<ref id="B290">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perea</surname><given-names>J. R.</given-names></name><name><surname>Llorens-Martin</surname><given-names>M.</given-names></name><name><surname>Avila</surname><given-names>J.</given-names></name><name><surname>Bolos</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>The role of microglia in the spread of tau: relevance for tauopathies.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>12</volume>:<issue>172</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2018.00172</pub-id>
<pub-id pub-id-type="pmid">30042659</pub-id></mixed-citation>
</ref>
<ref id="B291">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perner</surname><given-names>C.</given-names></name><name><surname>Perner</surname><given-names>F.</given-names></name><name><surname>Stubendorff</surname><given-names>B.</given-names></name><name><surname>Forster</surname><given-names>M.</given-names></name><name><surname>Witte</surname><given-names>O. W.</given-names></name><name><surname>Heidel</surname><given-names>F. H.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients.</article-title>
<source/><italic>J. Neuroinflamm.</italic>
<volume>15</volume>:<issue>99</issue>. <pub-id pub-id-type="doi">10.1186/s12974-018-1135-3</pub-id>
<pub-id pub-id-type="pmid">29592817</pub-id></mixed-citation>
</ref>
<ref id="B292">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>V. H.</given-names></name><name><surname>O’Connor</surname><given-names>V.</given-names></name></person-group> (<year>2010</year>). <article-title>The role of microglia in synaptic stripping and synaptic degeneration: a revised perspective.</article-title>
<source/><italic>ASN Neuro</italic>
<volume>2</volume>:<issue>e00047</issue>. <pub-id pub-id-type="doi">10.1042/AN20100024</pub-id>
<pub-id pub-id-type="pmid">20967131</pub-id></mixed-citation>
</ref>
<ref id="B293">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perugi</surname><given-names>G.</given-names></name><name><surname>Quaranta</surname><given-names>G.</given-names></name><name><surname>Belletti</surname><given-names>S.</given-names></name><name><surname>Casalini</surname><given-names>F.</given-names></name><name><surname>Mosti</surname><given-names>N.</given-names></name><name><surname>Toni</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>General medical conditions in 347 bipolar disorder patients: clinical correlates of metabolic and autoimmune-allergic diseases.</article-title>
<source/><italic>J. Affect. Disord.</italic>
<volume>170</volume>
<fpage>95</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2014.08.052</pub-id>
<pub-id pub-id-type="pmid">25237732</pub-id></mixed-citation>
</ref>
<ref id="B294">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>J. V.</given-names></name><name><surname>Passos</surname><given-names>I. C.</given-names></name><name><surname>Librenza-Garcia</surname><given-names>D.</given-names></name><name><surname>Marcon</surname><given-names>G.</given-names></name><name><surname>Schneider</surname><given-names>M. A.</given-names></name><name><surname>Conte</surname><given-names>J. H.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Neuron-glia interaction as a possible pathophysiological mechanism of bipolar disorder.</article-title>
<source/><italic>Curr. Neuropharmacol.</italic>
<volume>16</volume>
<fpage>519</fpage>–<lpage>532</lpage>. <pub-id pub-id-type="pmid">28847296</pub-id></mixed-citation>
</ref>
<ref id="B295">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platten</surname><given-names>M.</given-names></name><name><surname>Kretz</surname><given-names>A.</given-names></name><name><surname>Naumann</surname><given-names>U.</given-names></name><name><surname>Aulwurm</surname><given-names>S.</given-names></name><name><surname>Egashira</surname><given-names>K.</given-names></name><name><surname>Isenmann</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>54</volume>
<fpage>388</fpage>–<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1002/ana.10679</pub-id>
<pub-id pub-id-type="pmid">12953273</pub-id></mixed-citation>
</ref>
<ref id="B296">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Posfai</surname><given-names>B.</given-names></name><name><surname>Cserep</surname><given-names>C.</given-names></name><name><surname>Orsolits</surname><given-names>B.</given-names></name><name><surname>Denes</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>New insights into microglia-neuron interactions: a neuron’s perspective.</article-title>
<source/><italic>Neuroscience</italic>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2018.04.046</pub-id>
<pub-id pub-id-type="pmid">29753862</pub-id></mixed-citation>
</ref>
<ref id="B297">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prada</surname><given-names>I.</given-names></name><name><surname>Furlan</surname><given-names>R.</given-names></name><name><surname>Matteoli</surname><given-names>M.</given-names></name><name><surname>Verderio</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Classical and unconventional pathways of vesicular release in microglia.</article-title>
<source/><italic>Glia</italic>
<volume>61</volume>
<fpage>1003</fpage>–<lpage>1017</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22497</pub-id>
<pub-id pub-id-type="pmid">23625857</pub-id></mixed-citation>
</ref>
<ref id="B298">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prada</surname><given-names>I.</given-names></name><name><surname>Gabrielli</surname><given-names>M.</given-names></name><name><surname>Turola</surname><given-names>E.</given-names></name><name><surname>Iorio</surname><given-names>A.</given-names></name><name><surname>D’Arrigo</surname><given-names>G.</given-names></name><name><surname>Parolisi</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterations.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>135</volume>
<fpage>529</fpage>–<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-017-1803-x</pub-id>
<pub-id pub-id-type="pmid">29302779</pub-id></mixed-citation>
</ref>
<ref id="B299">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pribiag</surname><given-names>H.</given-names></name><name><surname>Stellwagen</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Neuroimmune regulation of homeostatic synaptic plasticity.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>78</volume>
<fpage>13</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.06.008</pub-id>
<pub-id pub-id-type="pmid">23774138</pub-id></mixed-citation>
</ref>
<ref id="B300">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prins</surname><given-names>M.</given-names></name><name><surname>Greco</surname><given-names>T.</given-names></name><name><surname>Alexander</surname><given-names>D.</given-names></name><name><surname>Giza</surname><given-names>C. C.</given-names></name></person-group> (<year>2013</year>). <article-title>The pathophysiology of traumatic brain injury at a glance.</article-title>
<source/><italic>Dis. Model Mech.</italic>
<volume>6</volume>
<fpage>1307</fpage>–<lpage>1315</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.011585</pub-id>
<pub-id pub-id-type="pmid">24046353</pub-id></mixed-citation>
</ref>
<ref id="B301">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pyonteck</surname><given-names>S. M.</given-names></name><name><surname>Akkari</surname><given-names>L.</given-names></name><name><surname>Schuhmacher</surname><given-names>A. J.</given-names></name><name><surname>Bowman</surname><given-names>R. L.</given-names></name><name><surname>Sevenich</surname><given-names>L.</given-names></name><name><surname>Quail</surname><given-names>D. F.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>CSF-1R inhibition alters macrophage polarization and blocks glioma progression.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>19</volume>
<fpage>1264</fpage>–<lpage>1272</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3337</pub-id>
<pub-id pub-id-type="pmid">24056773</pub-id></mixed-citation>
</ref>
<ref id="B302">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ragozzino</surname><given-names>D.</given-names></name><name><surname>Di Angelantonio</surname><given-names>S.</given-names></name><name><surname>Trettel</surname><given-names>F.</given-names></name><name><surname>Bertollini</surname><given-names>C.</given-names></name><name><surname>Maggi</surname><given-names>L.</given-names></name><name><surname>Gross</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>26</volume>
<fpage>10488</fpage>–<lpage>10498</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3192-06.2006</pub-id>
<pub-id pub-id-type="pmid">17035533</pub-id></mixed-citation>
</ref>
<ref id="B303">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajendran</surname><given-names>L.</given-names></name><name><surname>Bali</surname><given-names>J.</given-names></name><name><surname>Barr</surname><given-names>M. M.</given-names></name><name><surname>Court</surname><given-names>F. A.</given-names></name><name><surname>Kramer-Albers</surname><given-names>E. M.</given-names></name><name><surname>Picou</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Emerging roles of extracellular vesicles in the nervous system.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>34</volume>
<fpage>15482</fpage>–<lpage>15489</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3258-14.2014</pub-id><pub-id pub-id-type="pmid">25392515</pub-id></mixed-citation>
</ref>
<ref id="B304">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajendran</surname><given-names>L.</given-names></name><name><surname>Honsho</surname><given-names>M.</given-names></name><name><surname>Zahn</surname><given-names>T. R.</given-names></name><name><surname>Keller</surname><given-names>P.</given-names></name><name><surname>Geiger</surname><given-names>K. D.</given-names></name><name><surname>Verkade</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Alzheimer’s disease beta-amyloid peptides are released in association with exosomes.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>11172</fpage>–<lpage>11177</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0603838103</pub-id>
<pub-id pub-id-type="pmid">16837572</pub-id></mixed-citation>
</ref>
<ref id="B305">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajkowska</surname><given-names>G.</given-names></name><name><surname>O’Dwyer</surname><given-names>G.</given-names></name><name><surname>Teleki</surname><given-names>Z.</given-names></name><name><surname>Stockmeier</surname><given-names>C. A.</given-names></name><name><surname>Miguel-Hidalgo</surname><given-names>J. J.</given-names></name></person-group> (<year>2007</year>). <article-title>GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>32</volume>
<fpage>471</fpage>–<lpage>482</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1301234</pub-id>
<pub-id pub-id-type="pmid">17063153</pub-id></mixed-citation>
</ref>
<ref id="B306">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>A. I.</given-names></name><name><surname>de Hoz</surname><given-names>R.</given-names></name><name><surname>Salobrar-Garcia</surname><given-names>E.</given-names></name><name><surname>Salazar</surname><given-names>J. J.</given-names></name><name><surname>Rojas</surname><given-names>B.</given-names></name><name><surname>Ajoy</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The role of microglia in retinal neurodegeneration: alzheimer’s disease, parkinson, and glaucoma.</article-title>
<source/><italic>Front. Aging Neurosci.</italic>
<volume>9</volume>:<issue>214</issue>
<pub-id pub-id-type="doi">10.3389/fnagi.2017.00214</pub-id></mixed-citation>
</ref>
<ref id="B307">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rancan</surname><given-names>M.</given-names></name><name><surname>Otto</surname><given-names>V. I.</given-names></name><name><surname>Hans</surname><given-names>V. H.</given-names></name><name><surname>Gerlach</surname><given-names>I.</given-names></name><name><surname>Jork</surname><given-names>R.</given-names></name><name><surname>Trentz</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Upregulation of ICAM-1 and MCP-1 but not of MIP-2 and sensorimotor deficit in response to traumatic axonal injury in rats.</article-title>
<source/><italic>J. Neurosci. Res.</italic>
<volume>63</volume>
<fpage>438</fpage>–<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1002/1097-4547(20010301)63:5&lt;438::AID-JNR1039&gt;3.0.CO;2-P</pub-id><pub-id pub-id-type="pmid">11223919</pub-id></mixed-citation>
</ref>
<ref id="B308">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name><name><surname>Cardona</surname><given-names>A. E.</given-names></name></person-group> (<year>2010</year>). <article-title>The myeloid cells of the central nervous system parenchyma.</article-title>
<source/><italic>Nature</italic>
<volume>468</volume>
<fpage>253</fpage>–<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1038/nature09615</pub-id>
<pub-id pub-id-type="pmid">21068834</pub-id></mixed-citation>
</ref>
<ref id="B309">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name><name><surname>Perry</surname><given-names>V. H.</given-names></name></person-group> (<year>2009</year>). <article-title>Microglial physiology: unique stimuli, specialized responses.</article-title>
<source/><italic>Annu. Rev. Immunol.</italic>
<volume>27</volume>
<fpage>119</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132528</pub-id>
<pub-id pub-id-type="pmid">19302036</pub-id></mixed-citation>
</ref>
<ref id="B310">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>J. S.</given-names></name><name><surname>Harry</surname><given-names>G. J.</given-names></name><name><surname>Rapoport</surname><given-names>S. I.</given-names></name><name><surname>Kim</surname><given-names>H. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>15</volume>
<fpage>384</fpage>–<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2009.47</pub-id>
<pub-id pub-id-type="pmid">19488045</pub-id></mixed-citation>
</ref>
<ref id="B311">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathnasamy</surname><given-names>G.</given-names></name><name><surname>Foulds</surname><given-names>W. S.</given-names></name><name><surname>Ling</surname><given-names>E. A.</given-names></name><name><surname>Kaur</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Retinal microglia – A key player in healthy and diseased retina.</article-title>
<source/><italic>Prog. Neurobiol.</italic>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2018.05.006</pub-id>
<pub-id pub-id-type="pmid">29864456</pub-id></mixed-citation>
</ref>
<ref id="B312">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reaux-Le Goazigo</surname><given-names>A.</given-names></name><name><surname>Van Steenwinckel</surname><given-names>J.</given-names></name><name><surname>Rostene</surname><given-names>W.</given-names></name><name><surname>Melik Parsadaniantz</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Current status of chemokines in the adult CNS.</article-title>
<source/><italic>Prog. Neurobiol.</italic>
<volume>104</volume>
<fpage>67</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2013.02.001</pub-id>
<pub-id pub-id-type="pmid">23454481</pub-id></mixed-citation>
</ref>
<ref id="B313">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Réus</surname><given-names>G. Z.</given-names></name><name><surname>Fries</surname><given-names>G. R.</given-names></name><name><surname>Stertz</surname><given-names>L.</given-names></name><name><surname>Badawy</surname><given-names>M.</given-names></name><name><surname>Passos</surname><given-names>I. C.</given-names></name><name><surname>Barichello</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders.</article-title>
<source/><italic>Neuroscience</italic>
<volume>300</volume>
<fpage>141</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.05.018</pub-id>
<pub-id pub-id-type="pmid">25981208</pub-id></mixed-citation>
</ref>
<ref id="B314">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>B. M. M.</given-names></name><name><surname>do Carmo</surname><given-names>M. R. S.</given-names></name><name><surname>Freire</surname><given-names>R. S.</given-names></name><name><surname>Rocha</surname><given-names>N. F. M.</given-names></name><name><surname>Borella</surname><given-names>V. C. M.</given-names></name><name><surname>de Menezes</surname><given-names>A. T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine.</article-title>
<source/><italic>Schizophr. Res.</italic>
<volume>151</volume>
<fpage>12</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2013.10.040</pub-id>
<pub-id pub-id-type="pmid">24257517</pub-id></mixed-citation>
</ref>
<ref id="B315">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>J. T.</given-names></name><name><surname>Morganti</surname><given-names>J. M.</given-names></name><name><surname>Bachstetter</surname><given-names>A. D.</given-names></name><name><surname>Hudson</surname><given-names>C. E.</given-names></name><name><surname>Peters</surname><given-names>M. M.</given-names></name><name><surname>Grimmig</surname><given-names>B. A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>16241</fpage>–<lpage>16250</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3667-11.2011</pub-id>
<pub-id pub-id-type="pmid">22072675</pub-id></mixed-citation>
</ref>
<ref id="B316">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>M. L.</given-names></name><name><surname>Hughes</surname><given-names>J. T.</given-names></name><name><surname>Esiri</surname><given-names>M. M.</given-names></name><name><surname>Coakham</surname><given-names>H. B.</given-names></name><name><surname>Brownell</surname><given-names>D. B.</given-names></name></person-group> (<year>1987</year>). <article-title>Immunohistological study of mononuclear cell infiltrate in malignant gliomas.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>74</volume>
<fpage>269</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1007/BF00688191</pub-id><pub-id pub-id-type="pmid">3314311</pub-id></mixed-citation>
</ref>
<ref id="B317">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roumier</surname><given-names>A.</given-names></name><name><surname>Bechade</surname><given-names>C.</given-names></name><name><surname>Poncer</surname><given-names>J. C.</given-names></name><name><surname>Smalla</surname><given-names>K. H.</given-names></name><name><surname>Tomasello</surname><given-names>E.</given-names></name><name><surname>Vivier</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>24</volume>
<fpage>11421</fpage>–<lpage>11428</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2251-04.2004</pub-id>
<pub-id pub-id-type="pmid">15601948</pub-id></mixed-citation>
</ref>
<ref id="B318">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rufino-Ramos</surname><given-names>D.</given-names></name><name><surname>Albuquerque</surname><given-names>P. R.</given-names></name><name><surname>Carmona</surname><given-names>V.</given-names></name><name><surname>Perfeito</surname><given-names>R.</given-names></name><name><surname>Nobre</surname><given-names>R. J.</given-names></name><name><surname>Pereira</surname></name><etal></etal></person-group> (<year>2017</year>). <article-title>Extracellular vesicles: novel promising delivery systems for therapy of brain diseases.</article-title>
<source/><italic>J. Control Release</italic>
<volume>262</volume>
<fpage>247</fpage>–<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2017.07.001</pub-id>
<pub-id pub-id-type="pmid">28687495</pub-id></mixed-citation>
</ref>
<ref id="B319">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saber</surname><given-names>M.</given-names></name><name><surname>Kokiko-Cochran</surname><given-names>O.</given-names></name><name><surname>Puntambekar</surname><given-names>S. S.</given-names></name><name><surname>Lathia</surname><given-names>J. D.</given-names></name><name><surname>Lamb</surname><given-names>B. T.</given-names></name></person-group> (<year>2017</year>). <article-title>Triggering receptor expressed on myeloid cells 2 deficiency alters acute macrophage distribution and improves recovery after traumatic brain injury.</article-title>
<source/><italic>J. Neurotr.</italic>
<volume>34</volume>
<fpage>423</fpage>–<lpage>435</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2016.4401</pub-id>
<pub-id pub-id-type="pmid">26976047</pub-id></mixed-citation>
</ref>
<ref id="B320">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saman</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>W.</given-names></name><name><surname>Raya</surname><given-names>M.</given-names></name><name><surname>Visnick</surname><given-names>Y.</given-names></name><name><surname>Miro</surname><given-names>S.</given-names></name><name><surname>Saman</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>287</volume>
<fpage>3842</fpage>–<lpage>3849</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.277061</pub-id>
<pub-id pub-id-type="pmid">22057275</pub-id></mixed-citation>
</ref>
<ref id="B321">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santello</surname><given-names>M.</given-names></name><name><surname>Bezzi</surname><given-names>P.</given-names></name><name><surname>Volterra</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>TNFalpha controls glutamatergic gliotransmission in the hippocampal dentate gyrus.</article-title>
<source/><italic>Neuron</italic>
<volume>69</volume>
<fpage>988</fpage>–<lpage>1001</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.02.003</pub-id>
<pub-id pub-id-type="pmid">21382557</pub-id></mixed-citation>
</ref>
<ref id="B322">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>A. R.</given-names></name><name><surname>Comprido</surname><given-names>D.</given-names></name><name><surname>Duarte</surname><given-names>C. B.</given-names></name></person-group> (<year>2010</year>). <article-title>Regulation of local translation at the synapse by BDNF.</article-title>
<source/><italic>Prog. Neurobiol.</italic>
<volume>92</volume>
<fpage>505</fpage>–<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2010.08.004</pub-id>
<pub-id pub-id-type="pmid">20713125</pub-id></mixed-citation>
</ref>
<ref id="B323">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>C.</given-names></name><name><surname>Basu</surname><given-names>B.</given-names></name><name><surname>Chakroborty</surname><given-names>D.</given-names></name><name><surname>Dasgupta</surname><given-names>P. S.</given-names></name><name><surname>Basu</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>The immunoregulatory role of dopamine: an update.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>24</volume>
<fpage>525</fpage>–<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2009.10.015</pub-id>
<pub-id pub-id-type="pmid">19896530</pub-id></mixed-citation>
</ref>
<ref id="B324">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saud</surname><given-names>K.</given-names></name><name><surname>Herrera-Molina</surname><given-names>R.</given-names></name><name><surname>Von Bernhardi</surname><given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>Pro- and anti-inflammatory cytokines regulate the ERK pathway: implication of the timing for the activation of microglial cells.</article-title>
<source/><italic>Neurotox Res.</italic>
<volume>8</volume>
<fpage>277</fpage>–<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1007/BF03033981</pub-id>
<pub-id pub-id-type="pmid">16371322</pub-id></mixed-citation>
</ref>
<ref id="B325">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savaskan</surname><given-names>N. E.</given-names></name><name><surname>Fan</surname><given-names>Z.</given-names></name><name><surname>Broggini</surname><given-names>T.</given-names></name><name><surname>Buchfelder</surname><given-names>M.</given-names></name><name><surname>Eyupoglu</surname><given-names>I. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Neurodegeneration and the brain tumor microenvironment. [corrected].</article-title>
<source/><italic>Curr. Neuropharmacol.</italic>
<volume>13</volume>
<fpage>258</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.2174/1570159X13666150122224158</pub-id><pub-id pub-id-type="pmid">26411769</pub-id></mixed-citation>
</ref>
<ref id="B326">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savaskan</surname><given-names>N. E.</given-names></name><name><surname>Heckel</surname><given-names>A.</given-names></name><name><surname>Hahnen</surname><given-names>E.</given-names></name><name><surname>Engelhorn</surname><given-names>T.</given-names></name><name><surname>Doerfler</surname><given-names>A.</given-names></name><name><surname>Ganslandt</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>14</volume>
<fpage>629</fpage>–<lpage>632</lpage>. <pub-id pub-id-type="doi">10.1038/nm1772</pub-id>
<pub-id pub-id-type="pmid">18469825</pub-id></mixed-citation>
</ref>
<ref id="B327">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>D. P.</given-names></name><name><surname>Lehrman</surname><given-names>E. K.</given-names></name><name><surname>Kautzman</surname><given-names>A. G.</given-names></name><name><surname>Koyama</surname><given-names>R.</given-names></name><name><surname>Mardinly</surname><given-names>A. R.</given-names></name><name><surname>Yamasaki</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner.</article-title>
<source/><italic>Neuron</italic>
<volume>74</volume>
<fpage>691</fpage>–<lpage>705</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.03.026</pub-id>
<pub-id pub-id-type="pmid">22632727</pub-id></mixed-citation>
</ref>
<ref id="B328">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schall</surname><given-names>T.</given-names></name></person-group> (<year>1997</year>). <article-title>Fractalkine–a strange attractor in the chemokine landscape.</article-title>
<source/><italic>Immunol. Today</italic>
<volume>18</volume>:<issue>147</issue>
<pub-id pub-id-type="doi">10.1016/S0167-5699(97)84655-5</pub-id></mixed-citation>
</ref>
<ref id="B329">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiffer</surname><given-names>D.</given-names></name><name><surname>Mellai</surname><given-names>M.</given-names></name><name><surname>Bovio</surname><given-names>E.</given-names></name><name><surname>Annovazzi</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>The neuropathological basis to the functional role of microglia/macrophages in gliomas.</article-title>
<source/><italic>Neurol. Sci.</italic>
<volume>38</volume>
<fpage>1571</fpage>–<lpage>1577</lpage>. <pub-id pub-id-type="doi">10.1007/s10072-017-3002-x</pub-id>
<pub-id pub-id-type="pmid">28593528</pub-id></mixed-citation>
</ref>
<ref id="B330">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmierer</surname><given-names>B.</given-names></name><name><surname>Hill</surname><given-names>C. S.</given-names></name></person-group> (<year>2007</year>). <article-title>TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>8</volume>
<fpage>970</fpage>–<lpage>982</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2297</pub-id>
<pub-id pub-id-type="pmid">18000526</pub-id></mixed-citation>
</ref>
<ref id="B331">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>A.</given-names></name><name><surname>Simons</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders.</article-title>
<source/><italic>Cell Tissue Res.</italic>
<volume>352</volume>
<fpage>33</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-012-1428-2</pub-id>
<pub-id pub-id-type="pmid">22610588</pub-id></mixed-citation>
</ref>
<ref id="B332">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>R. C.</given-names></name><name><surname>Krivacic</surname><given-names>K.</given-names></name><name><surname>Kirby</surname><given-names>B.</given-names></name><name><surname>Vaccariello</surname><given-names>S. A.</given-names></name><name><surname>Wei</surname><given-names>T.</given-names></name><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Monocyte chemoattractant protein (MCP)-1 is rapidly expressed by sympathetic ganglion neurons following axonal injury.</article-title>
<source/><italic>Neuroreport</italic>
<volume>12</volume>
<fpage>601</fpage>–<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-200103050-00034</pub-id>
<pub-id pub-id-type="pmid">11234772</pub-id></mixed-citation>
</ref>
<ref id="B333">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>C.</given-names></name><name><surname>Gomez Perdiguero</surname><given-names>E.</given-names></name><name><surname>Chorro</surname><given-names>L.</given-names></name><name><surname>Szabo-Rogers</surname><given-names>H.</given-names></name><name><surname>Cagnard</surname><given-names>N.</given-names></name><name><surname>Kierdorf</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>A lineage of myeloid cells independent of Myb and hematopoietic stem cells.</article-title>
<source/><italic>Science</italic>
<volume>336</volume>
<fpage>86</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1126/science.1219179</pub-id>
<pub-id pub-id-type="pmid">22442384</pub-id></mixed-citation>
</ref>
<ref id="B334">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>M.</given-names></name><name><surname>Butovsky</surname><given-names>O.</given-names></name><name><surname>Bruck</surname><given-names>W.</given-names></name><name><surname>Hanisch</surname><given-names>U. K.</given-names></name></person-group> (<year>2006</year>). <article-title>Microglial phenotype: is the commitment reversible?</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>29</volume>
<fpage>68</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="pmid">16406093</pub-id></mixed-citation>
</ref>
<ref id="B335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setiawan</surname><given-names>E.</given-names></name><name><surname>Wilson</surname><given-names>A. A.</given-names></name><name><surname>Mizrahi</surname><given-names>R.</given-names></name><name><surname>Rusjan</surname><given-names>P. M.</given-names></name><name><surname>Miler</surname><given-names>L.</given-names></name><name><surname>Rajkowska</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.</article-title>
<source/><italic>JAMA Psychiatry</italic>
<volume>72</volume>
<fpage>268</fpage>–<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.2427</pub-id>
<pub-id pub-id-type="pmid">25629589</pub-id></mixed-citation>
</ref>
<ref id="B336">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sewell</surname><given-names>D. L.</given-names></name><name><surname>Nacewicz</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Macvilay</surname><given-names>S.</given-names></name><name><surname>Erdei</surname><given-names>A.</given-names></name><name><surname>Lambris</surname><given-names>J. D.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist.</article-title>
<source/><italic>J. Neuroimmunol.</italic>
<volume>155</volume>
<fpage>55</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2004.06.003</pub-id>
<pub-id pub-id-type="pmid">15342196</pub-id></mixed-citation>
</ref>
<ref id="B337">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Liddelow</surname><given-names>S. A.</given-names></name><name><surname>Smith</surname><given-names>S. T.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Luo</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.</article-title>
<source/><italic>Nature</italic>
<volume>549</volume>
<fpage>523</fpage>–<lpage>527</lpage>. <pub-id pub-id-type="doi">10.1038/nature24016</pub-id>
<pub-id pub-id-type="pmid">28959956</pub-id></mixed-citation>
</ref>
<ref id="B338">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>J.</given-names></name><name><surname>Pizzi</surname><given-names>M. A.</given-names></name><name><surname>Brent Peel</surname><given-names>J.</given-names></name><name><surname>Alejos</surname><given-names>D.</given-names></name><name><surname>Mbabuike</surname><given-names>N.</given-names></name><name><surname>Brown</surname><given-names>B. L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Update on neurocritical care of stroke.</article-title>
<source/><italic>Curr. Cardiol. Rep.</italic>
<volume>19</volume>:<issue>67</issue>. <pub-id pub-id-type="doi">10.1007/s11886-017-0881-7</pub-id>
<pub-id pub-id-type="pmid">28646445</pub-id></mixed-citation>
</ref>
<ref id="B339">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sielska</surname><given-names>M.</given-names></name><name><surname>Przanowski</surname><given-names>P.</given-names></name><name><surname>Wylot</surname><given-names>B.</given-names></name><name><surname>Gabrusiewicz</surname><given-names>K.</given-names></name><name><surname>Maleszewska</surname><given-names>M.</given-names></name><name><surname>Kijewska</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.</article-title>
<source/><italic>J. Pathol.</italic>
<volume>230</volume>
<fpage>310</fpage>–<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1002/path.4192</pub-id>
<pub-id pub-id-type="pmid">23520016</pub-id></mixed-citation>
</ref>
<ref id="B340">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simmons</surname><given-names>G. W.</given-names></name><name><surname>Pong</surname><given-names>W. W.</given-names></name><name><surname>Emnett</surname><given-names>R. J.</given-names></name><name><surname>White</surname><given-names>C. R.</given-names></name><name><surname>Gianino</surname><given-names>S. M.</given-names></name><name><surname>Rodriguez</surname><given-names>F. J.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.</article-title>
<source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>70</volume>
<fpage>51</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0b013e3182032d37</pub-id>
<pub-id pub-id-type="pmid">21157378</pub-id></mixed-citation>
</ref>
<ref id="B341">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>S.</given-names></name><name><surname>Kong</surname><given-names>X.</given-names></name><name><surname>Acosta</surname><given-names>S.</given-names></name><name><surname>Sava</surname><given-names>V.</given-names></name><name><surname>Borlongan</surname><given-names>C.</given-names></name><name><surname>Sanchez-Ramos</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Granulocyte-colony stimulating factor promotes brain repair following traumatic brain injury by recruitment of microglia and increasing neurotrophic factor expression.</article-title>
<source/><italic>Restor. Neurol. Neurosci.</italic>
<volume>34</volume>
<fpage>415</fpage>–<lpage>431</lpage>. <pub-id pub-id-type="doi">10.3233/RNN-150607</pub-id>
<pub-id pub-id-type="pmid">26923619</pub-id></mixed-citation>
</ref>
<ref id="B342">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soriano</surname><given-names>S. G.</given-names></name><name><surname>Amaravadi</surname><given-names>L. S.</given-names></name><name><surname>Wang</surname><given-names>Y. F.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Yu</surname><given-names>G. X.</given-names></name><name><surname>Tonra</surname><given-names>J. R.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury.</article-title>
<source/><italic>J. Neuroimmunol.</italic>
<volume>125</volume>
<fpage>59</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-5728(02)00033-4</pub-id>
<pub-id pub-id-type="pmid">11960641</pub-id></mixed-citation>
</ref>
<ref id="B343">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sousa</surname><given-names>N.</given-names></name><name><surname>Cerqueira</surname><given-names>J. J.</given-names></name><name><surname>Almeida</surname><given-names>O. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Corticosteroid receptors and neuroplasticity.</article-title>
<source/><italic>Brain Res. Rev.</italic>
<volume>57</volume>
<fpage>561</fpage>–<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresrev.2007.06.007</pub-id>
<pub-id pub-id-type="pmid">17692926</pub-id></mixed-citation>
</ref>
<ref id="B344">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spangenberg</surname><given-names>E. E.</given-names></name><name><surname>Lee</surname><given-names>R. J.</given-names></name><name><surname>Najafi</surname><given-names>A. R.</given-names></name><name><surname>Rice</surname><given-names>R. A.</given-names></name><name><surname>Elmore</surname><given-names>M. R.</given-names></name><name><surname>Blurton-Jones</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-beta pathology.</article-title>
<source/><italic>Brain</italic>
<volume>139</volume>
<fpage>1265</fpage>–<lpage>1281</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aww016</pub-id>
<pub-id pub-id-type="pmid">26921617</pub-id></mixed-citation>
</ref>
<ref id="B345">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stadelmann</surname><given-names>C.</given-names></name><name><surname>Kerschensteiner</surname><given-names>M.</given-names></name><name><surname>Misgeld</surname><given-names>T.</given-names></name><name><surname>Bruck</surname><given-names>W.</given-names></name><name><surname>Hohlfeld</surname><given-names>R.</given-names></name><name><surname>Lassmann</surname><given-names>H.</given-names></name></person-group> (<year>2002</year>). <article-title>BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?</article-title>
<source/><italic>Brain</italic>
<volume>125</volume>
<fpage>75</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="pmid">11834594</pub-id></mixed-citation>
</ref>
<ref id="B346">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stellwagen</surname><given-names>D.</given-names></name><name><surname>Beattie</surname><given-names>E. C.</given-names></name><name><surname>Seo</surname><given-names>J. Y.</given-names></name><name><surname>Malenka</surname><given-names>R. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>25</volume>
<fpage>3219</fpage>–<lpage>3228</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4486-04.2005</pub-id>
<pub-id pub-id-type="pmid">15788779</pub-id></mixed-citation>
</ref>
<ref id="B347">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stellwagen</surname><given-names>D.</given-names></name><name><surname>Lewitus</surname><given-names>G. M.</given-names></name></person-group> (<year>2014</year>). <article-title>The complexity of homeostasis at the synapse.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>78</volume>
<fpage>1</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.10.019</pub-id>
<pub-id pub-id-type="pmid">24184418</pub-id></mixed-citation>
</ref>
<ref id="B348">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stence</surname><given-names>N.</given-names></name><name><surname>Waite</surname><given-names>M.</given-names></name><name><surname>Dailey</surname><given-names>M. E.</given-names></name></person-group> (<year>2001</year>). <article-title>Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices.</article-title>
<source/><italic>Glia</italic>
<volume>33</volume>
<fpage>256</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1002/1098-1136(200103)33:3&lt;256::AID-GLIA1024&gt;3.0.CO;2-J</pub-id>
<pub-id pub-id-type="pmid">11241743</pub-id></mixed-citation>
</ref>
<ref id="B349">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephenson</surname><given-names>J.</given-names></name><name><surname>Nutma</surname><given-names>E.</given-names></name><name><surname>van der Valk</surname><given-names>P.</given-names></name><name><surname>Amor</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Inflammation in CNS neurodegenerative diseases.</article-title>
<source/><italic>Immunology</italic>
<volume>154</volume>
<fpage>204</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1111/imm.12922</pub-id>
<pub-id pub-id-type="pmid">29513402</pub-id></mixed-citation>
</ref>
<ref id="B350">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stertz</surname><given-names>L.</given-names></name><name><surname>Fries</surname><given-names>G. R.</given-names></name><name><surname>Rosa</surname><given-names>A. R.</given-names></name><name><surname>Kauer-Sant’anna</surname><given-names>M.</given-names></name><name><surname>Ferrari</surname><given-names>P.</given-names></name><name><surname>Paz</surname><given-names>A. V.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Damage-associated molecular patterns and immune activation in bipolar disorder.</article-title>
<source/><italic>Acta Psychiatr. Scand.</italic>
<volume>132</volume>
<fpage>211</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1111/acps.12417</pub-id>
<pub-id pub-id-type="pmid">25891376</pub-id></mixed-citation>
</ref>
<ref id="B351">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>B.</given-names></name><name><surname>Allen</surname><given-names>N. J.</given-names></name><name><surname>Vazquez</surname><given-names>L. E.</given-names></name><name><surname>Howell</surname><given-names>G. R.</given-names></name><name><surname>Christopherson</surname><given-names>K. S.</given-names></name><name><surname>Nouri</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>The classical complement cascade mediates CNS synapse elimination.</article-title>
<source/><italic>Cell</italic>
<volume>131</volume>
<fpage>1164</fpage>–<lpage>1178</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.10.036</pub-id>
<pub-id pub-id-type="pmid">18083105</pub-id></mixed-citation>
</ref>
<ref id="B352">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stokes</surname><given-names>L.</given-names></name><name><surname>Spencer</surname><given-names>S. J.</given-names></name><name><surname>Jenkins</surname><given-names>T. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Understanding the role of P2X7 in affective disorders-are glial cells the major players?</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>9</volume>:<issue>258</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00258</pub-id>
<pub-id pub-id-type="pmid">26217184</pub-id></mixed-citation>
</ref>
<ref id="B353">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Streit</surname><given-names>W. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Microglial response to brain injury: a brief synopsis.</article-title>
<source/><italic>Toxicol. Pathol.</italic>
<volume>28</volume>
<fpage>28</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1177/019262330002800104</pub-id>
<pub-id pub-id-type="pmid">10668987</pub-id></mixed-citation>
</ref>
<ref id="B354">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzumura</surname><given-names>A.</given-names></name><name><surname>Sawada</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>H.</given-names></name><name><surname>Marunouchi</surname><given-names>T.</given-names></name></person-group> (<year>1993</year>). <article-title>Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>151</volume>
<fpage>2150</fpage>–<lpage>2158</lpage>. <pub-id pub-id-type="pmid">8345199</pub-id></mixed-citation>
</ref>
<ref id="B355">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szalay</surname><given-names>G.</given-names></name><name><surname>Martinecz</surname><given-names>B.</given-names></name><name><surname>Lenart</surname><given-names>N.</given-names></name><name><surname>Kornyei</surname><given-names>Z.</given-names></name><name><surname>Orsolits</surname><given-names>B.</given-names></name><name><surname>Judak</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>7</volume>:<issue>11499</issue>. <pub-id pub-id-type="doi">10.1038/ncomms11499</pub-id>
<pub-id pub-id-type="pmid">27139776</pub-id></mixed-citation>
</ref>
<ref id="B356">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takenouchi</surname><given-names>T.</given-names></name><name><surname>Tsukimoto</surname><given-names>M.</given-names></name><name><surname>Iwamaru</surname><given-names>Y.</given-names></name><name><surname>Sugama</surname><given-names>S.</given-names></name><name><surname>Sekiyama</surname><given-names>K.</given-names></name><name><surname>Sato</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Extracellular ATP induces unconventional release of glyceraldehyde-3-phosphate dehydrogenase from microglial cells.</article-title>
<source/><italic>Immunol. Lett.</italic>
<volume>167</volume>
<fpage>116</fpage>–<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.imlet.2015.08.002</pub-id>
<pub-id pub-id-type="pmid">26277554</pub-id></mixed-citation>
</ref>
<ref id="B357">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamboli</surname><given-names>I. Y.</given-names></name><name><surname>Barth</surname><given-names>E.</given-names></name><name><surname>Christian</surname><given-names>L.</given-names></name><name><surname>Siepmann</surname><given-names>M.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>285</volume>
<fpage>37405</fpage>–<lpage>37414</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.149468</pub-id>
<pub-id pub-id-type="pmid">20876579</pub-id></mixed-citation>
</ref>
<ref id="B358">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>J.</given-names></name><name><surname>Town</surname><given-names>T.</given-names></name><name><surname>Mullan</surname><given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>275</volume>
<fpage>37224</fpage>–<lpage>37231</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M002006200</pub-id>
<pub-id pub-id-type="pmid">10978311</pub-id></mixed-citation>
</ref>
<ref id="B359">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarozzo</surname><given-names>G.</given-names></name><name><surname>Bortolazzi</surname><given-names>S.</given-names></name><name><surname>Crochemore</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>S. C.</given-names></name><name><surname>Lira</surname><given-names>A. S.</given-names></name><name><surname>Abrams</surname><given-names>J. S.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Fractalkine protein localization and gene expression in mouse brain.</article-title>
<source/><italic>J. Neurosci. Res.</italic>
<volume>73</volume>
<fpage>81</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.10645</pub-id>
<pub-id pub-id-type="pmid">12815711</pub-id></mixed-citation>
</ref>
<ref id="B360">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>D. L.</given-names></name><name><surname>Jones</surname><given-names>F.</given-names></name><name><surname>Kubota</surname><given-names>E. S.</given-names></name><name><surname>Pocock</surname><given-names>J. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>25</volume>
<fpage>2952</fpage>–<lpage>2964</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4456-04.2005</pub-id>
<pub-id pub-id-type="pmid">15772355</pub-id></mixed-citation>
</ref>
<ref id="B361">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thome</surname><given-names>A. D.</given-names></name><name><surname>Standaert</surname><given-names>D. G.</given-names></name><name><surname>Harms</surname><given-names>A. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Fractalkine signaling regulates the inflammatory response in an alpha-synuclein model of parkinson disease.</article-title>
<source/><italic>PLoS One</italic>
<volume>10</volume>:<issue>e0140566</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0140566</pub-id>
<pub-id pub-id-type="pmid">26469270</pub-id></mixed-citation>
</ref>
<ref id="B362">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Kaarela</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name></person-group> (<year>2012</year>). <article-title>Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases.</article-title>
<source/><italic>J. Neuroinflamm.</italic>
<volume>9</volume>:<issue>155</issue>. <pub-id pub-id-type="doi">10.1186/1742-2094-9-155</pub-id>
<pub-id pub-id-type="pmid">22747919</pub-id></mixed-citation>
</ref>
<ref id="B363">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tofaris</surname><given-names>G. K.</given-names></name></person-group> (<year>2017</year>). <article-title>A critical assessment of exosomes in the pathogenesis and stratification of Parkinson’s Disease.</article-title>
<source/><italic>J. Parkinsons Dis.</italic>
<volume>7</volume>
<fpage>569</fpage>–<lpage>576</lpage>. <pub-id pub-id-type="doi">10.3233/JPD-171176</pub-id>
<pub-id pub-id-type="pmid">28922170</pub-id></mixed-citation>
</ref>
<ref id="B364">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres-Platas</surname><given-names>S. G.</given-names></name><name><surname>Cruceanu</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>G. G.</given-names></name><name><surname>Turecki</surname><given-names>G.</given-names></name><name><surname>Mechawar</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>42</volume>
<fpage>50</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2014.05.007</pub-id>
<pub-id pub-id-type="pmid">24858659</pub-id></mixed-citation>
</ref>
<ref id="B365">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Town</surname><given-names>T.</given-names></name><name><surname>Nikolic</surname><given-names>V.</given-names></name><name><surname>Tan</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>The microglial “activation” continuum: from innate to adaptive responses.</article-title>
<source/><italic>J. Neuroinflamm.</italic>
<volume>2</volume>:<issue>24</issue>.</mixed-citation>
</ref>
<ref id="B366">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trang</surname><given-names>T.</given-names></name><name><surname>Beggs</surname><given-names>S.</given-names></name><name><surname>Salter</surname><given-names>M. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain.</article-title>
<source/><italic>Neuron Glia Biol.</italic>
<volume>7</volume>
<fpage>99</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1017/S1740925X12000087</pub-id>
<pub-id pub-id-type="pmid">22613083</pub-id></mixed-citation>
</ref>
<ref id="B367">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trang</surname><given-names>T.</given-names></name><name><surname>Beggs</surname><given-names>S.</given-names></name><name><surname>Wan</surname><given-names>X.</given-names></name><name><surname>Salter</surname><given-names>M. W.</given-names></name></person-group> (<year>2009</year>). <article-title>P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>29</volume>
<fpage>3518</fpage>–<lpage>3528</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5714-08.2009</pub-id>
<pub-id pub-id-type="pmid">19295157</pub-id></mixed-citation>
</ref>
<ref id="B368">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>M. E.</given-names></name><name><surname>Lowery</surname><given-names>R. L.</given-names></name><name><surname>Majewska</surname><given-names>A. K.</given-names></name></person-group> (<year>2010</year>). <article-title>Microglial interactions with synapses are modulated by visual experience.</article-title>
<source/><italic>PLoS Biol.</italic>
<volume>8</volume>:<issue>e1000527</issue>. <pub-id pub-id-type="doi">10.1371/journal.pbio.1000527</pub-id>
<pub-id pub-id-type="pmid">21072242</pub-id></mixed-citation>
</ref>
<ref id="B369">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>M. E.</given-names></name><name><surname>Majewska</surname><given-names>A. K.</given-names></name></person-group> (<year>2011</year>). <article-title>A role for microglia in synaptic plasticity?</article-title>
<source/><italic>Commun. Integr. Biol.</italic>
<volume>4</volume>
<fpage>220</fpage>–<lpage>222</lpage>. <pub-id pub-id-type="doi">10.4161/cib.4.2.14506</pub-id>
<pub-id pub-id-type="pmid">21655446</pub-id></mixed-citation>
</ref>
<ref id="B370">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trotta</surname><given-names>T.</given-names></name><name><surname>Panaro</surname><given-names>M. A.</given-names></name><name><surname>Cianciulli</surname><given-names>A.</given-names></name><name><surname>Mori</surname><given-names>G.</given-names></name><name><surname>Di Benedetto</surname><given-names>A.</given-names></name><name><surname>Porro</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Microglia-derived extracellular vesicles in Alzheimer’s Disease: a double-edged sword.</article-title>
<source/><italic>Biochem. Pharmacol.</italic>
<volume>148</volume>
<fpage>184</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2017.12.020</pub-id>
<pub-id pub-id-type="pmid">29305855</pub-id></mixed-citation>
</ref>
<ref id="B371">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truman</surname><given-names>L. A.</given-names></name><name><surname>Ford</surname><given-names>C. A.</given-names></name><name><surname>Pasikowska</surname><given-names>M.</given-names></name><name><surname>Pound</surname><given-names>J. D.</given-names></name><name><surname>Wilkinson</surname><given-names>S. J.</given-names></name><name><surname>Dumitriu</surname><given-names>I. E.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis.</article-title>
<source/><italic>Blood</italic>
<volume>112</volume>
<fpage>5026</fpage>–<lpage>5036</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2008-06-162404</pub-id>
<pub-id pub-id-type="pmid">18799722</pub-id></mixed-citation>
</ref>
<ref id="B372">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrin</surname><given-names>N. P.</given-names></name><name><surname>Rivest</surname><given-names>S.</given-names></name></person-group> (<year>2006</year>). <article-title>Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>26</volume>
<fpage>143</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4032-05.2006</pub-id><pub-id pub-id-type="pmid">16399681</pub-id></mixed-citation>
</ref>
<ref id="B373">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tynan</surname><given-names>R. J.</given-names></name><name><surname>Naicker</surname><given-names>S.</given-names></name><name><surname>Hinwood</surname><given-names>M.</given-names></name><name><surname>Nalivaiko</surname><given-names>E.</given-names></name><name><surname>Buller</surname><given-names>K. M.</given-names></name><name><surname>Pow</surname><given-names>D. V.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>24</volume>
<fpage>1058</fpage>–<lpage>1068</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2010.02.001</pub-id>
<pub-id pub-id-type="pmid">20153418</pub-id></mixed-citation>
</ref>
<ref id="B374">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>M.</given-names></name><name><surname>Fujita</surname><given-names>Y.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Kikuta</surname><given-names>J.</given-names></name><name><surname>Ishii</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Layer V cortical neurons require microglial support for survival during postnatal development.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>16</volume>
<fpage>543</fpage>–<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3358</pub-id>
<pub-id pub-id-type="pmid">23525041</pub-id></mixed-citation>
</ref>
<ref id="B375">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulmann</surname><given-names>L.</given-names></name><name><surname>Levavasseur</surname><given-names>F.</given-names></name><name><surname>Avignone</surname><given-names>E.</given-names></name><name><surname>Peyroutou</surname><given-names>R.</given-names></name><name><surname>Hirbec</surname><given-names>H.</given-names></name><name><surname>Audinat</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Involvement of P2X4 receptors in hippocampal microglial activation after status epilepticus.</article-title>
<source/><italic>Glia</italic>
<volume>61</volume>
<fpage>1306</fpage>–<lpage>1319</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22516</pub-id>
<pub-id pub-id-type="pmid">23828736</pub-id></mixed-citation>
</ref>
<ref id="B376">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vakilian</surname><given-names>A.</given-names></name><name><surname>Khorramdelazad</surname><given-names>H.</given-names></name><name><surname>Heidari</surname><given-names>P.</given-names></name><name><surname>Sheikh Rezaei</surname><given-names>Z.</given-names></name><name><surname>Hassanshahi</surname><given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>CCL2/CCR2 signaling pathway in glioblastoma multiforme.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>103</volume>
<fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2016.12.013</pub-id>
<pub-id pub-id-type="pmid">28025034</pub-id></mixed-citation>
</ref>
<ref id="B377">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valdinocci</surname><given-names>D.</given-names></name><name><surname>Radford</surname><given-names>R. A.</given-names></name><name><surname>Siow</surname><given-names>S. M.</given-names></name><name><surname>Chung</surname><given-names>R. S.</given-names></name><name><surname>Pountney</surname><given-names>D. L.</given-names></name></person-group> (<year>2017</year>). <article-title>Potential modes of intercellular alpha-synuclein transmission.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>18</volume>:<issue>E469</issue>. <pub-id pub-id-type="doi">10.3390/ijms18020469</pub-id>
<pub-id pub-id-type="pmid">28241427</pub-id></mixed-citation>
</ref>
<ref id="B378">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Beek</surname><given-names>E. M.</given-names></name><name><surname>Cochrane</surname><given-names>F.</given-names></name><name><surname>Barclay</surname><given-names>A. N.</given-names></name><name><surname>van den Berg</surname><given-names>T. K.</given-names></name></person-group> (<year>2005</year>). <article-title>Signal regulatory proteins in the immune system.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>175</volume>
<fpage>7781</fpage>–<lpage>7787</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.175.12.7781</pub-id><pub-id pub-id-type="pmid">16339510</pub-id></mixed-citation>
</ref>
<ref id="B379">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Berckel</surname><given-names>B. N.</given-names></name><name><surname>Bossong</surname><given-names>M. G.</given-names></name><name><surname>Boellaard</surname><given-names>R.</given-names></name><name><surname>Kloet</surname><given-names>R.</given-names></name><name><surname>Schuitemaker</surname><given-names>A.</given-names></name><name><surname>Caspers</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>64</volume>
<fpage>820</fpage>–<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2008.04.025</pub-id>
<pub-id pub-id-type="pmid">18534557</pub-id></mixed-citation>
</ref>
<ref id="B380">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Weering</surname><given-names>H. R.</given-names></name><name><surname>de Jong</surname><given-names>A. P.</given-names></name><name><surname>de Haas</surname><given-names>A. H.</given-names></name><name><surname>Biber</surname><given-names>K. P.</given-names></name><name><surname>Boddeke</surname><given-names>H. W.</given-names></name></person-group> (<year>2010</year>). <article-title>CCL21-induced calcium transients and proliferation in primary mouse astrocytes: CXCR3-dependent and independent responses.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>24</volume>
<fpage>768</fpage>–<lpage>775</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2009.04.007</pub-id>
<pub-id pub-id-type="pmid">19401230</pub-id></mixed-citation>
</ref>
<ref id="B381">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varnum</surname><given-names>M. M.</given-names></name><name><surname>Kiyota</surname><given-names>T.</given-names></name><name><surname>Ingraham</surname><given-names>K. L.</given-names></name><name><surname>Ikezu</surname><given-names>S.</given-names></name><name><surname>Ikezu</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>The anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer’s disease.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>36</volume>
<fpage>2995</fpage>–<lpage>3007</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.07.027</pub-id>
<pub-id pub-id-type="pmid">26315370</pub-id></mixed-citation>
</ref>
<ref id="B382">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vass</surname><given-names>K.</given-names></name><name><surname>Lassmann</surname><given-names>H.</given-names></name></person-group> (<year>1990</year>). <article-title>Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system.</article-title>
<source/><italic>Am. J. Pathol.</italic>
<volume>137</volume>
<fpage>789</fpage>–<lpage>800</lpage>. <pub-id pub-id-type="pmid">2121041</pub-id></mixed-citation>
</ref>
<ref id="B383">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vereker</surname><given-names>E.</given-names></name><name><surname>O’Donnell</surname><given-names>E.</given-names></name><name><surname>Lynch</surname><given-names>M. A.</given-names></name></person-group> (<year>2000</year>). <article-title>The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>20</volume>
<fpage>6811</fpage>–<lpage>6819</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-18-06811.2000</pub-id>
<pub-id pub-id-type="pmid">10995825</pub-id></mixed-citation>
</ref>
<ref id="B384">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verney</surname><given-names>C.</given-names></name><name><surname>Monier</surname><given-names>A.</given-names></name><name><surname>Fallet-Bianco</surname><given-names>C.</given-names></name><name><surname>Gressens</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Early microglial colonization of the human forebrain and possible involvement in periventricular white-matter injury of preterm infants.</article-title>
<source/><italic>J. Anat.</italic>
<volume>217</volume>
<fpage>436</fpage>–<lpage>448</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7580.2010.01245.x</pub-id>
<pub-id pub-id-type="pmid">20557401</pub-id></mixed-citation>
</ref>
<ref id="B385">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilette</surname><given-names>D.</given-names></name><name><surname>Courte</surname><given-names>J.</given-names></name><name><surname>Peyrin</surname><given-names>J. M.</given-names></name><name><surname>Coudert</surname><given-names>L.</given-names></name><name><surname>Schaeffer</surname><given-names>L.</given-names></name><name><surname>Andreoletti</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Cellular mechanisms responsible for cell-to-cell spreading of prions.</article-title>
<source/><italic>Cell. Mol. Life Sci.</italic>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="doi">10.1007/s00018-018-2823-y</pub-id>
<pub-id pub-id-type="pmid">29761205</pub-id></mixed-citation>
</ref>
<ref id="B386">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Bernhardi</surname><given-names>R.</given-names></name><name><surname>Heredia</surname><given-names>F.</given-names></name><name><surname>Salgado</surname><given-names>N.</given-names></name><name><surname>Munoz</surname><given-names>P.</given-names></name></person-group> (<year>2016</year>). <article-title>Microglia function in the normal brain.</article-title>
<source/><italic>Adv. Exp. Med. Biol.</italic>
<volume>949</volume>
<fpage>67</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-40764-7_4</pub-id>
<pub-id pub-id-type="pmid">27714685</pub-id></mixed-citation>
</ref>
<ref id="B387">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakselman</surname><given-names>S.</given-names></name><name><surname>Bechade</surname><given-names>C.</given-names></name><name><surname>Roumier</surname><given-names>A.</given-names></name><name><surname>Bernard</surname><given-names>D.</given-names></name><name><surname>Triller</surname><given-names>A.</given-names></name><name><surname>Bessis</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>8138</fpage>–<lpage>8143</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1006-08.2008</pub-id>
<pub-id pub-id-type="pmid">18685038</pub-id></mixed-citation>
</ref>
<ref id="B388">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>F. R.</given-names></name><name><surname>Nilsson</surname><given-names>M.</given-names></name><name><surname>Jones</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Acute and chronic stress-induced disturbances of microglial plasticity, phenotype and function.</article-title>
<source/><italic>Curr. Drug Targets</italic>
<volume>14</volume>
<fpage>1262</fpage>–<lpage>1276</lpage>. <pub-id pub-id-type="doi">10.2174/13894501113149990208</pub-id>
<pub-id pub-id-type="pmid">24020974</pub-id></mixed-citation>
</ref>
<ref id="B389">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J. W.</given-names></name><name><surname>Chen</surname><given-names>S. D.</given-names></name><name><surname>Zhang</surname><given-names>X. L.</given-names></name><name><surname>Jonas</surname><given-names>J. B.</given-names></name></person-group> (<year>2016</year>). <article-title>Retinal microglia in glaucoma.</article-title>
<source/><italic>J. Glaucoma</italic>
<volume>25</volume>
<fpage>459</fpage>–<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1097/IJG.0000000000000200</pub-id>
<pub-id pub-id-type="pmid">25646715</pub-id></mixed-citation>
</ref>
<ref id="B390">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Ulland</surname><given-names>T. K.</given-names></name><name><surname>Ulrich</surname><given-names>J. D.</given-names></name><name><surname>Song</surname><given-names>W.</given-names></name><name><surname>Tzaferis</surname><given-names>J. A.</given-names></name><name><surname>Hole</surname><given-names>J. T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques.</article-title>
<source/><italic>J. Exp. Med.</italic>
<volume>213</volume>
<fpage>667</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20151948</pub-id>
<pub-id pub-id-type="pmid">27091843</pub-id></mixed-citation>
</ref>
<ref id="B391">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S. C.</given-names></name><name><surname>Hong</surname><given-names>J. H.</given-names></name><name><surname>Hsueh</surname><given-names>C.</given-names></name><name><surname>Chiang</surname><given-names>C. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model.</article-title>
<source/><italic>Lab. Invest.</italic>
<volume>92</volume>
<fpage>151</fpage>–<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.2011.128</pub-id>
<pub-id pub-id-type="pmid">21894147</pub-id></mixed-citation>
</ref>
<ref id="B392">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Nowrangi</surname><given-names>D.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Lu</surname><given-names>T.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice.</article-title>
<source/><italic>J. Neuroinflamm.</italic>
<volume>15</volume>:<issue>2</issue>. <pub-id pub-id-type="doi">10.1186/s12974-017-1039-7</pub-id>
<pub-id pub-id-type="pmid">29301581</pub-id></mixed-citation>
</ref>
<ref id="B393">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Balaji</surname><given-names>V.</given-names></name><name><surname>Kaniyappan</surname><given-names>S.</given-names></name><name><surname>Kruger</surname><given-names>L.</given-names></name><name><surname>Irsen</surname><given-names>S.</given-names></name><name><surname>Tepper</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The release and trans-synaptic transmission of Tau via exosomes.</article-title>
<source/><italic>Mol. Neurodegener.</italic>
<volume>12</volume>:<issue>5</issue>. <pub-id pub-id-type="doi">10.1186/s13024-016-0143-y</pub-id>
<pub-id pub-id-type="pmid">28086931</pub-id></mixed-citation>
</ref>
<ref id="B394">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Cella</surname><given-names>M.</given-names></name><name><surname>Mallinson</surname><given-names>K.</given-names></name><name><surname>Ulrich</surname><given-names>J. D.</given-names></name><name><surname>Young</surname><given-names>K. L.</given-names></name><name><surname>Robinette</surname><given-names>M. L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model.</article-title>
<source/><italic>Cell</italic>
<volume>160</volume>
<fpage>1061</fpage>–<lpage>1071</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.01.049</pub-id>
<pub-id pub-id-type="pmid">25728668</pub-id></mixed-citation>
</ref>
<ref id="B395">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wesolowska</surname><given-names>A.</given-names></name><name><surname>Kwiatkowska</surname><given-names>A.</given-names></name><name><surname>Slomnicki</surname><given-names>L.</given-names></name><name><surname>Dembinski</surname><given-names>M.</given-names></name><name><surname>Master</surname><given-names>A.</given-names></name><name><surname>Sliwa</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Microglia-derived TGF-beta as an important regulator of glioblastoma invasion–an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.</article-title>
<source/><italic>Oncogene</italic>
<volume>27</volume>
<fpage>918</fpage>–<lpage>930</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1210683</pub-id>
<pub-id pub-id-type="pmid">17684491</pub-id></mixed-citation>
</ref>
<ref id="B396">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieghofer</surname><given-names>P.</given-names></name><name><surname>Prinz</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Genetic manipulation of microglia during brain development and disease.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1862</volume>
<fpage>299</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2015.09.019</pub-id>
<pub-id pub-id-type="pmid">26432479</pub-id></mixed-citation>
</ref>
<ref id="B397">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wohleb</surname><given-names>E. S.</given-names></name></person-group> (<year>2016</year>). <article-title>Neuron-microglia interactions in mental health disorders: “for better, and for worse”.</article-title>
<source/><italic>Front. Immunol.</italic>
<volume>7</volume>:<issue>544</issue>. <pub-id pub-id-type="pmid">27965671</pub-id></mixed-citation>
</ref>
<ref id="B398">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>Y.</given-names></name><name><surname>Yona</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>K. W.</given-names></name><name><surname>Jung</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Microglia, seen from the CX3CR1 angle.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>7</volume>:<issue>26</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2013.00026</pub-id>
<pub-id pub-id-type="pmid">23507975</pub-id></mixed-citation>
</ref>
<ref id="B399">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>G. J.</given-names></name><name><surname>Jones</surname><given-names>M.</given-names></name><name><surname>Puklavec</surname><given-names>M. J.</given-names></name><name><surname>Brown</surname><given-names>M. H.</given-names></name><name><surname>Barclay</surname><given-names>A. N.</given-names></name></person-group> (<year>2001</year>). <article-title>The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans.</article-title>
<source/><italic>Immunology</italic>
<volume>102</volume>
<fpage>173</fpage>–<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2567.2001.01163.x</pub-id>
<pub-id pub-id-type="pmid">11260322</pub-id></mixed-citation>
</ref>
<ref id="B400">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>A.</given-names></name><name><surname>Wei</surname><given-names>J.</given-names></name><name><surname>Kong</surname><given-names>L. Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Priebe</surname><given-names>W.</given-names></name><name><surname>Qiao</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Glioma cancer stem cells induce immunosuppressive macrophages/microglia.</article-title>
<source/><italic>Neuro Oncol.</italic>
<volume>12</volume>
<fpage>1113</fpage>–<lpage>1125</lpage>. <pub-id pub-id-type="doi">10.1093/neuonc/noq082</pub-id>
<pub-id pub-id-type="pmid">20667896</pub-id></mixed-citation>
</ref>
<ref id="B401">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Bie</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>J. J.</given-names></name><name><surname>Brown</surname><given-names>D. L.</given-names></name><name><surname>Naguib</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>34</volume>
<fpage>2843</fpage>–<lpage>2852</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2013.06.003</pub-id>
<pub-id pub-id-type="pmid">23855980</pub-id></mixed-citation>
</ref>
<ref id="B402">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>X.</given-names></name><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Lou</surname><given-names>F.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Monocytes, microglia, and CD200-CD200R1 signaling are essential in the transmission of inflammation from the periphery to the central nervous system.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>141</volume>
<fpage>222</fpage>–<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13972</pub-id>
<pub-id pub-id-type="pmid">28164283</pub-id></mixed-citation>
</ref>
<ref id="B403">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamuro</surname><given-names>K.</given-names></name><name><surname>Kimoto</surname><given-names>S.</given-names></name><name><surname>Rosen</surname><given-names>K. M.</given-names></name><name><surname>Kishimoto</surname><given-names>T.</given-names></name><name><surname>Makinodan</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Potential primary roles of glial cells in the mechanisms of psychiatric disorders.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>9</volume>:<issue>154</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2015.00154</pub-id></mixed-citation>
</ref>
<ref id="B404">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>I.</given-names></name><name><surname>Han</surname><given-names>S. J.</given-names></name><name><surname>Kaur</surname><given-names>G.</given-names></name><name><surname>Crane</surname><given-names>C.</given-names></name><name><surname>Parsa</surname><given-names>A. T.</given-names></name></person-group> (<year>2010</year>). <article-title>The role of microglia in central nervous system immunity and glioma immunology.</article-title>
<source/><italic>J. Clin. Neurosci.</italic>
<volume>17</volume>
<fpage>6</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.jocn.2009.05.006</pub-id>
<pub-id pub-id-type="pmid">19926287</pub-id></mixed-citation>
</ref>
<ref id="B405">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Boza-Serrano</surname><given-names>A.</given-names></name><name><surname>Dunning</surname><given-names>C. J. R.</given-names></name><name><surname>Clausen</surname><given-names>B. H.</given-names></name><name><surname>Lambertsen</surname><given-names>K. L.</given-names></name><name><surname>Deierborg</surname><given-names>T.</given-names></name></person-group> (<year>2018a</year>). <article-title>Inflammation leads to distinct populations of extracellular vesicles from microglia.</article-title>
<source/><italic>J. Neuroinflamm.</italic>
<volume>15</volume>:<issue>168</issue>. <pub-id pub-id-type="doi">10.1186/s12974-018-1204-7</pub-id>
<pub-id pub-id-type="pmid">29807527</pub-id></mixed-citation>
</ref>
<ref id="B406">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>X. J.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2018b</year>). <article-title>Loss of neuronal CD200 contributed to microglial activation after acute cerebral ischemia in mice.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>678</volume>
<fpage>48</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2018.05.004</pub-id>
<pub-id pub-id-type="pmid">29729356</pub-id></mixed-citation>
</ref>
<ref id="B407">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group> (<year>2011</year>). <article-title>Brain-derived neurotrophic factor (BDNF) infusion restored astrocytic plasticity in the hippocampus of a rat model of depression.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>503</volume>
<fpage>15</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2011.07.055</pub-id>
<pub-id pub-id-type="pmid">21843601</pub-id></mixed-citation>
</ref>
<ref id="B408">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Z. C.</given-names></name><name><surname>Sontheimer</surname><given-names>H.</given-names></name></person-group> (<year>1999</year>). <article-title>Glioma cells release excitotoxic concentrations of glutamate.</article-title>
<source/><italic>Cancer Res.</italic>
<volume>59</volume>
<fpage>4383</fpage>–<lpage>4391</lpage>.<pub-id pub-id-type="pmid">10485487</pub-id></mixed-citation>
</ref>
<ref id="B409">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>F. L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Tom</surname><given-names>I.</given-names></name><name><surname>Gonzalez</surname><given-names>L. C.</given-names></name><name><surname>Sheng</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>TREM2 binds to apolipoproteins, including APOE and CLU/APOJ, and thereby facilitates uptake of amyloid-beta by microglia.</article-title>
<source/><italic>Neuron</italic>
<volume>91</volume>
<fpage>328</fpage>–<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.06.015</pub-id>
<pub-id pub-id-type="pmid">27477018</pub-id></mixed-citation>
</ref>
<ref id="B410">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>M. H.</given-names></name><name><surname>Zhang</surname><given-names>E.</given-names></name><name><surname>Kang</surname><given-names>J. W.</given-names></name><name><surname>Shin</surname><given-names>Y. N.</given-names></name><name><surname>Byun</surname><given-names>J. Y.</given-names></name><name><surname>Oh</surname><given-names>S. H.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Expression of CD200 in alternative activation of microglia following an excitotoxic lesion in the mouse hippocampus.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1481</volume>
<fpage>90</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2012.08.053</pub-id>
<pub-id pub-id-type="pmid">22975132</pub-id></mixed-citation>
</ref>
<ref id="B411">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yirmiya</surname><given-names>R.</given-names></name><name><surname>Rimmerman</surname><given-names>N.</given-names></name><name><surname>Reshef</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Depression as a microglial disease.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>38</volume>
<fpage>637</fpage>–<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2015.08.001</pub-id>
<pub-id pub-id-type="pmid">26442697</pub-id></mixed-citation>
</ref>
<ref id="B412">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>P.</given-names></name><name><surname>Condello</surname><given-names>C.</given-names></name><name><surname>Keene</surname><given-names>C. D.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Bird</surname><given-names>T. D.</given-names></name><name><surname>Paul</surname><given-names>S. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy.</article-title>
<source/><italic>Neuron</italic>
<volume>90</volume>
<fpage>724</fpage>–<lpage>739</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.05.003</pub-id>
<pub-id pub-id-type="pmid">27196974</pub-id></mixed-citation>
</ref>
<ref id="B413">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuyama</surname><given-names>K.</given-names></name><name><surname>Igarashi</surname><given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Physiological and pathological roles of exosomes in the nervous system.</article-title>
<source/><italic>Biomol. Concepts</italic>
<volume>7</volume>
<fpage>53</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1515/bmc-2015-0033</pub-id>
<pub-id pub-id-type="pmid">26812803</pub-id></mixed-citation>
</ref>
<ref id="B414">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuyama</surname><given-names>K.</given-names></name><name><surname>Igarashi</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Exosomes as carriers of alzheimer’s amyloid-ss.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>11</volume>:<issue>229</issue>
<pub-id pub-id-type="doi">10.3389/fnins.2017.00229</pub-id></mixed-citation>
</ref>
<ref id="B415">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuyama</surname><given-names>K.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Usuki</surname><given-names>S.</given-names></name><name><surname>Sakai</surname><given-names>S.</given-names></name><name><surname>Hanamatsu</surname><given-names>H.</given-names></name><name><surname>Mioka</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>A potential function for neuronal exosomes: sequestering intracerebral amyloid-beta peptide.</article-title>
<source/><italic>FEBS Lett.</italic>
<volume>589</volume>
<fpage>84</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2014.11.027</pub-id>
<pub-id pub-id-type="pmid">25436414</pub-id></mixed-citation>
</ref>
<ref id="B416">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaborowski</surname><given-names>M. P.</given-names></name><name><surname>Balaj</surname><given-names>L.</given-names></name><name><surname>Breakefield</surname><given-names>X. O.</given-names></name><name><surname>Lai</surname><given-names>C. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Extracellular vesicles: composition, biological relevance, and methods of study.</article-title>
<source/><italic>Bioscience</italic>
<volume>65</volume>
<fpage>783</fpage>–<lpage>797</lpage>. <pub-id pub-id-type="doi">10.1093/biosci/biv084</pub-id>
<pub-id pub-id-type="pmid">26955082</pub-id></mixed-citation>
</ref>
<ref id="B417">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zalesky</surname><given-names>A.</given-names></name><name><surname>Fornito</surname><given-names>A.</given-names></name><name><surname>Seal</surname><given-names>M. L.</given-names></name><name><surname>Cocchi</surname><given-names>L.</given-names></name><name><surname>Westin</surname><given-names>C. F.</given-names></name><name><surname>Bullmore</surname><given-names>E. T.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Disrupted axonal fiber connectivity in schizophrenia.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>69</volume>
<fpage>80</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.08.022</pub-id>
<pub-id pub-id-type="pmid">21035793</pub-id></mixed-citation>
</ref>
<ref id="B418">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanier</surname><given-names>E. R.</given-names></name><name><surname>Marchesi</surname><given-names>F.</given-names></name><name><surname>Ortolano</surname><given-names>F.</given-names></name><name><surname>Perego</surname><given-names>C.</given-names></name><name><surname>Arabian</surname><given-names>M.</given-names></name><name><surname>Zoerle</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Fractalkine receptor deficiency is associated with early protection but late worsening of outcome following brain trauma in mice.</article-title>
<source/><italic>J. Neurotr.</italic>
<volume>33</volume>
<fpage>1060</fpage>–<lpage>1072</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2015.4041</pub-id>
<pub-id pub-id-type="pmid">26180940</pub-id></mixed-citation>
</ref>
<ref id="B419">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeilhofer</surname><given-names>H. U.</given-names></name></person-group> (<year>2008</year>). <article-title>Loss of glycinergic and GABAergic inhibition in chronic pain–contributions of inflammation and microglia.</article-title>
<source/><italic>Int. Immunopharmacol.</italic>
<volume>8</volume>
<fpage>182</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2007.07.009</pub-id>
<pub-id pub-id-type="pmid">18182224</pub-id></mixed-citation>
</ref>
<ref id="B420">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>H.</given-names></name><name><surname>Heppner</surname><given-names>F. L.</given-names></name><name><surname>Tsirka</surname><given-names>S. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Microglia/macrophages promote glioma progression.</article-title>
<source/><italic>Glia</italic>
<volume>59</volume>
<fpage>472</fpage>–<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1002/glia.21117</pub-id>
<pub-id pub-id-type="pmid">21264953</pub-id></mixed-citation>
</ref>
<ref id="B421">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>Y.</given-names></name><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Sforazzini</surname><given-names>F.</given-names></name><name><surname>Weinhard</surname><given-names>L.</given-names></name><name><surname>Bolasco</surname><given-names>G.</given-names></name><name><surname>Pagani</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>17</volume>
<fpage>400</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3641</pub-id>
<pub-id pub-id-type="pmid">24487234</pub-id></mixed-citation>
</ref>
<ref id="B422">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Yin</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name></person-group> (<year>2018</year>). <article-title>CD200-, CX3CL1-, and TREM2-mediated neuron-microglia interactions and their involvements in Alzheimer’s disease.</article-title>
<source/><italic>Rev. Neurosci.</italic>
<comment>[Epub ahead of print]</comment>.</mixed-citation>
</ref>
<ref id="B423">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Eitan</surname><given-names>E.</given-names></name><name><surname>Wu</surname><given-names>T. Y.</given-names></name><name><surname>Mattson</surname><given-names>M. P.</given-names></name></person-group> (<year>2018</year>). <article-title>Intercellular transfer of pathogenic alpha-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>61</volume>
<fpage>52</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2017.09.016</pub-id>
<pub-id pub-id-type="pmid">29035751</pub-id></mixed-citation>
</ref>
<ref id="B424">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Abels</surname><given-names>E. R.</given-names></name><name><surname>Redzic</surname><given-names>J. S.</given-names></name><name><surname>Margulis</surname><given-names>J.</given-names></name><name><surname>Finkbeiner</surname><given-names>S.</given-names></name><name><surname>Breakefield</surname><given-names>X. O.</given-names></name></person-group> (<year>2016</year>). <article-title>Potential transfer of polyglutamine and CAG-Repeat RNA in extracellular vesicles in huntington’s disease: background and evaluation in cell culture.</article-title>
<source/><italic>Cell Mol. Neurobiol.</italic>
<volume>36</volume>
<fpage>459</fpage>–<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-016-0350-7</pub-id>
<pub-id pub-id-type="pmid">26951563</pub-id></mixed-citation>
</ref>
<ref id="B425">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X. Y.</given-names></name><name><surname>Zhou</surname><given-names>D. F.</given-names></name><name><surname>Wu</surname><given-names>G. Y.</given-names></name><name><surname>Cao</surname><given-names>L. Y.</given-names></name><name><surname>Tan</surname><given-names>Y. L.</given-names></name><name><surname>Haile</surname><given-names>C. N.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>33</volume>
<fpage>2200</fpage>–<lpage>2205</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1301619</pub-id>
<pub-id pub-id-type="pmid">17987059</pub-id></mixed-citation>
</ref>
<ref id="B426">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Manaenko</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>P.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Activation of dopamine D2 receptor suppresses neuroinflammation through alphab-crystalline by inhibition of nf-kappab nuclear translocation in experimental ICH mice model.</article-title>
<source/><italic>Stroke</italic>
<volume>46</volume>
<fpage>2637</fpage>–<lpage>2646</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.115.009792</pub-id>
<pub-id pub-id-type="pmid">26251254</pub-id></mixed-citation>
</ref>
<ref id="B427">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Jia</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>C. C.</given-names></name><name><surname>Rong</surname><given-names>Z.</given-names></name><name><surname>Zhong</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>TREM2 promotes microglial survival by activating wnt/beta-catenin pathway.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>37</volume>
<fpage>1772</fpage>–<lpage>1784</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2459-16.2017</pub-id>
<pub-id pub-id-type="pmid">28077724</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>